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CHAPTER 1 
GENERAL INTRODUCTION AND AIM OF THE STUDY 
Partially based on: 
Nuclear genes of human complex I of the mitochondrial electron transport chain: state 
of the art 
Human Molecular Genetics 1998 7:1573-1579 
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Chapter 1 
Energy production, storage and use are just as essential for cells as fuels are to the world 
economy. The provision of energy in mammalian cells is one of the most intriguing yet 
immense complex aspects of cellular function, with tentacles spreading to all corners of the 
cell. Mitochondria are the power plants of eukaryotic cells, which maintain an adequate 
cellular energy status. By means of a process called respiration, mitochondria convert 
nutrients into the energy-yielding compound adenosine triphosphate (ATP) to fuel the cell's 
activities. 
ATP synthesis. 
One of the main sources of ATP in the aerobic state of the cell is glucose. The complete 
oxidation of glucose to HiO and CO? can be divided in three main parts: 
I. Glycolysis, 
II. Citric acid cycle, 
III. Oxidative phosphorylation. 
Glycolysis takes place in the cytoplasm of the cell. The overall reaction contains the 
conversion of the six-carbon compound glucose into two three-carbon molecules of pyruvate. 
A total of nine enzymatic steps are necessary to complete this conversion (Fig. 1.1). The net 
reaction of this transformation is: 
glucose + IP, + 2ADP + 2NAD+ -> 2pyruvate + 2ATP + 2NADH + 2H+ + 2H2O 
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Figure 1.1 The glycolytic pathway l=Hcxokmasc; 2=Phosphoglucose isomerjse, 3=Phosphofruclokinase-l, 
4=Aldolase; 5=Triose phosphate isomcrasc, 6=Glyccraldchyde 3-phosphale dehydrogenase; 7=Phosphoglycera(e 
kinase, 8=Phosphoglyccromutasc, 9=Enolase, 10=Pyruvale kinase 
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Under anaerobic conditions, pyruvate is mainly converted into lactate by the enzyme lactate 
dehydrogenase, resulting in the overall reaction 
Pyruvate + NADH + H+ ^ > Lactate + NAD+ 
The regeneration of NAD+ maintains the operation of glycolysis under anaerobic conditions 
Lactic acid is mainly secreted into the bloodstream, atter which it is processed by the liver 
Here the lactate is reoxidised into pyruvate, which is either further metabolised into CO2 or 
converted into glucose The heart can maintain aerobic metabolism at times when skeletal 
muscle already converts pyruvate into lactate (e g during prolonged exercise) Therefore the 
heart can provide a serious contribution to the clearance ol lactic acid from the blood 
Under aerobic conditions, pyruvate is transported trom the cytoplasm into the matrix of the 
mitochondrion Immediately on entering the matrix, pyruvate reacts with Coenzyme A to 
generate CO? and acetyl-CoA This highly exergonic conversion is catalysed by the Pyruvate 
Dehydrogenase complex (PDHc) 
pyruvate + CoA + NAD+ -» acetyl-CoA + CO2 + NADH + H+ 
Acetyl-CoA enters the citric acid cycle (Krebs cycle) where it is further processed (Fig 1 2) 
Fatty acids are released into the blood, from which they are taken up and oxidised by most 
cells On the outer mitochondrial membrane, free fatty acids are coupled to Coenzyme A by 
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Figure 1 2 The citric acid cycle l=Citratc synthase 2 + 1= Acomtase 4=Iso(.itrate dehydrogenase 
5=a Ketoglutarate dehydrogenase complex 6=Siiccinyl CoA synthetase 7=Succinale dehydrogenase 
8=Fumarase 9=Malate dehydrogenase 
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acyl-CoA synthetase to form an acyl-CoA. This is an endcrgonic reaction, which is linked to 
the hydrolysis of ATP. Long-chain acyl-CoA molecules cannot traverse the inner 
mitochondrial membrane and are carried across this membrane by carnitine. Carnitine 
palmitoyl transferase I transfers the acyl group from acyl-CoA to carnitine, after which the 
acyl-carnitine is transported across the inner mitochondrial membrane by carnitine 
acylcarnitine translocase. The acyl group is then reattached to CoA by carnitine palmitoyl 
transferase II, by which the acyl-CoA is regenerated. In a cyclic process, which is called 
ß-oxidation, the acyl-CoA is shortened by two carbon atoms (acetyl-CoA). Concomitantly, 
one molecule of NAD+ and FAD are reduced to NADH and FADHi. This cycle continues 
until all carbon atoms are converted into acetyl-CoA, which enters the citric acid cycle. 
The citric acid cycle consists of nine reactions (Fig. 1.2) with the net result: 
acetyl-CoA + 3NAD+ + FAD + GDP + P, + 2H 2 0 -> 2 C 0 2 + 3NADH + FADH2 + GTP + 
2H+ + CoA 
Several reactions of glycolysis, citric acid cycle and ß-oxidation result in the reduction of 
NAD+ and FAD to NADH and FADH2, respectively. These reduced coenzymes are reoxidised 
by molecular oxygen in a multi-step process called oxidative phosphorylation (Fig. 1.3). The 
overall reaction of the oxidation of NADH is: 
NADH + H+ + VTOÌ-* NAD+ + HjO 
During the oxidation of NADH two electrons are released. In contrary to protons, electrons 
cannot exist in aqueous solutions. The electrons are therefore transported to oxygen via four 
multi-protein complexes together constituting the respiratory chain, which is embedded in the 
inner mitochondrial membrane. This transport is thermodynamically downhill and much of 
the released energy is conserved by the movement of protons from the mitochondrial matrix to 
the intermilochondrial membrane space. 
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Figure 1.3 The oxidalive phosphorylation system. I = complex I (NADH:uhiquinone oxidoreduclase), 
II = complex II (succinatc:ubiquinonc oxidoreduclase). U = ubiquinone. Ill = complex III 
(uhiquinonexytochromc c oxidoreduclase), C = cytochrome c. IV = complex IV (cytochrome c oxidase), 
V = complex V (ATP synlhase). IMS = inlermembrane space; e = eleclron. 
12 
General introduction and aim of the \tud\ 
Briefly, NADH donates two electrons to the first complex of the respiratory chain, which is 
called NADH ubiquinone oxidoreductase or complex I The electrons travel through the 
prosthetic groups of complex I towards ubiquinone (U) also called Coenzyme Q (CoQ) 
FADH2 also transfers its electrons to ubiquinone but via succinate ubiquinone oxidoreductase 
or complex II Ubiquinone transports the electrons to ubiquinone cytochrome c 
oxidoreductase or complex III Cytochrome t accepts the electrons from complex III and 
transfers them to cytochrome c oxidase which catalyses the reduction of oxygen As 
mentioned previously, energy which is released by this electron transport is preserved by the 
translocation of protons across the inner mitochondrial membrane For each two electrons 
accepted Irom NADH, complex I transports four protons towards the intermembrane space, 
complex III two and complex IV four, which adds up to a total of ten protons Since complex 
II does not translocate protons, two electrons donated by FADH? result in the total 
translocation of six protons across the inner mitochondrial membrane The created proton 
gradient is used by ATP synthase or complex V to generate ATP The respiratory chain 
together with ATP synthase is called the oxidative phosphorylation (OXPHOS) system In the 
next section I will focus on the first and largest complex of the respiratory chain (also the 
main subject ol this thesis) complex I 
Complex I. 
Evolution, composition and (spatial and junctional) organisation of complex I 
Although complex I studies have been performed in many species, most knowledge regarding 
the composition, spatial and functional organisation of the first mitochondrial electron 
transport chain (mtETC) enzyme complex has been obtained from Escherichia coli. 
Neurospora crassa and Bos taurus (Hatefi 1985, Weiss et al 1991, Walker 1992, Walker et al 
1992, Weidner et al 1993, Guenebaut et al 1997, Grigoneff 1998) Many bacteria (like E coli) 
contain two NADH dehydrogenases, which are called NDH-I and NDH-II (Yagi 1993, 
Weidner et al 1993) NDH-I is like mitochondrial complex I, a multiple-protein enzyme 
complex and links electron transport to proton translocation It contains many redox centres, 
namely one flavine mononucleotide (FMN) and possibly up to nine Fe-S clusters (Friedrich 
1998) NDH-I is built up of fourteen subumts, which have been named NADH ubiquinone 
oxidoreductase (Nuo) A to Ν (in some bacteria Nuo C and D are lused to NuoCD) and is 
generally considered to be the minimal form of a proton-pumping NADH ubiquinone 
oxidoreductase (Leif et al 1993, Table 1 1, page 16) NDH-II is a single polypeptide enzyme, 
which is in practice a non-proton pumping NADH ubiquinone oxidoreductase 
Complex I ol E coli can be fragmented into three parts, an NADH dehydrogenase fragment, a 
connecting fragment and a membrane fragment (Leif et al 1993) The NADH dehydrogenase 
part consists of NuoE, F and G containing the NADH binding site, the FMN and four electron 
paramagnetic detectable iron-sulphur clusters (Friedrich 1998), and is considered to be the 
electron input part of complex I The connecting fragment is made up of NuoB, CD and I and 
contains Iron-Sulphur cluster N2 (Leif et al 1995) Finally, the membrane fragment is built of 
NuoA, H and J-N Little is known about the functions of the membrane part of E coli 
complex I It probably participates in the binding of ubiquinone and the transport of protons 
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(Friedrich 1998) 
Complex I of the fungus /V eras m has a dual genetic origin The majority ol its proteins are 
encoded by the nucleus, synthesised in the cytoplasm and imported into mitochondria, where 
they assemble together with several mitochondrial encoded proteins into the complete 
complex Ν crassa contains a complex I which probably consists of at least 35 different 
proteins of which 7 are encoded by mtDNA (Weiss el al 1991, Table 1 1) Currently, not all 
subumts are characterised at cDNA level All subumts which are present in NDH-I of bacteria 
are present in the eukaryotic complex I of Ν crassa As mentioned previously, Ν crassa 
complex I appears under the electron microscope as an L-shaped structure, with one arm 
embedded in the mitochondrial membrane, while the other arm protrudes into the matrix 
(Guenebaut et al 1997) So far, the FMN and only tour Fe-S clusters have been identified 
Besides the subumts which are also present in the minimal form of complex I seen in bacteria, 
many additional proteins are present m complex I of JV crassa In many cases they do not 
seem to have similarity to other proteins It has been speculated that many of these proteins 
isolate the complex in order to prevent electrons from escaping the enzyme (Friedrich and 
Weiss 1997) 
Experiments performed with Ν e rassa cells, in which radioactivity of pulse-labelled amino 
acids was followed, showed that the membrane arm and the arm protruding into the matrix are 
separately assembled (Tuschen et al 1990) These findings were confirmed in Ν crassa using 
disruption experiments of single complex I genes In addition, the membrane arm seems to be 
synthesised by fusion of two intermediates (Schulte et al 1994) The crystal structure of the JV 
craw« complex has been determined and, by immunolabelhng, the 49 kDa subunit has been 
pinpointed to the matrix-localised protruding arm of the complex (Guenebaut et al 1997) 
Immunolabelhng of other subumts will give lurthcr insight into the interrelationships of the 
various subumts 
The species evolutionary closest to man of which complex I has been studied extensively is 
Bos taurus Bovine complex I has -42 subumts (Table 1 1) with a total molecular mass of 
-900 kDa It consists ol seven mitochondrial- and at least 35 nuclear-encoded subumts and 
has, like in Ν crassa an L-shaped configuration of which the peripheral arm protrudes in the 
mitochondrial matrix (Guenebaut et al 1997, Grigorieft 1998) The bovine complex differs 
trom that ot Ν crassa by having a thin stalk region linking the membrane-bound globular arm 
with the intrinsic membrane domain It is however clear that the form of complex I is highly 
conserved between prokaryotes like E colt and eukaryotes like Ν crassa and Bos taurus 
(Friedrich 1998, Grigorieft 1998) Most of the electron carriers, which exist ol one flavine 
mononucleotide (FMN) and at least six Fe-S clusters (proven by electron paramagnetic 
resonance imaging (EPR)), are located in the peripheral arm With the use of chaotropic 
agents, the complex can be separated into three different fractions (Galante and Hatefi 1978 
and 1979) The flavoprolein (FP) fraction and the iron-sulphur protein (IP) fraction are both 
water-soluble, whereas the hydrophobic protein (HP) fraction forms a water-insoluble 
aggregate The FP traction (51, 24 and 10 kDa) and the IP traction (75, 49, 30, 18, 15, 13 kDa, 
Β13 and TYKY) form the principal catalytic sector and arc located in the peripheral arm of 
the complex (Belogrudov and Hatcti 1994) Whether the TYKY subunit is present in the IP 
Iraclion or in the HP traction is subject of debate Masui and co-workers located the TYKY 
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subunit in the IP fraction (Masui et al 1991), while others did not Since the prokaryotic 
TYKY equivalent (Nuol) is present in the connecting fragment (located between the 
dehydrogenase fragment and the membrane fragment), it could be possible that slight 
differences in the complex I purification and fractionation process result in the presence of 
TYKY in different fractions The HP fraction (containing the seven mitochondrial encoded 
subumts and -24 nuclear encoded subumts) is probably involved in proton translocation 
(Ohmshi et al 1985, Belogrudov and Hatefi 1994) This traction contains, besides 
hydrophobic subumts, also globular water-soluble ones and the presence of a particular 
subunit in this traction should not be taken to imply that the protein is either hydrophobic or a 
component of the membrane part of the enzyme complex (Walker 1992). 
Most aspects of complex 1 function regarding electron and proton transport are unknown, 
however some aspects have been elucidated The 51 kDa FP subunit carries the NADH-
binding site (Chen and Guillory 1981, Deng et al 1990), contains an FMN and a tetranuclear 
iron-sulphur cluster (Pilkington et al 1991) The 24 kDa FP subunit contains a binuclear iron-
sulphur cluster (Pilkington and Walker 1989) The 75 kDa IP subunit contains a tetranuclear 
and a binuclear iron-sulphur cluster (Runswick et al 1989) Sequencing of the bovine TYKY 
(23 kDa) IP subunit revealed that this subunit contains two cysteine motifs, which probably 
provide the hgands to accommodate two 4Fe-4S clusters (Dupuis et al 1991) Such a 
conserved cysteine motif has also been encountered in the PSST (20 kDa) HP subunit (Walker 
1992) The FP and IP water-soluble fractions make contact through the 51 kDa FP and 75 kDa 
IP subumts The FP and IP subunit stoichiometry, which is a sine qua non for the study of the 
structure of an enzyme complex, and the substrate-induced conformational changes have been 
partly elucidated by Belogrudov and Hateli in 1996 They showed that the proximity of the 
three FP subumts to one another, the proximity of the 51 kDa FP subunit to the 75 kDa IP 
subunit, and the proximity of all studied IP subumts to one another and to some of the HP 
subumts are altered when the catalytic sector of complex I is reduced by NADH or NADPH 
prior to the addition of a cross-linking reagent The authors speculated that these 
conformational changes may well be the device by which the energy denved from electron 
transfer through the catalytic components ot complex I is transduced and conveyed to the 
subumts of the membrane sector Here, pKj changes of appropriate residues induced by these 
conformational changes would result in proton uptake and release on opposite sides of the 
membrane 
Table 1 I lists the subunit composition of bacterial complex I (14 subumts), complex I ol Ν 
crassa (-35 subumts, currently not all molecular-genetically characterised) and Β taurus (-42 
subumts) The prokaryotic subumts (NuoA-N) are present in all three species and seem to 
form the catalytic core of the complex Ν crassa has numerous additional proteins, several of 
which do not seem to be conserved in Β taurus 
In summary, the overall function of complex I of the mtETC is the dehydrogenation of NADH 
and the transportation of electrons to ubiquinone This electron transport device is linked by a 
yet unknown mechanism to proton transport across the inner mitochondrial membrane to the 
intermembrane space (-4 protons for each two electrons) This proton gradient is the torce 
used for the production of ATP by Fj-Fo ATP-synthase (complex V) 
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E.c 
Name 
NuoA 
NuoB 
NuoC' 
NuoD1 
NuoE 
NuoF 
NuoG 
NuoH 
Nuol 
NuoJ 
NuoK 
NuoL 
NuoM 
NuoN 
-
-
-
-
-
-
-
-
-
-
-
-
-
-
_ 
_ 
_ 
. 
-
_ 
_ 
_ 
. 
. 
. 
. 
_ 
_ 
-
-
_ 
_ 
-
-
_ 
•oli 
kDa 
16.5 
25.1 
68.7 
68.7 
18.6 
49.3 
100.3 
36.2 
20.5 
19.9 
10.8 
66.4 
56.5 
45.7 
N. crassa 
Name 
ND-3 
19.3 kDa 
31 kDa 
49 kDa 
24 kDa 
51 kDa 
78 kDa 
ND-1 
23 kDa 
ND-6 
ND-L4 
ND-5 
ND-4 
ND-2 
-
21.3 kDa 
-
29.9 kDa 
40 kDa 
12.3 kDa 
20.8 kDa 
-
-
-
-
-
14.8 kDa 
-
9.3 kDa 
10.5 kDa 
9.6 kDa 
-
12kDa 
-
-
17.8 kDa 
21 kDa 
12 kDa 
21.3 kDa 
9.5 kDa 
21.3 kDa 
18.3 kDa 
kDa 
6.0 
25.0 
32.3 
54.0 
2X.S 
54.3 
81.7 
41.6 
24 Ί 
9.8 
79.8 
65.8 
24.5 
30.9 
43.0 
20.9 
14.8 
9.3 
10.5 
14 5 
12.3 
2(1 1 
21.0 
12 J 
21.3 
9.3 
21.4 
21.8 
B. taunts 
Name 
ND-3 
PSST 
30 kDa (IP) 
49 kDa (IP) 
24 kDa (FP) 
51kDa(FP) 
75 kDa (IP) 
ND-1 
TYKY (IP) 
ND-6 
ND-4L 
ND-5 
ND-4 
ND-2 
lOkDa(FP) 
AQDQ(IP) 
15 kDa (IP) 
13 kDa (IP) 
B13(1P) 
42 kDa 
39 kDa 
B22 
PDSW 
K.FY1 
PGIV 
ASH1 
SGDH 
BI8 
Β 17.2 
817 
B15 
B14 
B14.5a 
B14.5b 
B12 
B9 
B8 
SDAP 
MLRQ 
AGGG 
MWFE 
MNLL 
-
-
-
-
-
-
_ 
kDa 
13.1 
23.8 
30.3 
49.2 
27.3 
50.7 
79.4 
35.7 
23.9 
19.2 
10.8 
68.3 
53.8 
39.3 
11.9 
19.8 
12.7 
13.4 
13.3 
39.3 
42.8 
21.8 
21.0 
8.8 
20.1 
21.7 
21.6 
16.4 
17.1 
15.5 
15.2 
15.1 
12.7 
14.1 
11.1 
9.3 
11.1 
10.1 
9.3 
12.3 
8.1 
7.0 
Table 1.1 Complex I subunit composition of E. coli. Ν. crassa and Β. taurus. All proteins were retrieved from 
the NCBI protein database, using Basic Local Alignment Search Tool (BLAST, Altschul et al 1990). ' In some 
prokaryotes like E. coli NuoC and NuoD are fused to NuoCD. Subunits that are in the same row arc homologous 
between the species. 
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Human complex I deficiency. 
Among the group of mitochondnocytopathies (estimated incidence 1 10,000 live births, 
Bourgeron et al 1995), isolated complex I deficiency is frequently encountered (von Kleist-
Retzow et al 1998) The primary genetic cause of the observed deficiencies may either be at 
the mtDNA or at the nDNA level Elucidation of the genetic defects of these disorders is 
important for genetic counselling and will extend our knowledge of the functional properties 
of the individual subumts A great variety in clinical presentation, age of onset, course of the 
disease and clinical-chemical abnormalities exists in complex I deficient patients It may 
therefore not come as a surprise that the diagnostic process is rather complicated and that the 
judgement of instituted treatments is almost impossible in individual patients 
In general, most affected tissues are those with a high-energy demand, such as the brain, heart, 
kidney and skeletal muscle Ophthalmological signs like external ophthalmoplegia, ptosis, 
cataract and retinopathy are also frequently observed (Pitkanen et dl 1996) The diagnosis 
'enzymatic complex I deficiency' is often made in early childhood and, although exceptions 
exist, the course is often that of a multi-system disorder with a fatal outcome In most patients 
lactic acidemia (with increased lactate pyruvate ratios due to the altered redox state of the 
mitochondria) is present, although we are aware of several cases of complex I deficiency in 
which lactic acid, even after provocation (exercise, glucose tolerance test), is completely 
normal (this thesis) In order to correlate genotype to phenotype, a detailed clinical description 
ot patients is of utmost importance In suspected patients, diagnosis can be made by enzymatic 
measurements, for which a skeletal muscle biopsy sample is the tissue of choice, cultured 
fibroblasts can also be used Noteworthy in this context is that not all deficiencies observed in 
skeletal muscle specimens are present in fibroblasts (Ruitenbeek et al 1996) This 
phenomenon, together with the diverse involvement of tissues and organs in affected patients, 
may be caused by differences in tissue expression of the individual subumts of the complex 
In nearly all patients, a considerable residual enzymatic activity is observed To the best of our 
knowledge, few patients have been described with an immeasurable low complex I activity 
Under certain conditions prenatal diagnosis of respiratory chain disorders is possible at the 
enzymatic level and has been performed with success in specialised laboratories (Ruitenbeek 
et al 1992 and 1996) Because of the fact that the interpretation of the results of these 
measurements is difficult, it would be very helpful if prenatal diagnosis of complex I 
deficiency would be possible at DNA level One can easily obtain RNA and DNA from 
chorionic villi, on which mutational analysis can be performed by means of RT-PCR followed 
by direct sequencing, or in case of known mutations, by PCR combined with restriction 
fragment length polymorphisms (RFLP) 
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Genetics of OXPHOS disorders. 
a. Mutations in mtDNA. 
Since the first description of a patient with a disturbance in the mitochondrial energy-
generating system by Ernster in 1959, numerous reviews about the mitochondrial electron 
transport chain (mtETC) and delects of its individual complexes have been published 
(Sengers et al 1984, DiMauro et al 1985, Trijbels et al 1988, Lombes et al 1989, Wallace 
1992, Morgan-Hughes 1994, Johns 1995, Tem 1996, Schapira 1998a) 
One of the most intriguing aspects of the OXPHOS system is its dual genomic control About 
30 years ago, the first structural characterisation of human mitochondrial DNA (mtDNA) 
appeared in literature (Clayton and Vinograd 1967, Hudson and Vinograd 1967) The mtDNA, 
a 16,569 base-pair genome is present in several hundred copies per cell, encodes two rRNAs, 
22 iRNAs and 13 mRNAs (Anderson et al 1981, Taanman 1999) The mRNAs encode 
subunits of three of four respiratory chain complexes (7 out of 42 complex I proteins, 1 out of 
11 complex III proteins and 3 out of 13 complex IV proteins) as well as ATP synthase (2 out 
ot 14 proteins) The remaining components of the OXPHOS system as well as all proteins 
involved in its assembly, maintenance and regulation are encoded on the nuclear DNA 
(nDNA) 
Due to its easy accessibility and relatively small genome, mutational analysis studies of 
disorders of the OXPHOS system have the last ten years concentrated on the mtDNA Since 
1988, numerous mtDNA mutations (rearrangements as well as point mutations) have been 
reported to occur in patients with mitochondnocytopathies, of which more than one hundred 
are considered pathogenic (Zeviam et al 1998a, Chinnery and Turnbull 1999) In general, 
mutations ol mtDNA can be divided in major rearrangemenls and point mutations In the 
following sections a brief summary of the most important mtDNA mutations and their 
accompanying clinical phenotypes are described 
Two aspects ol the mitochondrial genome are especially important in the relation between 
mtDNA and OXPHOS deficiencies Firstly, mtDNA is transmitted only by the mother (Giles 
el al 1980) The mtDNA donated by sperm cells to the oocyte alter lerlilisalion is actively 
degraded (Shitaraet al 1998) This maternal inheritance pattern implicates that in the pedigree 
of patients with mtDNA mutations affected siblings can be expected only in the maternal 
lineage and only in the ollspnng ot lemales Secondly, mutated and wild-type mtDNA can 
coexist within a single cell, especially in the case of point mutations This condition is termed 
heteroplasmy When there is heteroplasmy for a given mutation (rearrangements as well as 
point mutations), this suggests either that it arose relatively recent (no time to become 
homoplasmic) or the mutation cannot be tolerated in the homoplasmic state Different 
amounts ol heteroplasmy can be present between adjacent cells It has been hypothesised that 
this feature of different amounts of mtDNA heteroplasmy between patients is responsible for 
the diversity in clinical phenotypes seen in carriers ol the same mtDNA mutation 
Furthermore, it seems likely that a cell needs to cross a certain threshold for mutated mtDNA 
before it gets affected For many mtDNA mutations, a relation has been found between the 
amount ol heteroplasmy and the phenotype (MELAS (Chinnery et al 1997), MERRF 
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(Hammans et al 1993), NARP (Uziel et al 1997) but other lack such a correlation (LHON 
(Ghosh et al 1996)) 
Large-scale rearrangements At the end of the eighties, large-scale rearrangements of mtDNA 
were for the first time linked to specific clinical phenotypes 
Progressive external ophthalmoplegia (PEO, bilateral ptosis, ophthalmoplegia with or without 
general muscle weakness, OMIM 157640, 601226, 601227, 603280, 604005) has been linked 
to large deletions in mtDNA (Moraes et al 1989) It is transmitted in an autosomal-dominant 
manner with male to male transmission, indicating a nuclear gene predisposing to mtDNA 
deletions Linkage analysis mapped PEO to three dillerent regions in different lamihes while 
in a fourth family these three regions were excluded Therefore at least four different nuclear 
genes are involved in PEO (PEO type 1-4), which remain to be elucidated (Suomalainen et al 
1995, Kaukonen et al 1996, Kaukonen et al 1999, Li et al 1999) PEO has also been described 
to inherit in an autosomal-recessive manner, associated with severe cardiomyopathy (Bohlega 
et al 1996) Kearns-Sayre syndrome (OMIM 530000), a disease characterised by 
ophthalmoplegia, pigmentary degeneration of the retina, cardiomyopathy, onset before age ot 
20 and a high protein content in CSF was also linked to a single large deletion of variable 
length in the mtDNA (Zeviam et al 1988, Lestienne and Ponsot 1988, Zeviam et al 1998b) 
Patients with Pearson syndrome (OMIM 557000) suffer from refractory sideroblastic anemia 
with vacuohsation of bonemarrow precursors and exocrine pancreas dysfunction, which has 
been associated with deletions or duplications in the mtDNA (Rotig et al 1989, Superti-Furga 
et al 1993) 
A disorder characterised by multiple deletions of mtDNA is myoneurogastrointestinal 
encephalopathy syndrome (MNGIE, OMIM 550900) (Mirano el al 1994) Recently, Nishino 
and colleagues revealed that the primary genetic defect of MNGIE is located in the gene 
coding for thymidine Phosphorylase (Nishino et al 1999) Besides deletions, also partial 
duplications ot the mtDNA are sometimes seen in mitochondrial myopathy (Poulton el al 
1989) Finally, a clinical phenotype with diabetes insipidus, diabetes mellitus, optic atrophy 
and deafness (DIDMOAD, Wolfram syndrome, OMIM 598500) may be linked to large-scale 
rearrangements (Rotig et al 1993, Bamentos et al 1996) Collier and colleagues however, 
found linkage in families with DIDMOAD patients to chromosome 4pl6 1 (Collier et al 1996) 
and in 1998 Inoue located the gene responsible lor a large percentage ol DIDMOAD patients, 
WFS1 (Inoue et al 1998), which has been confirmed by other groups (Strom et al 1998, Hardy 
et al 1999) 
Usually the inheritance pattern observed in patients with major mtDNA rearrangements is 
sporadic, probably because they occur in the germ-line In rare cases however, a heteroplasmic 
duplication of mtDNA and a large deletion is maternally transmitted in diabetes and dealness 
(Ballmger et al 1992, Dunbar et al 1993) 
Leber's hereditary optic neuropath\ (LHON, OMIM 535000) Many mtDNA point mutations 
have been reported in literature Several ol these mutations are linked to specific clinical 
phenotypes At the end of the eighties, Wallace and colleagues found the G11778A (ND-4) 
mutation in patients with Leber's hereditary optic neuropathy (LHON) (Wallace et al 1988a) 
LHON patients present in mid-life with acute or subacute central vision loss leading to central 
scotoma Other important mutations linked to LHON are the G3460A (ND-1) (Huoponen et al 
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1991, Howell et al 1991), G14459A (ND-6) (Jun et al 1994), T14484C (ND-6) (Mackey and 
Howell 1992) and G15257A (CYT B, Johns and Neuleld 1991) LHON mutations are 
maternally transmitted and are traditionally considered being familial, yet several patients 
have been reported as individual cases Biochemical analysis of the respiratory chain enzymes 
showed that complex I activity can be deficient in patients with LHON Since there seems to 
be a male preponderance present in patients with LHON, influence of an X-hnked nuclear 
gene has been suggested (Vilkki et al 1991) 
LHON and d\itonia The combination of LHON and dystonia is considered to be a separate 
clinical phenotype Two mutations have been found in these patients, namely the G14459A 
(ND-6) (Jun et al 1994) and the Al 1696G (ND-4) (De Vries et al 1996) 
Myotlonu epilepsy with ragged red fibres (MERRF, OMIM 545000) MERRF syndrome is a 
maternally transmitted clinical phenotype linked by Shoftner in 1990 to the mtDNA mutation 
A8344G (tRNA l y s) (Shoftner et al 1990) This mutation accounts for 80-90% of the MERRF 
patients (Shoffner and Wallace 1992) Biochemical studies of the respiratory chain in these 
patients often reveal combined deficiencies, with most prominently affected complex I and 
complex IV (Wallace et al 1988b) The common MERRF mutation has also been found in 
patients with Leigh syndrome, isolated myoclonus, familial lipomatosis and isolated myopathy 
(Silvestri et al 1993) 
Mitochondrial nnopathy, encephalopathy, lactic acidosis and stroke-like episodes (MtLAS, 
OMIM 540000) Another important clinical syndrome that has been connected lo a 
mitochondrial encoded tRNA gene (tRNA'eu) is MELAS Goto and colleagues found in 
several MELAS patients the A3243G mutation, which turned out to be the most common 
MELAS mutation (Goto et al 1990) The clinical phenotype of patients with MELAS is 
extremely diverse (de Vries et al 1994) Diversity is also encountered in the phenolypes 
associated with the A3243G mutation, which can be MELAS, PEO, isolated myopathy, 
cardiomyopathy and diabetes mellitus with deafness (Zeviani et al 1998a) As counts for the 
mutation found in the tRNA'y s gene seen in MERRF, mutations in the tRNAk u gene often 
result in multiple enzyme deficiencies of the respiratory chain, with a preference for complex I 
and IV deficiency 
NARP (OMIM 551500) / MILS (OMIM 516060) Holt et al found a Τ lo G Iransversion at 
nucleotide pair 8993 of the mtDNA (ATPase 6 subunit) in a family with adult-onset 
maternally inherited neurogenic muscle weakness, ataxia and retinitis pigmentosa (NARP) 
(Holt et al 1990) The clinical phenotype varied according to the amount of heteroplasmy 
found in each individual patient This T8993G mutation has also been lound in patients with 
Leigh syndrome (Tatuch et al 1992, Shoffner et al 1992) This form of Leigh syndrome caused 
by a mutation in the ATPase 6 gene, is also indicated in literature by the acronym MILS 
(maternally inherited Leigh syndrome) NARP and MILS can coexist within the same family 
In 1994 hypertrophic cardiomyopathy was added to the list of clinical phenotypes associated 
with the T8993G mutation (Pastores et al 1994) De Vries and colleagues found in 1993 a Τ to 
C transition at position 8993 in patients with juvenile Leigh syndrome (De Vnes el al 1993) It 
is believed that the T8993C mutation results in a milder dysfunction of complex V compared 
to the T8993G mutation The different phenotypes associated with the same mutation could be 
caused by a different amount of heteroplasmy of the mutations in tissues It has been 
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suggested that a higher percentage of mutated mtDNA (T8993G) results in Leigh syndrome, 
while lower amounts might result in NARP (Tatuch et al 1992) 
Parkinson disease (PD). Mitochondrial involvement in PD was a lact when a complex I 
deficiency was found in tissue of the substantia nigra of PD patients (Schapira et al 1989) The 
substantia nigra is the origin of the main clinical features of PD due to degeneration of 
dopaminergic neurons Studies of OXPHOS function in PD patients in other parts of the brain 
and other tissues revealed conflicting results (Schapira 1998b) There is however a uniform 
opinion that there is a complex I deficiency in platelets ot PD patients. The active metabolite 
l-methyl-4-phenylpyridinium (MPP) of the toxin l-methyl-4-phenyl-l,2,3,6-
telrahydropyndine (MPTP) is a selective complex I inhibitor which induces parkinsonism in 
humans This again stresses the possible involvement of complex I in the pathogenesis of PD 
Several studies have been perlormed to locate possible mutations in mitochondnally encoded 
complex I subumts, however with no consistent results Fusion studies between pn cells and 
platelets showed complex I deficiency in cybnds with PD patient platelets compared to 
normal complex I activity when control platelets were used This proves that the complex I 
deficiency in PD patients is ol mitochondrial nature (Gu et al 1998) The exact genetic cause 
remains to be elucidated 
b. Mutations in nDNA. 
Mutations in nuclear encoded subumts of the OXPHOS system were at the start of our study 
in 1997 limited to one Bourgeron and colleagues found an R554W substitution in the Fp 
subunit ol succinate ubiquinone oxidoreductase (complex II) This mutation was lound in two 
siblings born from consanguineous parents, suffering from Leigh syndrome (Bourgeron et al 
1995) 
In case of complex I, no mutations were described in nuclear encoded complex I genes at the 
start of our study At that time, only a few human nuclear encoded complex I subumts were 
charactensed at mRNA and amino acid level, so naturally, mutational analysis studies were 
scarce 
Chapter I 
Aim of the study. 
Many patients and tissue specimens of patients (mainly skeletal muscle and skin fibroblasts 
tissue) arc referred to our centre under suspicion of malfunctioning of the OXPHOS system 
These patients mainly concern children who present their initial symptoms in the first years of 
life Isolated complex I deficiency is a large contributor to this group, however the exact 
percentage at the start of our studies was unknown Patients diagnosed with complex I 
deficiency are always checked lor common mtDNA mutations These mutations are seldom 
encountered, especially in young children The impression exists that isolated complex I 
deficient patients (without common mtDNA mutations) express an autosomal recessive 
inheritance pattern instead of maternal Furthermore, there seems to be a high frequency of 
consanguinity in the families presented to our centre All these factors led to the hypothesis 
that nuclear-genetic causes may be present in our complex I deficient patients, e g situated in 
the nuclear encoded subumts of complex I The principle of our complex 1 enzyme assay is 
measurement of the amount of NADH which is oxidised to NAD+ by complex I in the 
presence of ubiquinone This measurement is performed in the absence and presence of 
rotenone, which is a specific complex I inhibitor Therefore it mainly measures whether the 
flux of electrons from NADH to ubiquinone is working properly Studies performed with Ν 
traiw complex I showed that isolates of the peripheral arm of complex I are capable of 
transporting electrons from NADH to ubiquinone This fragment (of which the IP fraction is 
the main contributor) is therefore one of the main candidates to host defective subumts in our 
complex I deficient patients 
Currently, therapy for the often latal developing complex 1 deficiency is not available It is 
therefore of utmost importance to elucidate the molecular-genetic cause of isolated complex I 
deficiency to offer the possibility of genetic counselling and prenatal diagnostics 
Furthermore, when the genetic cause(s) of complex I deficiency is (are) elucidated, this could 
help us forward in the process of understanding complex I deficiency, which eventually 
should lead to a rational and effective therapy 
At the start of this study the aims were as lollows 
1 Selection and clinical characterisation of an isolated complex I deficient patient group 
2 Exclusion of common mtDNA point mutations and major rearrangements within this 
group 
3 Elucidation of the cDNA and amino acid sequence of all human nuclear encoded complex 
I subumts 
4 Investigation of the presence of mutations in the nuclear genes coding lor Iron sulphur 
protein (IP) fraction subumts of complex I in our patients 
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CHAPTER 2 
ISOLATED COMPLEX I DEFICIENCY IN CHILDREN: CLINICAL, 
BIOCHEMICAL AND GENETIC ASPECTS 
Human Mutation 2000 15:123-134 
Abstract. 
We retrospectively examined clinical and biochemical characteristics of 27 patients with 
isolated enzymatic complex I deficiency (established in cultured skin fibroblasts) in whom 
common pathogenic mtDNA point mutations and major rearrangements were absent Clinical 
phenotypes present in this group are Leigh syndrome (n=7), Leigh-like syndrome (n=6), fatal 
infantile lactic acidosis (n=l), neonatal cardiomyopathy with lactic acidosis (n='i), 
macrocephaly with progressive leukodystrophy (n=2) and a residual group of unspecified 
encephalomyopathy (n=6) subdivided into progressive (n=4) and stable (n=2) variants 
Isolated complex I deficiency is one of the most frequently observed disturbances of the 
OXPHOS system In general, respiratory chain enzyme assays performed in cultured 
fibroblasts and skeletal muscle tissue reveal similar results, but for complete diagnostics we 
recommend enzyme measurements to be performed in at least two different tissues to 
minimise the possibility of overlooking the enzymatic diagnosis Lactate levels in blood and 
CSF and cerebral CT/MRI studies are highly informative, although normal findings do not 
exclude complex I deficiency With the discovery of mutations in nuclear encoded complex I 
subunits, adequate pre- and postnatal counselling becomes available Finally, considering 
information currently available, isolated complex I deficiency in children seems in the 
majority to be caused by mutations in nuclear DNA 
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Introduction. 
Since the first report of a patient with a decreased activity of NADH:ubiquinone 
oxidoreductase (complex I, OMIM 252010) of the mitochondrial respiratory chain by 
Morgan-Hughes and co-workers in 1979, over 100 cases followed, which placed isolated 
complex I deficiency on the map as an important inborn error of energy metabolism. Recent 
studies revealed that within the group of respiratory chain disorders, isolated complex 1 
deficiency is a major contributor (33%; von Kleist-Retzow et al 1998). 
Complex I is a large multi-protein assembly, which is partly located in the mitochondrial 
inner membrane and partly protruding into the matrix (Fig. 2.1). Its main function is transport 
of electrons from NADH to ubiquinone with simultaneous shunting of protons across the 
inner mitochondrial membrane to the intermembrane space. The subunit composition of 
complex I has been elucidated in several eukaryotes, such as Neurospora crassa (Weiss et al 
1991) and Bos taurus (Walker 1992, Skehel et al 1998), which appears to consist of -35 and 
-42 proteins, respectively. Of the 42 subunils present in human complex I, seven are encoded 
by mitochondrial DNA (mtDNA) (Chomyn et al 1986). Complex I can be fragmented by 
chaotropic agents in three different parts (Galante and Hatefi 1979). These parts represent the 
Flavoprotein fraction (FP; composed of three subunits, which contain the NADH-, Flavin 
mononucleotide- and several Fe-S cluster binding sites), the Iron-Sulphur protein fraction (IP; 
composed of approximately seven subunils, which contain several Fe-S cluster binding sites) 
and the residual membrane part called the Hydrophobic protein fraction (HP; contains among 
NADH 
NAD+ + H+ 
Matrix 
Inner 9 
membrane 
Figure 2.1 Human complex I Schematic overview of human complex 1 hlcctrons arc transtcrred Irom NADH 
to ubiquinone through three distincl parts of complex I, namely the Havoprolcin (HP) Iraction, Iron-Sulphur 
proiein (IP) traction and Ihc Hydrophobic prolein (HP) frachon. Simultaneously with this electron transport, 
proions are transported towards the inlermembrane space. U = ubiquinone; FMN = flavin mononucleotide; 
Pe-S = Iron-Sulphur cluster, e = electron 
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others all mitochondrial encoded subumts) In the past few years, 34 of at least 35 human 
nuclear encoded complex I subumts have been characterised (Loeffen et al 1998a, Smeitink 
and van den Heuvel 1999) 
Disorders of the oxidative phosphorylation (OXPHOS) system express a great variety in 
clinical symptoms (De Vivo 1993, Moms el al 1995, Jackson el al 1995, Munnich et al 1996) 
First presentation can occur in infancy with severe encephalopathy leading to early death, as 
well as in adulthood with mild exercise intolerance Similarly, the heredity patterns are also 
diverse varying from evident maternal, autosomal-dominant, autosomal-recessive to sporadic 
and X-hnked In the early 1990s, Robinson and colleagues published about 40-isolated 
complex I deficient patients (Robinson 1993, Pitkanen et al 1996a) These patients expressed 
mainly four clinical phenotypes severe neonatal lactic acidosis (OMIM 245400 Hoppel et al 
1987), teigh syndrome (OMIM 256000, Leigh 1951), cardtomvopath\ with cataract and 
lactic acidosis (OMIM 212350, Pitkanen et al 1996b) and hepatomegah with renal 
tubitlopalh\ (Robinson 1993) 
Some of these well-described clinical entities are clearly associated with mutations in the 
mtDNA Important characteristics ol mtDNA mutations are the maternal inheritance pattern 
(Giles et al 1980), age of disease presentation (often late childhood and adulthood) and 
variability in clinical course and intrafamilial presentation Previously identified mtDNA 
defects causing isolated complex I deficiency are listed in Table 2 1 In general, these 
abnormalities can be divided in two important groups, namely major rearrangements and 
point mutations The mtDNA point mutations linked to isolated complex I deficiency seem to 
concentrate in the iRNA1"11 gene (OMIM 590050), tRNA1 y" gene (OMIM 590060) and the 
ND genes (OMIM 516000-516006) No mutations in nuclear genes have been previously 
reported to cause isolated complex I deficiency 
Our centre examines many tissue specimens of children suspected of OXPHOS disorders 
Respiratory chain enzyme activities are preferably measured in fresh skeletal muscle tissue 
and additionally in cultured skin fibroblasts Evaluation of enzymatic OXPHOS system 
measurements in skeletal muscle over a five year period revealed in 23% of the patients an 
isolated complex I deficiency, which makes it the most frequently found deficiency of the 
OXPHOS system diagnosed in our centre (Table 2 2) Family data concerning these patients 
usually points to autosomal-recessive traits In our experience, screening for common mtDNA 
mutations in these patients is unsatisfactory (in less than 5% of patients suspected of 
OXPHOS disorders, common mtDNA mutations are encountered) Therefore, we started a 
research project concerning mutational analyses studies in nuclear encoded complex I 
subumts as a first step in resolving the suspected nuclear cause of isolated complex I 
deficiency This approach has been successful since we encountered up to now mutations in 
five different pedigrees (OMIM 602141 Loeffen et al 1998b, OMIM 602694 van den Heuvel 
et al 1998, OMIM 601825 Triepels et al 1999a, OMIM 161015 Schuelke et al 1999) 
In the present communication we review clinical, biochemical and genetic characteristics of 
our isolated complex I deficient patient group as established in cultured skin fibroblasts 
(n = 27), who all presented in infancy and young childhood In addition, we summarise data 
concerning mutations in nuclear encoded subumts as encountered in this group up to now and 
discuss the possible role of mtDNA and nuclear DNA (nDNA) mutations in isolated complex 
I deficiency 
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mtDNA 
abnormality 
Deletion 
A3243G 
tRNAk" 
T3250C 
tRNA1™ 
A3251G 
tRNAlc" 
T3271C 
tRNA1"1 
C3303T 
tRNA1"' 
T3394C 
ND1 
G3460A 
ND1 
A8344G 
tRNAly, 
G8363A 
tRNAlys 
Gn778A 
ND4 
G14459A 
ND6 
T14484C 
ND6 
Clinical phenotype 
diabetes. Fanconi syndrome 
cerebellar ataxia, hypogonadotropic 
hypogonadism, choroidal dystrophy 
MELAS 
isolated myopathy 
myopathy with lactic acidosis 
MELAS 
isolated myopathy 
long QT syndrome 
LHON 
MERFF 
MERRF 
LHON 
Leigh syndrome 
LHON 
Reference 
Luder and Barash 1994 
Barrientos et al 1997 
Goto et al 1992 
Ogle et al 1997 
Houshmand et al 1996 
Kirbyetal 1999 
Kirbyetal 1999 
Matsuoka et al 1999 
Howell et al 1991, Majander et al 1991 
Shoffner et al 1990 
Arenas et al 1999 
Larssonetal 1991 
Kirbyetal 1999 
Oostraetal 1995 
Table 2.1 mtDNA deletions and point mutations related to isolated complex I deficiency. 
Isolated deficiencies 
Complex I 
PDHc 
Complex III 
Complex IV 
Sue. cyt. c oxidoreductase 
Complex II 
% Combined deficiencies 
22.7% Complex I+IV 
19.9% Complex I+III 
10.3% Complex I+III+IV 
10.0% Complex I+PDHc 
3.3% Complex I+IV+PDHc 
1.3% Complex IV+PDHc 
Other combinations 
7.9% 
3.0% 
3.9% 
3.6% 
3.3% 
4.8% 
6.0% 
Total 67.5% Total 32.5% 
Table 2.2 Occurrence percentages of isolated and combined OXPHOS disorders (and combinations with 
Pyruvate Dehydrogenase complex (PDHc) deficiency) diagnosed in skeletal muscle tissue, assembled at our 
centre over a five year period (n=331 diagnosed patients). Sue. cyt. c = succinalexylochrome c. 
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Clinical phenotypes. 
We studied clinical, biochemical and genetic aspects of 27 patients (21 males, 6 females), all 
diagnosed with isolated complex I deficiency in fibroblasts Several distinct phenotypes could 
be distinguished Clinical, biochemical and genetic details of these patients are listed in Table 
2 3 The group Fatal Infantile Lactic Acidosis (FILA) is classified separately since they 
suffered from isolated complex I deficiency in fibroblasts, but combined complex I and IV 
deficiency in muscle tissue 
Isolated complex I deficiency in cultured fibroblasts. 
Leigh syndrome (LS) and Leigh like syndrome (LLS ) 
Clinical cntena for the diagnosis of Leigh syndrome (Rahman et al 1996) are summarised in 
Table 2 4 We did not use the cntena concerning increased lactate levels in blood and/or CSF, 
because several of our patients, some with neuropathologically proven Leigh syndrome, do 
not have increased lactate levels in blood and/or CSF The main symptoms observed in our 
patients are listed in Table 2 3 Leigh syndrome was confirmed by the histopathological 
findings post mortem in seven families, but no neuropathological studies were available in six 
patients who are classified as suffering from Leigh-like syndrome All but one patient died 
within the first 5 years of life, six of them died within the first year Two patients showed 
normal lactate levels in blood and CSF (van den Heuvel et al 1998, Tnepels et al 1999a), and 
in one of them (05), lactate levels remained within normal limits even after glucose loading 
Macrocephah nith progressive leukodystrophy (MLD) 
Macrocephaly in association with progressive leukodystrophy was the major clinical feature 
in two of our patients (Table 2 3) Clinical details of these patients have been reported 
previously (Diomsi-Vici et al 1997, Schuelke et al 1999) 
Neonatal cardiomyopathy with lactic acidosis (NCLA) 
Cardiomyopathy, congestive as well as hypertrophic, is a not uncommon sign in respiratory 
chain disorders (Antozzi and Zeviani 1997) Three patients presented at the first day of life 
with symptoms of hypertrophic cardiomyopathy and lactic acidosis One child died after 4 
days, one at the age ot 1 5 months, whereas the third child is currently alive at the age of 6 
months The metabolic acidosis together with the neonatal cardiomyopathy are the only 
abnormalities observed in this latter patient In all three patients there was no sign of cataract 
(the combination of cardiomyopathy, lactic acidosis and cataract has been described as a 
separate clinical entity in complex I deficiency (Pitkanen et al 1996b)) 
Unspecified encephalomyopathy (VE) 
Six of our patients showed variable neuromuscular symptoms that could not be assigned to a 
specific phenotype Virtually all of these patients were psychomotor retarded and had 
decreased muscle tone Four of these patients detenorated and died within 3 years after 
presentation Two patients with a milder disease course expressed relatively unusual 
phenotypes Patient 23 presented at 7 4 years with extrapyramidal signs, muscle weakness and 
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Table 2.3 Clinical, biochemical and genetic characteristics as encountered in our patient group. 
PMR = psychomotor retardation; Resp. = respiratory; RRFs = ragged red fibres; mlhs = months. +" patients are 
brothers; ' control range 0.6-2.1 mmol/l; 4 control range 11.5-16.5; 5 control range 1.4-1.9 mmol/1; 6 control 
range 0.11-0.28 mU/mU cytochrome c oxidase (η=Ι4); 7 control range 0.070-0.25 mU/mU citrate synthase 
(n=20); 8a control range 0.084-0.273 mU/mU citrate synthase (n=13) (homogenate);8b control range 0.101-0.389 
mU/mU cytochrome c oxidase {600x^);8c control range 8.9-27 mU/mg protein (600xg); congestive; average 
of residual complex I activity in fresh and frozen muscle tissue. All complex I activities are expressed as 
percentage of the lowest reference value. Bottom row lists mean values. 
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Criteria of Leigh syndrome. 
Clinical (I^eigh and Leigh-like syndrome): Neuropathological (IMgh syndrome): 
1. Progressive neurological disease with motor and 1. Bilateral, symmetrical spongiform lesions 
2. 
3. 
intellectual developmental delay 
Signs and symptoms of brainstem and/or basal 
ganglia disease 
Characteristic features of Leigh disease on 
neuroimaging 
2. 
3. 
4. 
5. 
6. 
Vacuolation of the neuropil 
Relative sparing of neurons 
Demyelination 
Gliosis 
Capillary proliferation 
Table 2.4 Clinical and neuropathological criteria of Leigh syndrome as published by Rahman et al 1996. 
Palienls whom we classified under Leigh syndrome met the clinical as well as the neuropathological criteria, 
while in palienls with Leigh-like disease no neuropathological studies were performed. 
optic nerve atrophy. The previous history was unremarkable except for mild psychomotor 
retardation. CSF lactate was elevated, but brain MRT and muscle histochemical studies 
revealed no abnormalities. He has remained relatively stable and is currently 10 years old. 
The other patient presented at the age of 9 months with severe ataxia and mild psychomotor 
retardation. Brain MRI showed severe cerebellar destruction while other brain parts were 
completely intact. The boy has subsequently remained stable and is currently 6 years old. 
Isolated complex I deficiency in cultured fibroblasts, combined I and IV deficiency in 
muscle tissue. 
Fatal infantile lactic acidosis (FILA). 
One of the most serious phenotypes associated with OXPHOS disorders in general and 
complex I deficiency in particular is FILA. This phenotype is characterised by extremely high 
lactate levels in blood and CSF and high L/P ratios, indicating a severely disturbed 
NADH/NAD+ ratio and demanding rigorous intervention of respiratory complications and 
severe metabolic acidosis. Three of our patients (all males, two are siblings) presented shortly 
after birth with tachypnoea and extreme metabolic acidosis caused by persistently high levels 
of lactate (Table 2.3). The two brothers rapidly deteriorated, eventually resulting in severe 
cardiorespiratory insufficiency and died within two weeks after birth. The third male infant 
(described previously by Bentlage et al in 1996) presented at birth with similar characteristics. 
All three infants expressed isolated complex 1 deficiency in fibroblasts (complex IV activity 
was repeatedly completely normal in different fibroblast cultures); however in skeletal muscle 
tissue severe complex I and IV deficiencies were found. 
Enzyme studies. 
Activities of respiratory chain enzyme complexes, pyruvate dehydrogenase complex (PDHc) 
and citrate synthase in muscle cells (quadriceps muscle biopsy) and skin fibroblasts (culture) 
were measured using the following enzyme assays (slightly modified): NADH:ubiquinone 
oxidorcductase and succinatexytochrome c oxidoreductase as described by Fischer et al 
(1985 and 1986); cytochrome c oxidase by Coopcrstein and Lazarow (1951); citrate synthase 
by Srere (1969); and PDHc according to van Laack et al (1988). In muscle tissue, enzyme 
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assays were performed in crude homogenates or 600^ supernatants of crude homogenates, 
while in fibroblasts mitochondrial enriched fractions were used The enzyme assays 
performed in cultured skin fibroblasts were slightly modified according to procedures as 
desenbed by Bentlage and co-workers in 1996 We considered a patient isolated complex I 
deficient when the activity was evidently decreased below the reference interval (0 11-0 28 
mU/mU cytochrome c oxidase) in two different fibroblast preparations In contrast to the 
complex I activity in muscle tissue which is usually referenced to citrate synthase activity, 
cytochrome c oxidase has been used as marker enzyme in fibroblasts This is because the 
activity of citrate synthase can be artificially decreased during the mitochondria enrichment 
process of fibroblasts due to leakage out of the mitochondrial matrix The other fibroblast 
respiratory chain enzyme activities had to be within normal limits as determined in a 
representative control population Complex I activity in fibroblasts was reduced in all patients 
(inclusion criterion), with a mean residual activity of 49% ol the lowest control value (range 
24% to 73%, Table 2 3) The complex I activity in skeletal muscle has been measured in 20 
patients In half of these patients, enzyme assays were performed in fresh muscle tissue, while 
in the other half muscle tissue has been deep frozen in liquid nitrogen alter biopsy 
Measurements in Iresh tissue preserve the possibility to measure oxidation rates and ATP and 
CrP production rates All but one patient showed reduced complex I activity (mean 32% of 
the lowest control value, range 9% to 68%, Table 2 3) When residual complex I activities of 
muscle tissue are compared to those of fibroblasts, 8 patients showed a more severely 
decreased activity in skeletal muscle (>15% additional decrease compared to fibroblasts), 10 
patients expressed comparable values (between 0% to 15% variation), while in only 2 patients 
complex I activity was actually higher in skeletal muscle (>I5%) 
Molecular-genetic studies. 
All patients included in our study were screened for major mtDNA rearrangements by a 
previously developed long template PCR technique (Li et al 1995) This revealed a Iragmenl 
of approximately 16 5 kb in all patients Furthermore, the following common pathogenic 
mtDNA mutations were excluded in fibroblasts in our patient group by restriction enzyme 
analysis A3243G (tRNAUu), T3271C (tRNAlxu), G3460A (ND 1), T4160A 
(ND-1), A4317G (tRNAGln), A8344G (tRNA^), T8356C (tRNALys), T8993G/C (ATPase 6), 
Gl 1778A (ND-4), G14459A (ND-6), T14484C (ND-6) 
Up till now, 10 nuclear encoded complex I subumts have been screened in twenty of our 
patients by a combination ol RT-PCR and direct DNA sequencing Candidate genes for 
mutational analysis studies were chosen on the basis of strong conservation during evolution 
and/or speculated functional aspects The NDUFVI (51 kDa) gene revealed an A341V 
mutation in a patient with macrocephaly and progressive leukodystrophy (18) and compound 
heterozygous mutations resulting in a R59X and T423M in two brothers (19 and 20) suffering 
from a progressive unspecified encephalomyopalhy (Schuelke et al 1999) The NDUFS4 (18 
kDa) gene contained a 5 bp duplication in a patient with Leigh-like syndrome (08, van den 
Heuvel et al 1998) A mutation was also found in the NDUFS7 gene (V122M) in two brothers 
with Leigh syndrome (05, Tnepels et al 1999a) and in the NDUFSH gene (compound 
heterozygous mutations resulting in P79L and RI02H in a patient with Leigh syndrome (04, 
V 
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Loeffen et al 1998b) Direct sequencing of the NDUFS5 (15 kDa) (Locffen et al 1999), 
NDUFAl (MWFE) (Loeffen et al 1998c), NDUFB3 (BI2), NDUFB6 (B17) (Smeitink et al 
1998a), NDUFAB1 (SDAP) (Triepels et al 1999b) and the NDUFA8 (PGIV) (Triepels et al 
1998) cDNAs revealed no mutations 
Discussion. 
During the last decade substantial progression has been made in the elucidation of complex I 
composition and its physiological aspects of many prokaryotes and eukaryolcs, including man 
(lor a review see Smeitink et al 1998b) The cDNA structure has been elucidated lor almost 
all known human complex I subumts, while the gene structure has been solved of about seven 
genes Many important genetic aspects ol the complex I subumts remain to be elucidated, like 
transcription and translation regulation, possible tissue specificity, but also interaction 
processes between the nuclear and mitochondrial genomes Also largely unknown is the 
targeting ol complex I proteins towards and into mitochondria, the assembly of complex I and 
the implantation into the inner mitochondrial membrane 
Information concerning pathophysiological aspects ol complex I deficiency remains also 
scarce Studies discussing clinical aspects of complex I deficient patients published by the 
group ol Robinson and very recently by the group of Thorburn and Dahl (Robinson 1993, 
Pitkanen el al 1996a, Kirby et al 1999) describe important clinical aspects, however 
differences with our patient population remain 
In our group of 27 patients a strong male preponderance is present (male temale = 35 1) 
Male predominance in complex I deficiency has been reported previously (Zhuchenko et al 
1996, von Kleist-Retzow et al 1998, Kirby et al 1999) Only one complex I subunit is known 
to be encoded on the X-chromosome (NDUFAl), in which no mutations have been reported 
The mean age at presentation in the entire group was 4 6 months All but five patients have 
died within the first five years of life (mean age of survival after first presentation among the 
deceased patients was 8 6 months) 67% of our patients died in the first two years of life Four 
of the survivors express a relatively stable course though severely disabled From this data it 
can be concluded that life expectancy of patients with an isolated complex I deficiency is very 
poor 
We distinguished six dillerent phenotypes within our patient group Leigh syndrome, Leigh-
hke syndrome, macrocephaly with progressive leukodystrophy, neonatal cardiomyopathy 
with lactic acidosis, unspecified encephalomyopathy (progressive or stable) and fatal infantile 
lactic acidosis (FILA) Compared to the phenotypes described by Robinson and Thorburn 
similarities, but also differences can be observed Both studies describe in keeping with our 
study Leigh syndrome as an important, if not the most important phenotype in isolated 
complex I deficiency 26% of our patient group was neuropathologically proven to suffer 
from this clinical entity When Leigh-like patients are added to this group the percentage 
increases to 48% Leigh syndrome is more and more recognised as an important phenotype in 
disorders of energy metabolism in general and complex I deficiency in particular (Morns et al 
1996, Rahman et al 1996) It is possible that most if not all patients present in our Leigh-like 
group are actually patients suffering from Leigh syndrome Neuropathological studies, which 
provide the ultimate evidence, were not performed in these patients 
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Cardiomyopathy is an important and often observed finding in disorders of energy 
metabolism In this study, eight patients suffered Irom cardiomyopathy O0%), which was in 7 
patients hypertrophic and in 1 patient congestive (Table 2 λ) The only two patients in our 
group with signs of RRFs suffered from cardiomyopathy RRFs are often associated with 
mutations in structural genes of the mtDNA We excluded the most common mtDNA 
mutations, however the possibility of unrecognised mutations remains The facts that family 
history in both patients (especially the maternal lineage) was negative for neuromuscular 
disorders and parents were consanguineous points in the direction of autosomal-recessive 
inheritance The phenotype of the two patients with RRFs did not differ significantly from the 
other patients in their group Robinson and colleagues have published several patients with 
cardiomyopathy, cataract and complex I deficiency All eight patients with cardiomyopathy in 
our group showed no signs of lens opacities Several patients have been described by our 
centre with a characteristic phenotype of cardiomyopathy and cataract but without complex I 
deficiency (Sengers et al 1985, Smeitink et al 1989) Patients classified in our residual group 
presented mainly with symptoms of encephalomyopathy Additional diagnostic studies could 
not provide further clues for a more defined phenotype and autopsy has not been performed 
Two patients in this group are alive at this moment and express a relatively stable course It is 
possible that mtDNA mutations, which tend to cause a more prolonged stable course are 
present in these latter two patients, yet family history did not provide evidence lor maternal 
inheritance and common mtDNA mutations were not encountered 
An important diagnostic determinant in disorders of energy metabolism is the lactate 
concentration m blood and CSF Twenty-three of our patients (85%) clearly expressed 
elevated blood lactate levels, while in four patients blood lactate remained within normal 
limits CSF lactate was measured in twenty-one patients, and turned out elevated in all but 
two patients (90%) The two patients with normal lactate levels in CSF also expressed normal 
lactate levels in blood Importantly, in both of these patients mutations have been found in 
nuclear encoded subumts of complex 1 (NDUFS7 and NDUFS4, respectively) Two of the 
patients with normal lactate levels in blood actually did have elevated lactate levels in CSF 
Strikingly, both patients expressed a relatively stable course It is possible that lactate levels 
change during the disease process They can be normal in relatively "good" disease periods, 
while they increase during disease worsening Many of the patients admitted to our centre 
have been referred by physicians from general hospitals Increased lactate levels in blood or 
CSF remain an important determinant whether or not to reler to a metabolic disease centre It 
is therefore quite possible that the percentage of elevated lactate levels in complex I 
deficiency is an overestimation of the actual situation Respiratory chain disorders with 
normal lactate levels could remain undetected, although generally lactic acid elevation is the 
rule rather than the exception The results of our study indicate that lactate measurements 
have to be performed in blood as well as CSF However, normal values in blood and CSF 
certainly do not exclude complex I deficiency 
Neuroimaging studies performed in patients suspected of or suffering from disorders of 
energy metabolism are generally considered to be very useful Many abnormalities have been 
reported varying from general brain destruction with wide cavitations, spotlike hypodense 
(CT) or hyperdense (T2 weighted MRI) lesions, cortical atrophy and generalised 
demyelmation In our patient group, CT and/or MRI scans have been made in eighteen 
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patients These resulted in typical lesions e g in basal ganglia in all patients with Leigh and 
Leigh-like syndrome Cortical atrophy was observed in five patients (distributed in different 
clinical subgroups) One patient with clear ataxic symptoms only expressed destructive 
lesions in the cerebellum Brain scans were normal in only one patient Since abnormalities 
seen with neuroimaging are olten present in patients with disorders of energy metabolism, it 
is not generally used for specific diagnostic purposes The importance of (successive) 
neuroimaging is to provide information about the extend of disease and disease progression as 
well as therapeutic effects 
Differences in residual respiratory chain enzyme activities between tissues have been 
previously reported (Bentlage et al 1996) This is especially the case in the three FILA 
patients with isolated complex 1 deficiency in fibroblasts (complex IV activity repeatedly 
normal), whereas complex I and IV were decreased in muscle tissue Fatal infantile lactic 
acidosis (FILA) is characterised by extremely high lactate levels in blood and CSF and high 
L/P ratios, indicating a severely disturbed NADH/NAD+ ratio and demanding rigorous 
intervention ot respiratory complications and severe metabolic acidosis There are several 
explanations possible for these intriguing tissue specific phenomena Tissues can express 
isoforms ot proteins involved in complex I Junction as, for example, has been described for 
complex IV This may concern proteins, which are actually within the complex, but also 
assembly or chaperone proteins In addition, differences in tissue stoichiometry of individual 
subumts may result in different residual complex I activities Since virtually all pathogenic 
mtDNA mutations are heteroplasmic it is also possible that tissues express different amounts 
of mutated mtDNA resulting in different residual activities (especially tRNA mutations are 
prone to result in combined deficiencies) Furthermore, it is possible that complex IV is 
secondarily affected by complex I (e g by oxygen radical production due to mallunctioning of 
complex I), which could be more pronounced in muscle tissue due to its higher energy 
demand Several of these intriguing phenomena are subjects of future studies In several 
patients presented to our centre, respiratory chain enzyme deficiencies were found in muscle 
tissue, while enzyme assays performed in cultured fibroblasts turned out completely normal 
It is therefore important to perform diagnostic studies of the OXPHOS system in at least two 
different tissues 
From the end of the eighties up to now, mutational analysis studies performed in patients with 
OXPHOS disorders mainly concerned mtDNA Shoffner (1996) reported common pathogenic 
mtDNA point mutations and rearrangements in patients with OXPHOS disorders to occur in 
30% of investigated adults and only in 4% ol children Many reports ol pathogenic mtDNA 
mutations describe patients who clinically presented in late childhood and adulthood, 
nevertheless onset in infancy has also been reported A literature study concerning mtDNA 
deletions and point mutations which have been related to isolated complex I deficiency 
revealed 14 mutations (two deletions and twelve point mutations) However, several patients 
have been described with mtDNA mutations in which respiratory chain enzyme assays were 
not performed Most mutations in mitochondrial encoded tRNAs and rRNAs result in 
multiple respiratory chain complex deficiencies, but the possibility of single affected 
complexes in individual patients always remains Mutations in the mitochondrial encoded 
tRNA1-"1 gene can result in isolated complex I deficiency In some of our patients the 
complete mitochondrial encoded tRNA cu gene has been sequenced which revealed no 
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mutations (unpublished results) In the study performed by Kirby and colleagues (Kirby et al 
1999) sequencing of the tRNA1^ of 51 complex I deficient patients revealed just one novel 
mutation and five known mutations 
Many pedigrees in our patient population indicate autosomal-recessive inheritance and family 
history did not reveal patients with similar phenotypes in the maternal lineage Seven non-
related patients were born from consanguineous parents (26%) As a start to elucidate the 
hypothesised nuclear cause of isolated complex I deficiency we sequenced the highly 
conserved structural complex I genes of twenty isolated complex I deficient patients, which 
revealed mutations in seven patients (five pedigrees) Strikingly, five of these patients (three 
pedigrees) expressed a Leigh(-like) phenotype, which was also the case in the published 
patient with a complex II mutation, as well as in the patients with mutations in the Surfeit-1 
gene (Bourgeron et al 1995, van den Heuvel et al 1998, Loeffen et al 1998b, Tiranti et al 
1998, Zhu et al 1998, Tnepels et al 1999a) In both families with more than one affected child 
in which nuclear mutations have been found (V122M in NDUFS7 subunit and R59X and 
T423M in NDUFV1 subunit) the brothers expressed a strongly resembling clinical phenotype 
This is in contrast with mutations found in mtDNA, where affected relatives often express 
variable clinical phenotypes 
In summary, we presented, biochemical, genetic and clinical data concerning 27 patients with 
isolated complex I deficiency expressed in cultured fibroblasts OXPHOS system enzyme 
assays in cultured fibroblasts and skeletal muscle tissue in general reveal similar results, but 
for complete diagnostics, we recommend enzyme measurements to be performed in at least 
two different tissues to minimise the possibility of overlooking the enzymatic diagnosis 
Lactate levels in blood and CSF and cerebral CT/MRI studies are highly informative, though 
normal findings do not exclude complex I deficiency With the discovery of mutations in 
nuclear encoded complex I subumts, adequate pre- and postnatal counselling becomes 
available Finally, considering information currently available, isolated complex I deficiency 
in children seems in the majority to be caused by mutations in the nuclear DNA 
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Introduction. 
The electron transport chain, the final step in the generation of ATP, consists of four protein 
enzyme complexes, of which NADH:ubiquinone oxidoreductase (complex I) is the largest. 
Complex I contains at least 42 subunits, seven of which are encoded by the mitochondrial 
DNA (ND 1-6 and ND4L), nuclear genes encode the remainder (Hatefi 1985, Walker et al 
1992, Robinson 1993). Complex I catalyses the transfer of electrons from NADH to 
ubiquinone, which is coupled to the translocation of hydrogen atoms across the inner 
mitochondrial membrane. Patients described with a (partially) complex I deficiency can 
generally be categorised in two major clinical phenotypes: an isolated myopathy, and a 
multisystem disorder, with predominantly encephalopathy. 
Respiratory chain defects may be inherited as autosomal or X-linked Mendelian traits 
(Orstavik et al 1993, Zhuchenko et al 1996), or in case of certain mutations in mitochondrial 
DNA, as maternal traits. To date, no mutations in a nuclear encoded subunit of complex I 
have been described. In our biochemically proven complex I deficient patients as well as 
among the affected sibs, (latter actually not all biochemically evaluated), we observed a 
strong male preponderance, suggestive for X-linked inheritance. 
Recently, the NDUFAl gene, one of the nuclear encoded complex I genes, was isolated, and 
mapped to chromosome Xq24 (Zhuchenko et al 1996). The NDUFAl gene is composed of 
three exons, and spans about 5.0 kb of genomic DNA. It shows 80% homology to the bovine 
MWFE subunit of complex I. The knowledge of function of the human NDUFAl, and the 
bovine MWFE subunit is very limited. The bovine MWFE subunit is thought to be situated in 
the extrinsic membrane domain of complex I (Walker 1992). 
We now report the results of a mutation analysis study of the NDUFAl gene in a patient 
group with an isolated decreased activity of complex I in cultured skin fibroblasts. We 
describe the offspring distribution of patient families, and we give an outline of the pattern ol 
tissue distribution of the mRNA transcript from the NDUFAl gene. 
Patients, material and methods. 
Seventeen patients (three females, and fourteen males, sex ratio 0.18), with an isolated 
decreased activity of NADH:ubiquinone oxidoreductase measured in cultured skin fibroblasts, 
were selected for a mutation analysis study of the cDNA sequence of the NDUFAl gene. 
Frequently encountered clinical features in our patient group were hypotonia (generalised, 
and/or axial), failure to thrive, seizures, psychomotor retardation, and respiratory distress. 
Lactic acidaemia, increased blood lactate/pyruvate ratio's, and increased cerebrospinal fluid 
lactate, were present in most patients. The patients come from fifteen families (two families 
have two sons represented in the patient group). In eleven families the pedigree could be 
retrieved. Three families (two male, and one female patient) were known with consanguinity. 
The enzymatic activity of complex 1 was measured in cultured skin fibroblasts according to 
established techniques (Bentlage et al 1996). Reference values ranged from 0.11-0.28 mU/mU 
cytochrome c oxidase. Patient values ranged from 0.026 to 0.080 mU/mU cytochrome c 
oxidase. 
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tmue expression and mutation detection 
To examine whether mutations in the NDUFAI gene are a common cause of isolated complex 
1 deficiency, skin fibroblasts from all patients were cultured, and harvested after reaching 
confluency Total RNA was extracted, and 5 μg of RNA was reverse transcribed to cDNA by 
Superscript II RNase Η reverse transcriptase (Life Technologies, The Netherlands), using 
oligo(dT), and random hexanucleotides (Ploos van Amstel et al 1996). A sample of the cDNA 
was amplified by Polymerase Chain Reaction (PCR), using primers designed according to the 
published sequence of the NDUFAI gene The generated PCR fragment spanned the entire 
coding region of the NDUFAI cDNA Both strands were screened for the presence of 
mutations in the cDNA of the NDUFAI subunit by direct sequencing, performed by 
automated sequencing (ABI Prism, model 377 version 2 1 2), using the ABI Prism Taq 
DyeDeoxy terminator cycle sequencing ready reaction kit (Perkin Elmer, The Netherlands) 
A master blot, containing poly(A)+ RNA isolated from various human tissues was purchased 
from Clontech, The Netherlands The quantity ol mRNA spotted for each tissue onto the 
master blot was normalised using eight different housekeeping gene transcripts as probes 
(nbosomal protein S9, ubiquitin, 23 kDa highly basic protein, hypoxanthine guanine 
phosphonhosyl transferase, tubulin, ß-actin, phosphohpase, and glyceraldehyde triphosphate 
dehydrogenase) A cDNA probe homologous to human NDUFAI was prepared by random 
pnmed labelling (Sambrook et al 1989), and hybridised to the master blot The filter was 
washed under stringent conditions, and analysed by autoradiography 
Results. 
The offspring distribution could be determined in eleven families, and consisted of seventeen 
subjects Seven were female, all healthy, ten were male, two healthy, and eight with proven 
decreased activity of complex I, or expressing a clinical phenotype strongly resembling the 
symptoms of the brother/sister in the patient group. 
We analysed the cDNA of the NDUFAI gene of all patients with complex I deficiency for 
abnormalities by direct sequencing, which revealed no mutations, nor polymorphisms We 
compared the transcription levels of NDUFAI mRNA in foetal, and adult human tissues to 
quantify the relative abundance of NDUFAI mRNA We used a dot blot containing carefully 
normalised quantities of poly (A+) RNA from a wide range of human tissues In foetal stages, 
NDUFAI mRNA was detected in all tissues tested without marked differences, but a clearly 
high amount was observed in foetal heart In adult stages dots with higher intensity were seen 
in (in descending order) human heart, skeletal muscle, liver, kidney, and gland tissues (see 
Fig 3 1) A diversity of brain structures expressed a moderate activity of the NDUFAI 
subunit compared to human heart and skeletal muscle 
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Fig. 3.1a Multiple tissue Master blot. The type and position of poly(A+) RNAs and controls dotted on the 
positively charged nylon membrane, subthal. = subthalamic. 
Figure 3.1b Human RNA multiple tissue blot data. Hybridisation was performed with a 
,2P-labelled cDNA probe of the NDUFA1 subunil. 
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tissue expression und mutation detection 
Discussion. 
The purpose of this mutation analysis study was to investigate the hypothesis of X-linked 
inheritance patterns in complex 1 disease as suggested by the strong male preponderance in 
our patientgroup and among the affected children in the sibs group. 
In literature many mutations in mitochondrial encoded genes of subunits of 
NADH:ubiquinone oxidoreductase have been described and linked to specific clinical 
presentations (for a review see Zeviani and Taroni 1994). The fact that in many patients with 
an isolated decreased activity of complex 1, a molecular defect in mtDNA has not been found, 
combined with the fact that at least 35 subunits are encoded on the nuclear genome, make 
defects in nuclear encoded subunits of the NADH:ubiquinone oxidoreductase certainly 
possible. 
Several human nuclear genes encoding for subunits of complex I have been cloned, and 
mapped to a specific chromosome (Procaccio et al 1997, Pata et al 1997, Gu et al 1996, 
Hyslop et al 1996, Hattori et al 1995, de Coo et al 1995, Ali et al 1993), but until now only 
one gene has been located on the X chromosome (Zhuchenko et al 1996). Up to now, no 
mutation analysis studies in nuclear encoded NADH:ubiquinone oxidoreductase subunits 
have been described in literature. 
We selected patients with an isolated decreased activity of complex I measured in cultured 
skin fibroblasts. The mutation analysis study was performed on cDNA obtained from RNA 
isolated out of cultured skin fibroblasts. This study revealed no mutations in the NDUFAI 
cDNA, so we conclude that mutations in this gene are not a frequent cause of isolated 
complex I deficiency. For many genes encoding subunits of NADH:ubiquinone 
oxidoreductase the sequence, and chromosomal localisation remain to be elucidated, so other 
genes responsible for complex I disease might be located on the X chromosome. 
We studied the tissue, and developmental expression of the NDUFAI mRNA because 
measurements of complex I activity in different tissues are not always conclusive. Some 
patients express reduced complex I activity in fibroblasts, others only in muscle or liver. In 
addition, isolated complex I disease gives a variety of clinical phenotypes, possibly because of 
tissue specific, or developmental expression of complex I subunits. The human RNA master 
blot expressed the NDUFAI mRNA in all human tissues present on the blot, and as expected 
a high expression was found in human heart, foetal heart, skeletal muscle, liver, and kidney 
(tissues with high metabolic activity). The central nervous system, known for it's high energy 
demand, is very often affected in complex I disease. Especially the basal nuclei are frequently 
involved in the disease process, which could be reflected in an increased dot intensity seen in 
the putamen compared to whole brain. An alternative explanation for differences of cDNA 
expression of the NDUFAI gene seen on the master blot, is the fact that it reflects the mRNA 
expression of the NDUFAI gene, so there may be a discrepancy between the mRNA 
expression, and the actual enzyme activity. 
We remain looking for other nuclear encoded genes in general, and X-linked genes in 
particular, as candidate for complex I deficiency in our patients. 
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CHAPTER 4 
MOLECULAR CHARACTERISATION AND MUTATIONAL ANALYSIS OF THE 
HUMAN NDUFB6 (B17) SUBUNIT OF THE MITOCHONDRIAL RESPIRATORY 
CHAIN COMPLEX I 
Human Genetics 1998 103:245-250 
Abstract. 
Bovine NADH ubiquinone oxidorcductase (complex I) ol the mitochondrial respiratory chain 
consists of about 35 nuclear-encoded subumts We review the current knowledge ol the 15 
human complex I subumts cloned so far, and report the 567-bp cDNA sequence, the 
chromosomal localisation and the tissue expression ol an additional subunit, the NDUFB6 
subunit The cDNA open reading frame of NDUFB6 comprises 387 bp and encodes a protein 
of 128 amino acids (calculated Mr 15 5 kDa) There is 82 7% and 78 1% homology, 
respectively, at the cDNA and amino acid level with the bovine counterpart The gene of the 
NDUFB6 subunit has been mapped to chromosome 2 A multiple-tissue dot-blot showed 
ubiquitous expression ol the mRNA with relatively higher expression in tissues known for 
their high-energy demand Of these, kidney showed the highest expression Mutational 
analysis of the subunit revealed no mutations or polymorphisms in 20 patients with isolated 
enzymatic complex I deficiency in cultured skin fibroblasts 
51 
Cluipm 4 
Introduction. 
The molecular biology of complex I (NADH ubiquinone oxidorcductase), the first mulli-
subumt enzyme complex of the mitochondrial respiratory chain, has been thoroughly 
investigated in Bos taurus The complex has about 42 subumts with a combined molecular 
mass of 970 kDa (Fearnley et al 1989, Walker 1992, Fearnley el al 1994, Walker 1995, 
Walker et al 1995, Skehel et al 1998) Ol these, seven subumts are encoded by the 
mitochondrial genome (ND1 6, ND4L) (Gibb and Ragan 1990) The remaining subumts are 
encoded by the nuclear genome The results of studies with the fungus Neurospora cmsici and 
bovine studies have revealed important information concerning the spatial and functional 
organisation oi complex 1 (Halefi 1985, Walker 1992, Belogrudov and Hatefi 1994, 
Guenebaut et al 1997) It is likely that, as in Ν crassa bovine complex I has an L-shaped 
configuration with an extrinsic globular domain attached to an intrinsic domain (Walker 1995, 
Guenebaut et al 1997) In the late 1960s, it was lound that most oi the electron carriers of 
complex I, which are predominantly located in the extramembranous part of complex I, can be 
isolated as two water-soluble complexes a flavoprotein (FP) and an iron-sulphur protein (IP) 
fraction (Hatefi and Stempel 1967) Both subcomplexes make contact through the 51- and 75-
kDa subumts (Belogrudov and Hatefi 1994) The FP fraction (51, 24 and 10 kDa) has, in 
contrast to the IP and the water-insoluble aggregate HP (hydrophobic protein fraction), 
catalytic properties (Ohmshi et al 1985) The IP fraction contains at least the 75-, 49-, 30-, 18-, 
15-, Π kDa and Β Π subumts The HP traction contains the seven mitochondrial (mt) DNA-
encoded subumts and about 25 nuclear encoded subumts In man the cDNA or gene structure 
ol complex I has currently been determined for 15 nuclear encoded subumts (Pilkington and 
Walker 1989, Chow et al 1991, Spencer et al 1992, Hyslop et al 1996, Zhuchenko et al 1996, 
Kim et al 1997, Pala et al 1997, Procaccio et al 1997, Ton et al 1997, van den Heuvel et al 
1998) These human complex I subumts, and, if known, their chromosomal localisation are 
summarised in Table 4 1 Information about the function of the individual human subumts is 
limited in man, and only a few mutational analyses have been performed (van den Heuvel et al 
1998, Loeflen et al 1998) Our most important reasons lor investigating the nuclear encoded 
complex I subumts in man are (I) to unravel the origin of the phenotypic complexity 
encountered in patients with inherited complex I deficiency and (2) to develop reliable tools 
for prenatal diagnosis Furthermore, assessment of nuclear mutations in complex I-dcficient 
patients will extend our knowledge ol the functional properties of the individual subumts 
The incidence of mitochondrial disorders, to which complex I deficiencies of the respiratory 
chain belong is approximately 1 10,000 living births (Bourgeron el al 1995) The clinical 
presentation and course ol complex I-dclicicnt patients vary greatly from neonatal death due 
to a multisystem disorder to mild exercise intolerance (Pitkanen et al 1996a) The observed 
differences in complex I-deficient phenotypes may, at least partially, be explained by genetic 
differences in the various complex I subumts So far, only a lew mlDNA mutations have been 
associated with complex I deficiency (Pitkanen et al 1996b) The exact composition of 
complex I, the number of individual subumts and their functional properties may dilfer in 
various developmental stages as well as in various tissues Clay and Ragan (1988) for 
example, showed that rat liver, kidney and lung were lacking the 17- and 18 kDa proteins 
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NDUFB6 (BUI subunit of the mitochondrial respiratory chain complex I 
found in brain, heart and skeletal muscle. 
In an attempt to elucidate the molecular defects in complex l-deficient patients we recently, 
started a research program in order to (I) determine the human cDNA and gene structure of all 
nuclear-encoded subunits of the respiratory chain complex I, (2) determine the chromosomal 
localisation of the various genes of these subunits, (3) obtain information regarding the tissues 
in which this complex is expressed, and, finally, (4) perform a mutational analysis of our 
complex I-deficient patients. By this approach we very recently found the first patient with a 
pathological mutation in one of the nuclear-encoded subunits of this intriguing enzyme 
complex (van den Heuvel et al 1998). Here, we review the present knowledge of human 
nuclear-encoded complex I subunits, and report the characterisation and the results of a 
mutational study of the human NDUFB6 subunit of this complex. 
Human name 
NDUFVI 
NDUFV2' 
NDUFV3 
NDUFSI 
NDUFS4 
NDUFS7 
NDUFS8 
NDUFA1 
NDUFA2 
NDUFA4 
NDUFA5 
NDUFA6 
NDUFB3 
NDUFB5 
NDUFCI 
Bovine name 
51kDa 
24kDa 
lOkDa 
75kDa 
18 kDa (AQDQ) 
PSST 
TYKY 
MWFE 
B8 
MLRQ 
B13 
B14 
B12 
SGDH 
KFYI 
Chromosome 
l l q l3 
18pll.31-ll.2 
21q22.3 
2q33-34 
5 
19pl3 
11 
Xq24-25 
7q32 
Reference 
Spenceretal 1992 
Pi]kington& Walker 1989 
de Coo et al 1997 
Chow et al 1991 
van den Heuvel et al 1998 
Hyslopetal 1996 
Procaccio et al 1997 
Zhuchenko et al 1996 
Ton et al 1997 
Kimelal 1997 
Paia et al 1997 
Ton et al 1997 
Ton et al 1997 
Ton et al 1997 
Ton et al 1997 
Table 4.1 Details of the presently known nuclear-encoded subunits of human complex 1 (human gene 
nomenclature according to (White et al 1997). pseudogene known (NDUFV2PI: chromosome I9ql3.3-ter). 
Material and methods. 
Cloning of the human NDUFB6 cDNA. 
Human NDUFB6 cDNA was obtained by reverse transcription using oligo(dT) and random 
hexamer primers on poly(A)+ RNA isolated from human heart tissue (Clontech, USA). 
Amplification by the polymerase chain reaction (PCR) was performed with cDNA as template 
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according to the protocol for Taq polymerase (Life Technologies, The Netherlands) using 
oligonucleotides 5 AACTAGTCCGTAGTTCGAGGG 3 and ì GGAACAAACTTAGGCTCATAAG 3 
Oligonucleotide sequences were based on several human expressed sequences tags (ESTs) 
resembling the bovine 5 and 3' open reading frame (ORF) of the NDUFB6 subunit The PCR 
product was purified for direct DNA sequencing DNA sequence analysis of both DNA 
strands was performed using Dyedeoxy terminators on an automated ABI 377 sequencer 
according to a protocol provided by the manufacturer (Perkin Elmer, The Netherlands) 
Chromosomal localisation oj the human NDUFB6 gene 
We searched the Genbank sequence-tagged site (STS) database using the cDNA sequence of 
the human NDUFB6 subunit This revealed an STS (Genbank accession number G30I77) of 
75 bp (100% match with the corresponding part of the human NDUFB6 transcript) 
Tissue distribution 
To determine the tissue- and developmental stage specific expression of the NDUFB6 mRNA, 
we used a Human RNA Master Blot (Clontech, USA) The blot was hybridised with an 
[a12P|dCTP-labelled NDUFB6 cDNA probe using Standard Hybridisation Solution 
(Sambrook et al 1989), washed twice with 2x SSC, 1% SDS at 650C, and subjected to 
autoradiography The quantity of mRNA spoiled tor each tissue on the Master Blot was 
normalised using eight different housekeeping gene transcripts as probes (nbosomal protein 
S9, ubiquitin, highly basic 23-kDa protein, hypoxanthine guanine phosphonbosyl transferase, 
tubulin, ß-actin, phospholipase and glyceraldehyde triphosphate dehydrogenase) 
Protein anahsis 
The average hydropathy of the human NDUFB6 subunit was calculated according to the 
procedure described by Kyle and Doohtte (1982), using computer software provided by 
CAOS/CAMM, University ol Nijmegen, The Netherlands 
Mutation detection 
Total RNA was extracted trom cultured skin fibroblasts of 20 patients (16 males, 4 females) 
with isolated complex I deficiency (Loeffen et al 1998) A 5 ^ g sample of RNA was reverse 
transcribed to cDNA in 1 h at 420C with 200 U of Superscript II reverse transcriptase (Life 
Technologies, The Netherlands), using oligo(dT) and random hexamer primers (Ploos van 
Amstel el al 1996) One microliter ol cDNA was subjected to PCR amplification A fragment 
encompassing the entire coding region was generated using the synthetic oligonucleotide 
primers described previously The PCR program consisted of 35 cycles of 60 s 94°C, 60 s 
550C and 60 s 720C The cycles were preceded by an initial denaturation step ol 2 mm at 940C 
and were followed by a final extension of 10 mm at 720C The producls of the PCR were 
analysed on a 2% TBE agarose gel with 0 5 μg/ml ethidium bromide The nucleotide 
sequences ol the PCR products were analysed by direct sequencing using the Taq Dye Deoxy 
Terminator Cycle Sequencing Kit according to the manulacturers recommendations (Perkin 
Elmer, The Netherlands) 
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Results. 
By reverse transcription-PCR using human heart RNA and oligonucleotide primers based 
upon the NDUFB6 cDNA sequence from cow and human ESTs, we obtained a 489-bp cDNA 
fragment of the human nuclear-encoded NDUFB6 gene. This comprises the ORF of 387 bp, 
which encodes a protein of 128 amino acids (Genbank accession number AF035840). The 
human NDUFB6 ORF showed 82.7% homology with the bovine equivalent (Fig. 4.1). The 
amino acid sequence showed 78.1% homology with the bovine NDUFB6 amino acid 
sequence. The calculated molecular weight of the protein encoded by the human NDUFB6 
ORF is 15.5 kDa. 
In contrast to, for example, the 18-kDa subunit (van den Heuvel et al 1998), the human 
NDUFB6 subunit contains no phosphorylation consensus site. Furthermore, no cysteine-rich 
motifs were present in the amino acid sequence. The prediction of the hydropathy of the 
protein, essentially calculated as described by Kyte and Doolittle (1982), revealed that 
approximately 20% of the protein has hydrophobic properties (data not shown). A search of 
the Genbank STS database using the determined human NDUFB6 cDNA sequence revealed a 
specific STS (Genbank accession number G30177) of 75 bp (100% match with the 
corresponding part of the human NDUFB6 subumt transcript), which has been mapped to 
chromosome 2. 
Determination of the tissue distribution showed the highest mRNA level in kidney (Fig. 4.2). 
Expression was also high in putamen, heart, skeletal muscle, liver and lung. In our group of 20 
isolated complex I-deficient patients, none of the following mtDNA mutations were present: 
A3243G (MELAS), T3271C (MELAS), A4317G (MELAS), A8344G (MERFF), T8993G/C 
(NARP/Leigh syndrome). Deletions of mtDNA were excluded by means of the long template 
PCR technique (Li et al 1995), which revealed a single band of 16.5-kb representing the full-
length linearised mtDNA. Furthermore, no mutations or polymorphisms were detected in any 
patient by complete sequencing of the human NDUFB6 ORF. Mutations in the nuclear-
encoded NDUFAl and 18-kDa (AQDQ) subunits have been previously excluded in this cohort 
of patients. 
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Figure 4.1 Human and bovine amino acid and cDNA sequences of the NDUFB6 subuml of NADHubiquinone 
oxidoreduclase. The human and bovine cDNA sequences show 82 T7c homology The bovine sequence was 
obtained from Genbank, USA (accession number X63212). Primers used to generate fragments encoding the 
complete sequence ot the human NDUFB6 cDNA with the polymerase chain reaction are underlined. The open 
reading trame obtained after sequencing is supplemented with bases prior to the ATG and after the TGA with the 
use of expressed sequence lags obtained via Genbank In the part of the figure, which shows amino acid 
similarity between human and bovine, one dot indicates that the amino acids are not identical but have similar 
chemical characteristics 
56 
Molecular characterisation and mutational analysis of the human 
NDUFB6 (817) subunit of the mitochondrial respiratory chain complex I 
8 
whole 
brain 
occipital 
lobe 
c heart 
d testis 
e kidney 
f appendix 
foetal 
brain 
yeast 
h RNA 
100 ng 
amygdala 
putamen 
aorta 
ovary 
liver 
lung 
foetal 
heart 
yeast 
IRNA 
lOOng 
caudate 
nucleus 
cerebel-
lum 
substantia temporal 
nigra lobe 
skeletal 
muscle 
pancreas 
small 
intestine 
foetal 
kidney 
E. coli 
rRNA 
lOOng 
colon 
pituitary 
gland 
spleen 
trachea placenta 
foetal 
liver 
E. coli 
DNA 
100 ng 
cerebral 
cortex 
thalamus 
bladder 
adrenal 
gland 
thymus 
foetal 
spleen 
poly r(A) 
100 ng 
frontal 
lobe 
subthal. 
nucleus 
thyroid 
gland 
peripheral 
leukocyte 
foetal 
thymus 
human 
Coti DNA 
100 ng 
hippo-
campus 
spinal 
cord 
prostate 
salivary 
gland 
lymph 
node 
foetal 
lung 
human 
DNA 
100 ng 
medulla 
oblongata 
stomach 
mammary 
gland 
bone 
marrow 
human 
DNA 
500 ng 
Figure 4.1a Multiple tissue Master blot. The type and position of poly(A+) RNAs and controls dotted on the 
positively charged nylon membrane, subthal. = subthalamic. 
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Figure 4.1b Human RNA multiple tissue Master blot data. Hybridisation was performed with a 
"P-labelled cDNA probe for the NDUFB6 gene. 
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Discussion. 
Complex I of the respiratory chain is embedded in the lipid bilayer of the inner mitochondrial 
membrane In Ν crassa the multiple subumts of this complex form an L-shaped configuration 
of which the extrinsic peripheral arm protrudes into the mitochondrial matrix (Guenebaut et dl 
1997) The three-dimensional structure of the human counterpart is not known The bovine 
NDUFB6 subumt is located in the intrinsic membrane domain of the complex (Walker 1992) 
Based upon the predicted protein analysis, revealing an important hydrophobic segment 
sufficiently long to form a transmembrane α-helix, we assume that, as in bovine, the human 
NDUFB6 subumt is part of the intrinsic membrane domain ol complex I Presumably, the 
human NDUFB6 subumt is, as assumed for bovine (Walker 1992), anchored into the inner 
mitochondrial membrane The more hydrophihc parts of the sequence probably interact with 
globular proteins in the large extrinsic membrane domain of the complex, which protrudes 
into the mitochondrial matrix (Walker 1992) 
Presently, information concerning the function of the human NDUFB6 subumt is lacking 
Based on the obtained results we assume that this subumt has no phosphorylation site Owing 
to the lack of cysteine-nch motifs it is highly unlikely that the human NDUFB6 subumt 
contains a binding site for an Iron-Sulphur cluster The human NDUFB6 ORF is 387 bp long 
and its nucleotide sequence has 82 7% homology with that of the cow The molecular weight 
calculated from the cDNA deducted amino acid sequence is 15 5 kDa The use of STSs has 
enabled the localisation of the NDUFB6 gene to chromosome 2 Multiple tissue dot-blot 
analysis showed the highest mRNA expression of the NDUFB6 subumt in organs known for 
their high-energy demand, with kidney showing the highest expression The latter result 
differs from the mRNA expression we observed in the NDUFA1 NADH ubiquinone 
oxidoreductase subumt (Loeffen et al 1998) 
Deficient activity of complex I of the respiratory chain may result directly from mutations in 
the mlDNA- or nuclear DNA-encoded subumts Apart from the recently found mutation in the 
nuclear-encoded complex I NDUFS4 subumt, various mtDNA mutations have been associated 
with complex I deficiency (Wallace 1992, Robinson 1993) Deletions and common mtDNA 
mutations were not present in our patients However, defects in other classes of genes, such as 
those involved in the regulation and assembly of the complex may also be involved We 
performed a mutational detection study at the RNA level in 20 complex I-deficient patients 
Neither mutations nor polymorphisms were detected in the ORF of the NDUFB6 cDNA of 
these patients However, the promoter region of the NDUtBó gene was not included in Ihis 
study At the moment we are in the process of mutational analysis of the presently known 
nuclear-encoded subumts and characterising presently unknown human nuclear-encoded 
complex I cDNA sequences in order to extend our mutation detection studies By this 
approach we are trying to extend indirectly our knowledge ol the lunction ol the individual 
subumts ot this vital complex Elucidation of the molecular detects in patients may be of great 
importance tor genetic counselling and prenatal diagnosis Currently this is only possible by 
enzymatic measurements in chorionic villi and ammocytes Interpretation ol the results ol 
mutational analysis studies will be more reliable 
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CHAPTER 5 
THE HUMAN NADH:UBIQUINONE OXIDOREDUCTASE NDUFS5 (15 kDa) 
SUBUNIT: cDNA CLONING, CHROMOSOMAL LOCALISATION, TISSUE 
DISTRIBUTION AND THE ABSENCE OF MUTATIONS IN ISOLATED COMPLEX 
I DEFICIENT PATIENTS 
Journal of Inherited Metabolic Disease 1999 22:19-28 
Abstract. 
We have cloned the cDNA of the NDUFS5 subumt (15 kDa) of the human mitochondrial 
respiratory chain complex NADH ubiquinone oxidoreductase (complex I) The open reading 
frame consists of 321 base-pairs, coding for 106 amino acids, with a calculated molecular 
weight (Mr) of 12 5 kDa There is an 81 0% identity with the bovine equivalent on cDNA 
level and 75 5% identity on amino acid basis PCR analysis ot rodent-human somatic cell 
hybrids revealed that the human NDUFS5 gene maps to chromosome 1 The NDUFS5 mRNA 
is expressed ubiquitously in human tissues, with a relative higher expression in human heart, 
skeletal muscle, liver, kidney and foetal heart A mutation detection study of twenty isolated 
enzymatic complex I deficient patients revealed no mutations, or polymorphisms 
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Introduction. 
NADH ubiquinone oxidorcductase (complex I), the first multisubumt inner membrane protein 
complex ot the mitochondrial electron transport chain, transiers two electrons with a high 
energy transfer potential from NADH to ubiquinone Simultaneously to this electron transfer, 
protons are translocated trom the mitochondrial matrix, across the inner mitochondrial 
membrane, to the intermembrane space Subsequently, protons are returned to the 
mitochondrial matrix by complex V, resulting in the generation of ATP, the main carrier of 
free energy in pro- and eukaryolic cells 
Complex I consists ol about 42 polypeptides, seven of which are encoded by the 
mitochondrial genome, nuclear genes encode the remainder (Walker 1992, Walker et al 1992, 
Robinson 1993, Walker 1995) Defects in mitochondrial encoded subunits of complex I have 
been described (Zeviam and Taroni 1994) Up till now, only one mutation in a nuclear 
encoded subunit ot complex I has been reported in literature (this thesis, van den Heuvel et al 
1998) 
Bovine complex I contains a number ol prosthetic groups which are involved in the transfer of 
electrons, namely flavin mononucleotide (FMN), and at least six and possibly eight iron-
sulphur clusters (binuclear and tetranuclear) (Runswick et al 1991, Yamaguchi and Hatefi 
1993, Albracht et al 1996) The bovine 15 kDa subunit is thought to be part of the complex I 
iron-sulphur protein fraction (IP) which is built up of -8 subunits (75, 49, 30, 18, 15, and 13 
kDa subunit, TYKY and the BH subunit) (Hatefi 1985, Ragan and Hatefi 1986, Masui et al 
1991) It is hypothesised that subunits of the IP fraction play a part in the redox reactions 
catalysed by the iron-sulphur clusters 
In the past decade numerous patients with a deficient enzymatic activity ot complex I have 
been reported Clinical phenotypes associated with complex I dehciency are latal neonatal 
lactic acidosis, myopathy with exercise intolerance and lactic acidosis, MELAS 
(mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes), MERRF 
(myoclonus epilepsy, and ragged red fibres), encephalomyopathy of childhood and adult life, 
Leigh syndrome, and Alpers disease (Morris et al 1995) In patients climcdlly suspected to 
suffer from a deficiency of complex I (or one ol the other complexes of the respiratory chain), 
definitive confirmation is usually obtained by biochemical analysis of a skeletal muscle 
biopsy. 
Molecular characterisation of nuclear encoded complex I subunits is of utmost importance, 
since in many isolated complex I dchcicnt patients, no mutations in mitochondrial encoded 
genes related to complex I have been found Mutational analysis studies could reveal nuclear 
delects, which hopefully will increase the understanding ot the function of complex I and its 
individual subunits Genetic diagnostics in chorion villi as well as in patient skin fibroblasts 
(preferred over biochemical diagnostics) then become available 
The cDNA of the Flavoprotein group (FP) subunits (NDUFVl, NDUFV2 and NUDFV3) was 
sequenced by Buddiger et al in 1997, which revealed no pathogenic mutations in a group of 20 
complex I dehcient patients We focus in our patient group on the second important subgroup, 
namely the Iron-Sulphur protein fraction (IP) The human cDNA sequence is known for the 
NDUFS4 (18 kDa) subunit ot complex I (van den Heuvel et al 1998), and a mutation 
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localisation tissue distribution and the absence of mutations m isolated complex I deficient patients 
detection study revealed the first mutation in a nuclear encoded subumt in our group of 
isolated complex I deficient patients This finding suggests other nuclear encoded complex I 
subumts should be taken into consideration as well 
In order to extend our current knowledge regarding the molecular defects of complex I 
deficiency, cloning of the human nuclear encoded complex I subumts is warranted In the 
present communication we report the cDNA sequence, and chromosomal localisation of the 
human NDUFS'S subumt, we describe the tissue distribution of the messenger RNA transcript, 
and data of a mutation detection study performed in twenty patients with an isolated 
deficiency ot NADH ubiquinone oxidoreductase determined in cultured skin fibroblasts 
Patients, material and methods. 
Patient group Twenty patients (four females, sixteen males, sex ratio 1 4) with an isolated 
decreased activity of complex I (measured in all cases in cultured skin fibroblasts), were 
selected for mutation detection on RNA level in the NDUFS5 subumt Age of clinical onset 
vaned from a lew days after birth, to the age ot ten months Thirteen patients deceased before 
the age of two years Clinical phenotypes varied from severe neonatal metabolic acidosis, 
followed by cardiorespiratory distress proceeding to death, to hypotonia and psychomotor 
retardation at the age ol eight months Four families were known with consanguinity 
Strikingly, four patients (20%) had a cardiomyopathy (Loeffen et al 1998) Neither 
mitochondrial DNA deletions, nor common mtDNA pathogenic mutations (A3243G 
(MELAS), T3271C (MELAS), A4317G (MELAS), A8344G (MERRF), T8993G/C 
(NARP/Leigh syndrome)) were present in this patient group In previous studies we searched 
for mutations in the cDNA of the nuclear encoded NDUFA1 (MWFE) and NDUFS4 (18 kDa) 
subumts in our patient group (Loeffen et al 1998, van den Heuvel et al 1998) 
Tissue culture and enzvnte measurements Deep-frozen skin fibroblasts of patients were 
cultured in M-199 medium, after addition of foetal calf serum, glutamine and antibiotics 
(penicillin and streptomycin) according to established procedures Cells were harvested after 
reaching confluency The enzymatic activity of complex I was measured according to 
procedures described by Bentlage et al in 1996 Reference values used ranged from 0 11-0 28 
mU/mU cytochrome c oxidase Patient values ranged from 0 026 to 0 080 mU/mU 
cytochrome c oxidase 
Cloning of the human NDUFS5 subumt Wild type mRNA was obtained from a human heart 
poly A+ RNA pool (Clontech, USA) The pool consisted of seven normal Caucasian males 
and lemdles, age range 20-78 First-strand cDNA was obtained by reverse transcription of 
mRNA by Superscript Π Rnase Η reverse transcriptase (Life Technologies, The Netherlands), 
during 1 hour at 420C in a total volume of 40 μΐ according to established procedures (Ploos 
van Amstel et al 1996) 
Human ESTs (retrieved from Genbank, USA, accession no W72456, W76515), resembling 
the bovine 15 kDa cDNA were used for PCR primer design Amplification was carried out in 
a total volume of 25 μΐ, containing 1 μΐ of cDNA, 2 5 μΐ lOx PCR buffer, 50 ng forward 
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(5'-GCCAGAGAAGAGTCAAGGGC-V), and reverse pnmer (V-CGTAAACAACCTTTCCAGTGG-V), 
0 25 mM dNTPs, 1 5 mM MgCN, and 0 5 unit of Taq Polymerase (Life Technologies, The 
Netherlands). Amplification parameters were as follows- 35 cycles, 1 min denaturation at 
940C, 1 mm. annealing at 550C, and 1 min primer extension at 720C The cycles were 
preceded by an initial denaturation step of 1 mm at 940C, and were lollowed by a linai 
extension of 10 mm. at 720C. 
Mutation detection studies in complex I deficient patients Patient total RNA was isolated 
from cultured skin fibroblasts using RNAzol"" Β (Biosolve, The Netherlands) (Chomczynski 
and Sacchi 1987) RNA was reverse transcribed to first strand cDNA as described before 
PCR conditions were similar as those described for cloning of the human NDUFS5 subunit 
Patient PCR product was purified from a 1% agarose gel, using the QIAquick GEL 
purification kit according to procedures as described by the manufacturer (Qiagen, The 
Netherlands) Both strands were screened for the presence of mutations by direct sequencing 
(ABI Prism, model 377 version 2 1 2), using the ABI Prism"" Taq DyeDeoxy terminator cycle 
sequencing ready reaction kil (Perkin Elmer, The Netherlands). 
Chromosomal localisation of the human NDUFS5 gene 
To determine the chromosomal localisation of the NDUFS5 gene, we performed a PCR on 
genomic DNA extracted from human-rodent somatic hybrid cells, containing defined human 
chromosomes (NIGMS mapping panel 2, Coriell Cell Repository, USA) The forward and 
reverse oligonucleotide used were respectively V-CACATTGGCAAGGGGGAG-V and 
v-ATTTTTACACACTTTGACAAGGAGG V. PCR product was visualised using a 4% agarose gel. 
Tissue distribution of the NDUFS5 mRNA For specific tissue and developmental stage 
expression of the NDUFS5 mRNA, a Human RNA Master Blot"11 (Clontech, USA) was used 
The quantity of RNA spotted for each tissue onto the master blot was normalised using eight 
dillerent housekeeping gene transcripts as probes (nbosomal protein S9, ubiquitin, 23 kDa 
highly basic protein, hypoxanthine guanine phosphonbosyl transferase, tubulin, ß-actin, 
phosphohpase, and glyceraldehyde triphosphate dehydrogenase) Blots were hybridised with a 
a- "P-dCTP labelled cDNA probe, using Standard Hybridisation Solution (Sambrook et al 
1989), washed twice with 2x SSC, 1% SDS at 650C, and were subjected lo autoradiography 
Calculated h\dropath\ of the human NDUFS5 subunit. We calculated the average hydropathy 
of the NDUFS5 subunit, using a method based on the procedure described by Kyte and 
Doohttle (1982). Computer software was used from the National Centre for Computer Aided 
Chemistry and Bioinlormatics (CAOS/CAMM, Nijmegen, The Netherlands) 
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Results. 
cDNA cloning of the human NDUFS5 subumt 
We performed a blast search (Genbank, USA) with the bovine cDNA sequence ot the 15 kDa 
subumt of complex I, which revealed several human ESTs, which we used for designing a 
forward and reverse oligonucleotide to clone the human homologue cDNA obtained after 
reverse transcription of mRNA from a Human Heart Poly A+ RNA pool was used as template 
for PCR We produced a 428 base-pair product (Genbank accession no AF020352), which 
constituted the full-length open reading frame of the human NDUFS5 transcript Fifteen 
expressed sequence tags (ESTs) retrieved from Genbank, which were not available at time of 
sequencing, were used to complete the 5'UTR and 3'UTR (Fig 5 la) The human NDUFS5 
subumt was named according to guidelines lor Human Gene Nomenclature (White et al 
1997) 
cDNA sequence and protein characteristics of the human NDUFS5 subumt 
The human as well as the bovine (15 kDa) NDUFS5 open reading frame consist of 321 
nucleotides coding for 106 amino acids Comparison of the open reading Irame ol the bovine 
15 kDa cDNA with the human equivalent revealed an 81 0% homology on nucleotide 
sequence level (Fig 5 la) Concerning the amino acid sequence, there was a 75 5% homology 
(Fig 5 lb) When amino acids with similar characteristics are considered equal, there is a 
95 3% homology The molecular weight calculated from the amino acid sequence (Mr) is 12 5 
kDa, the hypothetical isoelectric point (pi) is 9 8 The prediction of the hydropathy showed an 
overall hydrophihc protein The 3'UTR contains an AATAAA polyadenylation signal at 
nucleotide position 419 to 424 A poly A site is positioned 16 base-pairs downstream of the 
poly adenylation signal 
A blast search with the human NDUFS5 cDNA-, and amino acid sequence revealed the 
bovine sequence mentioned above and several human ESTs A blast search in mouse and 
residual EST databases (Genbank), revealed several significant matches lor mouse (82% 
identity in 152 base pair overlap, Genbank accession no AA529094) and rat (83% identity in 
119 base pair overlap, Genbank accession no H35001) 
Mutation detec lion m isolated complex I deficient patients 
Mutation detection on cDNA level was performed by PCR using primers specific for the 
human NDUFS5 subumt, followed by automatic DNA sequence analyses ot the entire open 
reading frame of both DNA strands No mutations or polymorphisms were observed in the 
NDUFS5 transcript 
Chromosomal localisation of the human NDUFS5 gene 
To determine the chromosomal localisation of the NDUFS5 gene, we amplified an intronless 
130 base pair part of the 3' region by PCR with genomic DNA extracted from human-rodent 
somatic hybrid cells as template The obtained PCR product was specific for man, and equal 
in size compared to the cDNA fragment A signal was observed in the lane containing 
chromosome 1 (results not shown) 
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Human 
Hum&n 
Bovine 
Bovine 
Human 
Bovine 
Human 
Bovine 
Human 
Bovine 
Human 
Bovine 
Human 
Bovine 
Human 
Human 
-50 
agtgggagcg 
1 
ATGCCTTTCT 
ATGCCTTTCT 
51 
GTTGACAATC 
GATGACAATC 
101 
ATGCTTTTGA 
ATGCTTTTGA 
151 
CGGGCAGAGA 
CGAGCAGAGA 
201 
GCTTCGGCAG 
GCTTCGACAG 
251 
ATAAGCTGAT 
AAAAGCTAAT 
301 
AAGGGGGAGC 
CAGGAGGAAC 
351 
attttcctgt 
401 
cttqtcaaaq 
-40 
gcggccagag 
11 
TGGACATCCA 
TTGATGTGCA 
61 
CAGAGTGGTG 
CAGAGTGCTG 
111 
AAAAGAATGG 
GAAGGAATGG 
161 
AAGAGTGCAA 
AGGAGTGCAA 
211 
AAAACGATGA 
AAAACGATGA 
261 
AAAGGAAGGA 
CAAGGAAGGG 
311 
CTCGGCCCTG 
CTCGGTCCTG 
361 
tctctgttct 
411 
tgtgtaaaaa 
-30 
aagagtcaag 
21 
GAAAAGGTTC 
GAAAAGGCTG 
71 
AACAGCCCTA 
AGCAGCCTCA 
121 
ATAGAATGTG 
ATAGAGTGTG 
171 
GATAGAATAT 
AATAGAATTT 
221 
GACGTGCAGG 
AACGTCTGCA 
271 
AAGTACACCC 
AAGTACACAC 
321 
Aacagagcag 
A 
371 
ccactggaaa 
421 
taaaggattg 
-20 
ggcacgagca 
31 
GGCCTTAACA 
GGTGTTGACC 
81 
CAAGATGGCT 
CAAGATCCCA 
131 
CACATGGAAT 
CACATGGAAT 
181 
GATGATTTCG 
GAGGATTTCA 
231 
TACCATCAGG 
TGCCATCAGG 
2Θ1 
CTCCACCTCA 
CCCCACCTCA 
331 
ctgctgatgt 
381 
ggttgtttac 
431 
ctccatccta 
-10 
tcgggtagcc 
41 
TAGATCGATG 
TAGATCGCTG 
91 
GGTCGATGCC 
TCCCGATGCC 
141 
CGGTTATACT 
CGGCAGTATC 
191 
TAGAGTGTTT 
GAGAGTGTCT 
241 
AAGCAGCGGG 
AGACAGCGGG 
291 
CCACATTGGC 
CCACTCAGGC 
341 
ctggaggctg 
391 
qacaaacctc 
441 
aaaaaaaaaa 
Figure 5.1a Human and bovine cDNA sequence of the NDUFSS subunil of complex I. Comparison of human 
and bovine cDNA sequence of the NDUFSS subunil of complex I (Gcnbank accession numbers AF020352 and 
X63220, rcspcclively) revealed 81 0% homology Primers used to generate fragments encoding the complete 
open reading trame of the human NDUFSS cDNA by PCR, are underlined Primers used lor chromosomal 
localisation ot the NDUFSS gene arc double underlined The 5'UTR, and 3'UTR of the NDUFSS cDNA were 
completed with sequences of human ESTs resembling the human NDUFSS open reading frame 
Human 
Bovine 
Human 
Bovine 
Human 
Bovine 
1 
MPFLDIQKRF 
MPFFDVQKRL 
51 
RAEKECKIEY 
RAEKECKIEF 
101 
KGEPRP 
QEEPRS 
11 
GLNIDRWLTI 
GVDLDRWMTI 
61 
DDFVECLLRQ 
EDFRECLLRQ 
21 
QSGEQPYKMA 
QSAEQPHKIP 
71 
KTMRRAGTIR 
KTMKRLHAIR 
31 
GRCHAFEKEW 
SRCHAFEKEW 
81 
KQRDKLIKEG 
RQREKLIKEG 
41 
IECAHGIGYT 
IECAHGIGSI 
91 
KYTPPPHHIG 
KYTPPPHHSG 
Figure 5.1b Human and bovine amino acid sequence of the NDUFSS subunit of complex I. Comparison of 
human and bovine amino acid sequence of the NDUFSS subumt of complex I revealed a 75 5% homology 
(: = identical amino acid, = amino acid with similar characteristics) 
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Tissue distribution of the NDUFS5 subunit mRNA 
The multiple tissue dot blot was hybridised using a 12P-labeled NDUFS5 cDNA probe, and 
was subjected to autoradiography (Fig 5 2) All human tissues expressed the NDUFS5 
mRNA A signal was also seen at ihe 100 and 500 ng human genomic DNA dots High 
intensity dots were seen in human tissues as (in descending order) heart, kidney, lung, liver, 
ovary, and skeletal muscle The foetal tissues loaded on the blot all expressed the NDUFS5 
mRNA, dots with high intensity are toelal heart, and foetal lung 
Discussion. 
Mitochondrial respiratory chain deficiency, with isolated complex 1 deficiency as a major 
contributor, occurs in approximately 1/10,000 live births (Bourgeron et al 1995) Complex 1 
consists of seven mitochondrial encoded subumts (Chomyn et al 1985 and 1986), the 
remainder are nuclear encoded of which sixteen have been cloned, and reported in literature 
(Chow et al 1991, Spencer et al 1992, Hattori et al 1995, de Coo et al 1995, Zhuchenko et al 
1996, Gu et al 1996, Hyslop et al 1996, Fata et al 1997, de Coo et al 1997, Procaccio et al 
1997, Kim et al 1997, Ton et al 1997, van den Heuvel et al 1998) Recently, the first mutation 
has been described in a nuclear encoded complex I subunit, which consisted of a live base 
pair duplication in the 18 kDa (AQDQ) subunit (van den Heuvel et al 1998) Hence, it seems 
worthwhile to analyse the nuclear encoded complex 1 genes for mutations in complex I 
deficient patients 
The human NDUFS5 subunit contains four cysteine residues, but not in a motif that provides 
hgands for binuclear and tetranuclear iron-sulphur centres There is therefore no indication 
that the NDUFS5 subunit is an iron-sulphur protein The same conclusion was drawn for the 
bovine 15 kDa subunit (Walker et al 1992) Alternatively, a ubiquinone binding protein can be 
isolated from bovine complex I with a molecular weight of 15 kDa It is suggested, based on 
molecular weight resemblance, that this ubiquinone binding protein is the NDUFS5 subunit 
(Suzuki and Ozawa 1986) In the IP fraction however there are two proteins with a molecular 
weight of 15 kDa, namely the NDUFS5, and the NDUFA5 (B13) subunit (Walker 1992) So 
whether the NDUFS5 subunit plays a direct role in the transfer of electrons or in the binding 
of ubiquinone remains to be elucidated 
The bovine 15 kDa subunit consists of 106 amino acids, which arc not post translationally 
modified (Walker 1992) The knowledge of the three dimensional structure and function of 
complex I in general, and from the NDUFS5 subunit in particular remains very limited The 
calculated hydropathy curve of the human NDUFS5 subunit expresses an overall hydrophilic 
protein, strongly resembling the curve published by Walker et al (1992) for the bovine 
equivalent This suggests that the NDUFS5 subunit is part of the extrinsic membrane domain 
of complex I This is in agreement with the NDUFS5 subunit being part of the l a fraction, 
which is thought to represent the external membrane part of complex I (Finel et al 1992) 
Because antibodies for Western Blotting were not available for the NDUFS5 subunit, we 
studied the tissue and developmental expression of the mRNA using a multiple tissue RNA 
master blot In our experience (Speri et al 1990, Bentlage et al 1996), measurement of 
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complex I activity for diagnostics in only one tissue (e g heart, liver, muscle, fibroblasts) is 
not always conclusive Some patients express enzyme defects only in muscle, others in 
fibroblasts In 1996 Pitkanen ci al published patients with a complex I deficiency in 
fibroblasts and heart tissue, but not in skeletal muscle (Pitkanen et al 1996) With "P-labeled 
NDUFS5 cDNA as a probe, we studied the expression of the mRNA in a diversity of human 
tissues, different human developmental stages, and some lower organisms (yeast and E coli) 
The probe was expressed in all human tissues present on the blot Dots with relative high 
expression were human heart, kidney, skeletal muscle, liver, lung, ovary, and foetal heart, all 
tissues with high metabolic activities, which are often clinically affected in complex I 
deficient patients The frequent involvement of basal ganglia seen in complex I deficient 
patients, is in agreement with the observed relative high expression of the NDUFS5 mRNA 
transcript in the putamen (as compared to whole brain) Also, the human genomic DNA dots 
display a hybridisation signal This may be caused by the presence of pseudogenes, or 
homology of the NDUFS5 cDNA sequence with repetitive nucleotide sequences in the human 
genome RNA samples are probably devoid of large quantities of genomic DNA 
contamination 
Our centre has wide experience with measurements of respiratory chain enzyme activities in 
different tissues, but especially difficulties with interpreting the measured values in chorion 
villi and ammocytes remain, making prenatal diagnosis rather complicated It would facilitate 
diagnostic procedures, and genetic counselling when molecular defects on genomic DNA 
level in complex 1 deficient patients could be established We are especially interested in the 
chromosomal localisation of the complex I subunits, considering the strong male 
preponderance present in our patient group In a previous study we sequenced therefore, the 
only known X-linked complex I subunit, namely the NDUFAl This revealed neither 
mutations nor polymorphisms (Loeffen et al 1998) The NDUFS5 subunit has been mapped 
on chromosome 1 
We have chosen for RT-PCR followed by direct sequencing as mutation detection method, 
because the possibility of missing mutations using this method is significant lower as with 
Single Strand Conformation Polymorphism (SSCP) We found no mutations in the NDUFS5 
cDNA We therefore hypothesise that mutations in the open reading frame of the NDUFS5 
subunit are not a frequent cause of complex I deficiency We remain searching for mutations 
in other nuclear encoded subunits of Ν ADH ubiquinone oxidoreductase in our patient group 
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Fig. 5.2a Multiple tissue Master blot. The type and position of poly(A+) RNAs and controls doited on the 
positively charged nylon membrane. 
Fig. 5.2b mRNA tissue distribution of the NDUFS5 subunit. The multiple tissue dot blot (Clontcch, USA) was 
hybridised using a "P-labeled NDUFS5 cDNA probe, and was subjected to autoradiography. The probe was 
ubiquitously expressed, especially in tissues with high-energy demand. 
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CHAPTER 6 
cDNA SEQUENCE AND CHROMOSOMAL LOCALISATION OF THE REMAINING 
THREE HUMAN NUCLEAR ENCODED IRON SULPHUR PROTEIN (IP) 
SUBUNITS OF COMPLEX I: THE HUMAN IP FRACTION IS COMPLETED 
Biochemical and Biophysical Research Communications 1998 247:751-758 
Abstract. 
NADH ubiquinone oxidoreductase (complex I) of the mitochondrial respiratory chain can be 
fragmented in a Flavoprotein (FP), Iron-Sulphur protein (IP) and Hydrophobic protein (HP) 
subfraclion The IP subfraction is hypothesised to be significant, since it contains important 
prosthetic groups highly conserved among species We cloned the cDNA of three remaining 
human NADH ubiquinone oxidoreductase subumts of this IP fraction the NDUFS2 (49 kDa), 
NDUFS3 (30 kDa), and NDUFS6 (13 kDa) subunit All presented cDNAs include the 
complete open reading frame (ORF), which consists of 1392, 795, and 375 base pairs, coding 
for 463, 264, and 124 amino acids, respectively The latter show 96%, 90%, and 83% 
homology with the corresponding bovine translation products The 3' untranslated regions 
(UTR) are complete in all three cDNAs 
Polymerase chain reaction performed with DNA isolated from somatic human-rodent cell 
hybrids containing defined human chromosomes as template, gave a human specific signal 
which mapped the NDUFS2 and NDUFS3 gene to chromosome 1 and 11, respectively In case 
of the NDUFS6 subunit a pseudogene may be present since signals were seen in the lanes 
containing chromosome 5 and 6 
The NDUFS2 contains a highly conserved protein kinase C phosphorylation site and the 
NDUFS3 subunit contains a highly conserved casein kinase II phosphorylation site which 
make them strong candidates for future mutation detection studies in enzymatic complex I 
deficient patients 
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Introduction. 
The energy generation ot human cells is highly dependent on an adequate lunclioning of the 
respiratory chain, which is situated in the mitochondrial inner membrane Four multiple-
subunit enzyme complexes, ubiquinone, and cytochrome c together constitute the respiratory 
chain, of which NADH'ubiquinone oxidoreductase (complex I) is the largest complex Each 
complex, with the exception ol succinate dehydrogenase (complex II), has one or more 
subunits encoded by the mitochondrial DNA (mtDNA) Bovine complex I consists of about 
42 subunits (Walker et al 1995, Walker 1995), seven of which are encoded by mtDNA 
(Chomyn et al 1985 and 1986) The remainder are nuclear encoded, and must be transported 
from the cylosol to the inner mitochondrial membrane At present, almost all cDNA 
sequences coding for bovine NADH ubiquinone oxidoreductase subunits have been cloned 
(Walker 1992, Walkeret al 1992, Arizmendi et al 1992) Complex I ot the tungus Neurospora 
crassa is also almost completely elucidated, and consists ot approximately 35 subunits (Weiss 
et al 1991), purple bacteria as Escherichia coli contain a less complex variant with only 14 
subunits (Weidner et al 1993) 
Complex 1 accepts electrons from the electron earner NADH and translers them to 
ubiquinone This electron transport is accompanied by the translocation of protons across the 
inner mitochondrial membrane to the intermembrane space Complex V (FiFo-ATP synthase) 
uses this proton gradient to generate ATP Several prosthetic groups lacihtate this transport ol 
electrons At present, these are hypothesised to be one, or two Flavine Mononucleotides 
(FMN) molecules, and six to eight binuclear and tetranuclear Iron-sulphur clusters (Runswick 
et al 1991, Yamaguchi and Hatefi 1993, Albracht et al 1996) For the majority ol the complex 
1 subunits, position within the complex as well as the function are unknown 
Bovine complex I can be fragmented with chaotropic agents, like Perchlorate This reveals a 
soluble component, consisting of the Flavoprotein fraction (FP) and the Iron-Sulphur protein 
Iraclion (IP), and a precipitate known as the hydrophobic protein fraction (HP) (Galante and 
Hateti 1978 and 1979) The FP fraction contains three subunits, namely the NDUFV1 (51 
kDa), NDUFV2 (24 kDa) and NDUFV3 (10 kDa) subumt, ot which the cDNA and nDNA 
have been cloned in man (Spencer et al 1992, Ali et al 1993, Hatton et al 1995, de Coo et al 
1995, de Coo et al 1997, Schuelke et al 1998) The IP fraction consists of the NDUFSl (75 
kDa), NDUFS2 (49 kDa), NDUFS3 (30 kDa), NDUFS4 (18 kDa), NDUFS5 (15 kDa), 
NDUFS6 (13 kDa), NDUFS8 (TYKY), and the NDUFA5 (B13) subumt, ot which NDUFSl, 
NDUFS4, NDUFS5, and NDUFA5 have been cloned (Chow et al 1991, Pala et al 1997, 
Procaccio et al 1997, van den Heuvel et al 1998, Loeffen et al 1999) The HP traction, which 
contains globular water-soluble as well as hydrophobic subunits, consists of about 24 
subunits The (partial) cDNA structure of ten of the 24 subunits (NDUFA1, NDUFA2, 
NDUFA4, NDUFA6, NDUFB3, NDUFB5, NDUFB6, NDUFB9, NDUFS7, NDUFC1) has 
been reported in literature (Zhuchenko et al 1996, Gu et al 1996, Hyslop et al 1996, Ton et al 
1997, Kim et al 1997, Smeitink et al 1998) 
The clinical phenotype expressed in complex I deficient patients is very heterogeneous, 
ranging from neonatal respiratory distress with extreme lactic acidosis at birth, to hypotonia 
with psychomotor retardation in the first years of life Since several studies mention a possible 
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male preponderance in respiratory chain deficiencies (Orstavik et al 1993, Zhuchenko el al 
1996, Loeffen et al 1998) suggesting an X-linked inheritance pattern, chromosomal mapping 
of complex I subunits is warranted. 
Most proteins incorporated in complex I are encoded by the nuclear DNA. In the past, much 
research has been performed on mtDNA in relation to complex I disease (Shoffner el al 1990, 
Goto et al 1990, Holt et al 1990). Recently, Buddiger published 20 complex I deficient 
patients who had no mutations in mitochondrial encoded subunits of complex I as well as in 
the three subunits situated in the FP subfraction (Buddiger et al 1997). We focus on the 
second important subgroup of complex I, the IP subfraction, which contains subunits with 
important prosthetic groups highly conserved among species. Therefore, elucidation of the 
cDNA structures and determination of the chromosomal localisation of all IP subunits is a 
rational prerequisite for future mutation detection studies in enzymatic complex I deficient 
patients. 
In the present communication we report the cloning and chromosomal mapping of the 
remaining three so far not characterised nuclear encoded IP subunits (NDUFS2, NDUFS3, 
and NDUFS6) of human complex I. 
Material and methods. 
Material. The following materials were obtained from commercial sources. Molecular size 
markers, Taq DNA polymerase, superscript II RNAse H" reverse transcriptase, and custom 
made oligonucleotide primers were purchased from Life Technologies Inc., the dRhodamine 
Dye Terminator Sequencing kit from Perkin Elmer, gel purification systems from Qiagen, 
poly A+ RNA pool from Clontech, NIGMS mapping panel 2 from Coriell Cell Repositary, and 
RNAzol from Biosolve BV. All other chemicals used were of analytical grade or as previously 
reported (van den Heuvel et al 1998). 
Software. Sequence alignments were performed with Sequence Navigator of Perkin Elmer. 
Homology searches were performed with the Basic Local Alignment Search Tool (BLAST) 
on the Internet at the server of the National Centre for Biotechnology Information (NCBI) 
(Altschul et al 1990). Molecular characteristics of cDNAs, and amino acid sequences were 
calculated using the OMIGA molecular biological software package (Hitachi). The average 
hydropathy was calculated using a window of 17 amino acids, according to the method 
described by Kyte and Doolittle (1982). We searched for amino acid motifs with use of 
PROSITE (hUp://www.embl-ebi.ac.uk/searches/prosite_input.html). Mitochondrial import 
sequences were determined with the program MiloProtll (Claros and Vincens 1996). 
cDNA cloning of the human NDUFS2, NDUFS3 and NDUFS6 subunit. Bovine cDNA 
sequences of the NDUFS2, NDUFS3 and NDUFS6 subunits (Genbank accession no. X14338, 
77 
Cluipler 6 
M58469, X63221) were used for a BLAST search in the Genbank (USA) human Expressed 
Sequence Tag (EST) database This revealed for each subumt several human ESTs, which 
were used in designing forward and reverse subumt specific oligonucleotides (Table 6 I) 
These oligonucleotides were applied in polymerase chain reaction 
mRNA obtained from a human heart poly A+ RNA pool (twelve normal Caucasian males and 
females, age range 20-78), was reverse transcribed to cDNA This process was earned out in I 
hour at 420C, and catalysed by superscript II RNAse H reverse transcriptase. The reaction 
mix (total volume 40 μΐ) contained RNA, oligo(dT) and random hexanucleotide primers 
(Ploos van Amstel et al 1996) 
PCR amplification was carried out in a reaction volume of 25 μΐ, containing Ι μΐ template, 2 5 
μΐ lOx PCR buffer, 50 ng forward and reverse pnmer, 0 25 mM MgCb, 0 25 mM dNTPs, and 
0 5 unit of Taq DNA Polymerase Polymerase chain reaction parameters are listed in Table 
6 1 PCR product was purified using the QIAquick PCR purification kit Wild type reaction 
products were cycle sequenced (ABI Pnsm, model 377 version 2 1 2) according to procedures 
as described by the manufacturer 
Chromosomal localisation of the NDUFS2, NDUFS3 and NDUFS6 gene To determine the 
chromosomal localisation of the NDUFS2, NDUFS3, and NDUFS6 gene, we designed a 
forward oligonucleotide primer in the 3' terminal part of the open reading frame, and a reverse 
oligonucleotide primer in the 3' untranslated region (UTR) of each subumt With these 
oligonucleotides (reaction conditions are listed in Table 6 1), PCR was performed with as 
template genomic DNA extracted from human-rodent somatic cell hybrids, containing defined 
human chromosomes (NIGMS mapping panel 2) PCR product was analysed using a 4% 
agarose gel The obtained cDNA fragments were sequenced using the ABI Prism, model 377 
version 2 I 2 in combination with the ABI"11 Taq Dyedeoxy terminator cycle ready reaction 
kit 
Results and discussion. 
Isolated complex I disease is a major contributor to respiratory chain deficiencies, which are 
estimated to occur in 1 10,000 live births (Bourgeron et al 1995) Molecular biological studies 
performed on mitochondrial encoded complex I subumts revealed in some patients a mutation 
in one of the mitochondrial tRNAs (Tiranti et al 1995, Houshmand et al 1996) or in one of the 
mitochondrial genes coding for complex I subumts (Oostra et al 1995, de Vries et al 1996) 
Yet many patients remain genotypic undiagnosed Recently we described a patient with a 5 bp 
duplication present in the NDUFS4 gene (18 kDa, van den Heuvel et al 1998) Both findings 
stress the need to characterise all nuclear encoded complex I subumts, especially those with a 
putative important function like the vanous IP subumts 
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Subunits Forward oligonucleotides Reverse oligonucleotides 
NDUFS2 NDUFS2F1 
(49kDa) NDUFS2F2 
TAAGATGGCGGCGCTGAGG 
GATTCAGCCCAGCAGAGGTG 
ATGGTGCGGAAGTGTGATCCTCA 
CCCTTTCTTCTGGCTGTTTG 
GACAATTGACATTGGGGTTG 
AAGCGAGCAGAGATGAAGAC 
CAGATGTCGTTGCCATCATAGG 
NDUFS2F4 
NDUFS2F5 
NDUFS2F6 
NDUFS2F7 
NDUFS3 NDUFS3F1 
(30kDa) NDUFS3F2 
NDUFS3F3 
NDUFS3F4 
NDUFS6 NDUFS6F1 
(ISkDa) NDUFS6F2 
NDUFS6F3 
CATCTGAGTAACATGGCGG 
GTTAGAGGTCTGTATCCATCC 
AGCCAACTGGTATGAAAGGG 
GAGAGTCTCAAGCTTGAAGCC 
AAATGGCGGCGGCGATGACC 
AAGACTACAGGAGAATTCGG 
CC AGTTC AGAC AGC AC CAC C AC 
NDUFS2R1 AGCTTCTCAGTGCCTCGGTG 
NDUFS2R2 GACACTCGCTCGTAGAACTC 
NDUFS2R3 ATCATAGGGCTGGGTCTTCC 
NDUFS2R4 GGTAGCCCTCAGTATACAAC 
NDUFS2R5 CACAGAAGAAGCTGATAGGC 
NDUFS3R1 CTGTGCATTGGTGTGATCCC 
NDUFS3R2 GGATCCTTCTTAGATCAGGG 
NDUFS3R3 CGCTGTCTAGGATCCACATGC 
NDUFS6R1 CATAAACCTGGCCAGTGTGCG 
NDUFS6R2 GCACAGAACCAGCGAGCTTCAC 
PCR conditions 
NDUFS2F1 + 
NDUFS2R5 
NDUFS3F1 + 
NDUFS3R3 
NDUFS6F1 + 
NDUFS6R2 
NDUFS2F7 + 
NDUFS2R5 
NDUFS3F4 + 
NDUFS3R3 
NDUFS6F3 + 
NDUFS6R2 
940C/1 min.; 940C/1 min., 58 0C/i min., 72 0C/1 min. (34 cycles); 72 oC/10 min. 
940C/1 min.; 940C/1 min., 57 0C/1 min., 72 0C/1 min. (34 cycles); 72 oC/10 min. 
940C/1 min.; 940C/1 min.. 57 °C/1 min., 72 0C/1 min. (34 cycles); 72 "C/IO min. 
940C/1 min.; 940C/1 min., 60 0C/1 min., 72 0C/5 min. (34 cycles); 72 oC/10 min. 
940C/1 min.; 940C/1 min., 60 0C/1 min., 72 0C/5 min. (34 cycles); 72 oC/10 min. 
940C/1 min.; 940C/1 min., 60 0C/1 min., 72 0C/5 min. (34 cycles); 72 oC/10 min. 
Table 6.1 Oligonucleotides listed here were used for cloning of the NDUFS2, NDUFS3 and NDUFS6 cDNAs 
(NDUFS2F1 + NDUFS2R5, NDUFS3F1 + NDUFS3R3, NDUFS6F1 + NDUFS6R2), for direct DNA 
sequencing reactions (NDUFS2F1, NDUFS2F2, NDUFS2F3, NDUFS2F4, NDUFS2F5, NDUFS2F6, 
NDUFS2R1, NDUFS2R2, NDUFS2R3, NDUFS2R4, NDUFS2R5, NDUFS3F1, NDUFS3F2, NDUFS3F3, 
NDUFS3R1, NDUFS3R2, NDUFS3R3, NDUFS6F1, NDUFS6F2, NDUFS6R1, NDUFS6R2), and in PCR with 
DNA isolated from human-rodent somatic cell hybrids as template (NDUFS2F7 + NDUFS2R5, NDUFS3F4 + 
NDUFS3R3, NDUFS6F3 + NDUFS6R2) F = Forward primer; R = Reverse primer. The lower part of Table 6.1 
contains the PCR conditions for each oligonucleotide pair used. Listed are respectively: preceding denaturation 
step; denaturation, annealing, extension; final extension step. 
The human NDUFS2, NDUFS3, and NDUFS6 cDNAs were amplified with PCR using the 
following oligonucleotide combinations: NDUFS2F1 + NDUFS2R5 , NDUFS3F1 + 
NDUFS3R3 , and NDUFS6F1 + NDUFS6R2 (Table 6.1 and Fig. 6.1). The oligonucleotides 
listed in Table 6.1 with exception of NDUFS2F7 and NDUFS3F4 were used in direct D N A 
sequencing reactions using the Dyedeoxy terminators. All three cDNAs contain the complete 
O R F (1392, 795, and 375 base pairs), coding for 463 , 264, and 124 amino acids, respectively 
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(Table 6.2). Molecular weights calculated from amino acid sequences are respectively 52.5, 
30.2, and 13.7 kDa. The 3' untranslated regions (UTR) were completed using several human 
ESTs retrieved from Genbank (poly A signals (AATAAA) and poly A tails are present). 
Comparison of amino acid sequences of bovine and human subunit equivalents revealed a 
similarity of 96% (NDUFS2), 90% (NDUFS3), and 83% (NDUFS6). High similarity between 
human and bovine housekeeping proteins is not uncommon (similarity of published nuclear 
encoded complex I proteins ranges from 79% to 95%). It can be hypothesised that high 
similarity percentages reflect strong conservation among species and therefore possible 
functional importance. cDNA similarity is highest in the region coding for the mature protein. 
We calculated the theoretical existence of a mitochondrial targeting sequence (MTS) with 
MitoProtll software, and compared the results with the experimental bovine data published by 
Walker et al 1992 (the bovine N-terminal part of the mature protein was sequenced by Edman 
degradation prior to the complete ORF). In man, possible cleavage sites are present between 
amino acid positions 20 and 21 in the NDUFS2, 36 and 37 in the NDUFS3 and 28 and 29 in 
the NDUFS6 subunit. In case of the bovine NDUFS2 subunit, the N-terminus of the 
mitochondrial targeting sequence is incomplete. For the NDUFS3 and NDUFS6 the cleavage 
site between MTS and mature protein was similar as predicted for man. The untranslated 
regions, as well as MTS coding regions clear reflect lower similarity percentages between man 
and Bos taurus. The NDUFS3 and NDUFS6 MTS are 55.6% and 60.7% similar, while the 
mature proteins are 94.7% and 89.6% similar. 
PCR performed with DNA extracted from somatic human-rodent cell hybrids containing 
defined human chromosomes as template gave signals specific for man in all three subunits. 
In case of the NDUFS2 subunit this fragment contained two (partial) exons and an intron, for 
the NDUFS3 and NDUFS6 the fragment was equal to the fragment when cDNA was used as 
template. The NDUFS2 fragment was present in the lane containing chromosome 1, the 
NDUFS3 in the lane containing chromosome 11, and unfortunately the NDUFS6 fragment 
was present in both the lanes containing chromosome 5, as chromosome 6. One of the bands 
is likely caused by a pseudogene. We could not differentiate which of the two was the 
pseudogene, since both bands contained the same nucleotide sequence in this short fragment. 
Subunit 
NDUFS2 
NDUFS3 
NDUFS6 
Genbank 
accession no. 
AF050640 
AF067139 
AF044959 
cDNA 
size 
1565 
887 
515 
ORF 
size 
1392 
795 
375 
No. 
a.a. 
463 
264 
124 
kDa 
52.5 
30.2 
13.7 
Signal 
peptide 
1-20 
1-36 
1-28 
H 
Β 
96% 
90% 
83% 
Η 
Ν 
62% 
46% 
_ 
Η 
Ε 
38% 
30% 
_ 
Η 
7 
2 
6 
No. cysteine 
Β 
6 
3 
4 
Ν Ε 
6 4 
3 0 
_ 
Table 6.2 Characteristics of the NDUFS2, NDUFS3, and NDUFS6 subunit. 
ORF = open reading frame, a.a. = amino acids; M
r
 = calculated molecular weight; H = /ƒ. sapiens; 
Β = B. taurus; Ν = N. crasser. E = E. coli. 
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NDUFS2F1 7 5 
agtaagATeeCeOCeCTeAeOGCTTTGTQCQGCTTCCGGGGCGTCGCGGCCCAOOTGCTGCGGCCTGGGGCTGGA 
N A A L R A L C G F R G V A A Q V L R P G A G 
NDUFS2F2 1 5 0 
GT^C(^TTGCCaATTCAeCCCJWC»aUUïeTarrCGG<^GTGGCAGCCAQATGTGGAATGGGCACAGCAGTTTGGG 
V R L P I Q F S R G V R Q H Q P D V E H A Q Q F G 
2 2 5 
GGAGCTGTTATGTACCCAAGCAAAGAAACAGCCCACTGGAAGCCTCCACCTTGGAATGATGTGGACCCTCCAAAG 
G A V M Y P S K E T A H M K P P P W N D V D P P K 
3 0 0 
GACACAATTGTGAAGAACATTACCCTGAACTTTGGGCCCCAACACCCAGCAGCGCATGGTGTCCTGCGACTAGTG 
D T I V K N I T L N F G P Q H P A A H G V L R L V 
NDUFS2F3 NDUFS2R1 3 7 5 
ATGGAATTGAGTGGGGAGATaaTacaaAJkaT0io&TCCTCACATCGGGCTccTGCftcc<uaacftCTaiuiA*acTc 
M E L S G E M V R K C D P H I G L L H R G T E K L 
4 5 0 
ATTGAATACAAGACCTATCTTCAGGCCCTTCCATACTTTGACCGGCTAGACTATGTGTCCATGATGTGTAACGAA 
I E Y K T Y L Q A L P Y F D R L D Y V S M M C N E 
5 2 5 
CAGGCCTATTCTCTAGCTGTGGAGAAGTTGCTAAACATCCGGCCTCCTCCTCGGGCACAGTGGATCCGAGTGCTG 
Q A Y S L A V E K L L N I R P P P R A Q W I R V L 
6 0 0 
TTTGGAQAAATCACACGTTTGTTGAACCACATCATGGCTGTGACCACACATGCCCTGGACCTTGGGGCCATGACC 
F G E I T R L L N H I M A V T T H A L D L G A M T 
NDUFS2F4 NDUFS2R2 675 
CCÎTfCl^^-ÎtWCTqTTTqAAGAAAQGGAGAAGATGTTTGAOTTCTACiaOCaABTaTC'l'GGAGCCCGAATGCAT 
P F F W L F E E R E K M F E F Y E R V S G A R M H 
7 5 0 
GCTGCTTATATCCGGCCAGGAGGAGTGCACCAGGACCTACCCCTTGGGCTTATGGATGACATTTATCAGTTTTCT 
A A Y I R P G G V H Q D L P L G L M D D I Y Q F S 
8 2 5 
AAGAACTTCTCTCyreGGCTTGATGAGTTGGAGGAGTTGCTGACCAACAATAGGATCTGGCGAAATCG<l»C»XTT 
K N F S L R L D E L E E L L T N N R I W R N R T I 
NDUFS2F5 9 0 0 
aftCkSVaaaOnOTAACAGCAGAAGAAeCACTTAACTATGGTTTTAGTGGAGTeATGCTTCGGGGCTCAGGCATC 
D I G V V T A E E A L N Y G F S G V M L R G S G I 
NDUFS2R3 9 7 5 
C^GTGGGACCTGCaakfteACTCJkaCCCTATOkTGTTTACGACCAGGTTGAGTTTGATGTTCCTGTTGGTTCTCGA 
Q W D L R K T Q P Y D V Y D Q V E F D V P V G S R 
1 0 5 0 
GGGGACTGCTATGATAGGTACCTGTGCCGGGTGGAGGAGATGCGCCAGTCCCTGAGAATTATCGCACAGTGTCTA 
G D C Y D R Y L C R V E E M R Q S L R I I A Q C L 
NDUFS2F6 1 1 2 5 
AACAAGATGCCTCCTGGGGAGATCAAGGTTQATGATGCCAAAGTGTCTCCACCTAAOCaAOCAOAaATaAAaACT 
N K M P P G E I K V D D A K V S P P K R A E M K T 
NDUFS2R4 1 2 0 0 
TCCATGGAGTCACTOATT^ATCACTTTAAXWTeTATACTOAeeGCTACCAAGTTCCTCCAGGAGCCACATATACT 
S M E 3 L I H H F K L Y T E G Y Q V P P G A T Y T 
1 2 7 5 
GCCATTQAGGCTCCCAAGGGAGAGTTTGGGGTGTACCTGGTGTCTGATGGCAGCAGCCGCCCTTATCGATGCAAG 
A I E A P K G E F G V Y L V S D G S S R P Y R C K 
1 3 5 0 
ATCAAGGCTCCTGGTTTTGCCCATCTGGCTGGTTTGGACAAGATGTCTAAGGGACACATGTTGGCJUUTinCOn 
I K A P G F A H L A G L D K M S K G H M L A D V V 
NDUFS2F7 1425 
eCCATCATAOGTACCCAAGATATTGTATTTGGAGAAGTAGATCGGTGAgcdggggagcagcgtttgatccccccL 
A I I G T Q D I V F G E V D R * 
NDUFS2R5 1500 
g c c t a t c a g c t t c t t c t g t g g a g c c t g t t c c t c a c t g g a a a t t g g c c t c a t g t t c a c g t a c a c t t g g c t g t c a g g 
poly a signal 1575 
c t t t c t g t g c a t g t a c t a a a a a a g g a g a a a t c a t a a t a a a t t a g c c g t c t t g c g c c c c t a g g c c t a a a a a a a a a a 
poly a s i t e 
Fig 6.1 (tonlinued) cDNA and amino acid sequence of the NDUFS2 subunit 
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NDUFS3F1 75 
catCtgagtaacATOGCOGCGGCGGCGGTAGCCAGGCTGTGGTGGCGCGGGATCTTGGGGGCCTCGGCGCTGACC 
M A A A A V A R L W W R G I L G A S A L T 
150 
AGGGGGACTGGGCGACCCTCCGTTCTGTTGCTGCCGGTGAGGCGGGAGAGCGCCGGGGCCGACACGCGCCCCACT 
R G T G R P S V L L L P V R R E S A G A D T H P T 
225 
GTCAGACCACGGAATGATGTGGCCCACAAGCAQCTCTCAGCTTTTGGAGAGTATGTGGCTGAAATCTTGCCCAAG 
V R P R N D V A H K Q L 3 A F G E Y V A E I L P K 
NDUFS3F2 300 
TATGTCCAACAAGTTCAGGTGTCCTGCTTCAATGAOTTAOkOaTCTOTATCCATCCTGATGGCGTCATCCCAGTG 
Y V Q Q V Q V S C F N E L E V C I H P D G V I P V 
NDUFS3R1 375 
CTGACT^TCCTCAeGGATCACACCAATOCACAGTTCAAATCTCTGGTTGACTTGACAGCAGTGGACGTCCCAACT 
L T F L R D H T N A Q F K S L V D L T A V D V P T 
450 
CGGOUUU^CCGTTTTGAGATTGTCTACAACCTGTTGTCTCTGCGCTTCAACTCACGGATCCGTGTGAAGACCTAC 
R Q N R F E I V Y N L L S L R F N S R I R V K T Y 
NDUFS3F3 525 
ACAGATGAGCTGACGCCCATTGAGTCTGCTGTCTCTGTeTTCAAGGCAaCCA&CTaeTATaAAAOQaAGATCTGG 
T D E L T P I E S A V S V F K A A N W Y E R E I W 
NDUFS3R2 600 
GACATGTTTGGAGTCTTCTTTGCTAACCACCCTaATCTAAGAAGaATCCTGACAGATTATGGCTTCGAGGGACAT 
D M F G V F F A N H P D L R R I L T D Y G F E G H 
675 
CCTTTCCGGAAAGACTTTCCTCTATCTGGCTATGTTGAGTTACGTTATGATGATGAAGTGAAGCGGGTGGTGGCA 
P F R K D F F L S G Y V E L R Y D D E V K R V V A 
750 
GAGCCGGTGGAGTTGGCCCAAGAGTTCCGCAAATTTGACCTGAACAGCCCCTGGGAGGCTTTCCCAGTCTATCGC 
E P V E L A Q E F R K F D L N 3 P W E A F P V Y R 
NDUFS3F4 825 
CAACCCCCGeMak0rCTCUU3CTTaiUU3CCGGAGACAAGAAGCCTGATeCCAAGTAGctccagggaacgcatgtg 
Q P P E S L K L E A G D K K P D A K * 
NDUFS3R3 poly s signal poly a site 900 
g a t c c t a g a c a g c g c c c t a t c t a t g a t t g a g t g t c c g t g t a a a C a a a t t c c t a c t t a g a c t t a a a a a a a a a a a a a 
Fig 6.1 (continued) cDNA and amino acid sequence ot the NDUkS^ subunit 
NDUFS6F1 75 
M A A A M T F C R L L N R C G E A A R S L P 
NDUFS6R1 150 
CTGGGCGCCAGGTGTTTCGGGGTGCGGGTCTCGCCGACCGGGGAGAAGGTCACGCACACTOeCCAGGTTTATGAT 
L G A R C F G V R V S P T G E K V T H T G Q V Y D 
NDUFS6F2 225 
GATAAAaACTACAeaAOAATTCaaTTTGTAGGTCGTCAGAAAGAGGTGAATGAAAACTTTGCCATTGATTTGATA 
D K D Y R R I R F V G R Q K E V N E N F A I D L I 
300 
GCAGAGCAGCCCGTGAGCOAGGTGGAGACTCGGGTGATAGCGTGCGATGGCGGCGGGGGAGCTCTTGGCCACCCA 
A E Q P V S E V E T R V I A C D G G G G A L G H P 
NDUFS6F3 375 
AAAGTGTATATAAACTTGGACAAAGAAACAAAAACCGGCACATGCGGTTACTGTGGGCTCCAOTTCAOACAGCAC 
K V Y I N L D K E T K T G T C G Y C G L Q F R Q H 
450 
CACCACTAGagcgtgtggcacgccgggggtcccgcagcatccCgtgagcatttccgcggggaagctgagcacgtg 
H H * 
NDUFS6R2 poly a signal poly a site 525 
aagctcgctggttctgtgcgaagggtattcctggtgctgaataaagggtgttgctgtcacggctgaaaaaaaaaa 
Fig 6.1 (continued) cDNA and amino acid sequence ot the NDUhS6 subunit Primers used lor PCR and 
sequence reactions arc shaded Primers are also listed in Table 6 1 Positions ol poly a signal and site have been 
indicated lor each subunit 5'UTR and VUTR were completed (when possible) with use ol ESTs retrieved trom 
Genbank, USA 
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(DNA sequence and chromosomal localisation of the remaining three human nuclear encoded iron-sulphur 
protein (IP) suhunits of complex I: the human IP fraction is completed 
Consensus amino acid patterns 
NDUFS2 
(49kDa) 
NDUFS3 
(30kDa) 
Name 
N-glycosylation site 
(NITL; NFSL; NRTI) 
Casein kinase II phosphorylation 
site 
(TAEE; SRGD: TSME; TAIE) 
N-myristoylation site 
(GVVTAE; GATYTA) 
Protein kinase C phosphorylation 
site 
(TEK; SLR; SLR; RGD) 
Tyrosine phosphorylation site 
(KLIEYKTY) 
cAMP phosphorylation site 
(RRES) 
Casein kinase II phosphorylation 
site 
(SLVD; TAVD; TYTD: TRIE; 
SPWE) 
N-myristoylation site 
(GILGAS, GVFFAN) 
Protein kinase C phosphorylation 
site 
(TGR; TVR; SLR; SLK) 
No. 
3 
4 
2 
4 
1 
1 
5 
2 
4 
A.A. 
position 
79 
250 
270 
279 
322 
373 
398 
276 
394 
120 
252 
340 
416 
122 
37 
110 
115 
145 
151 
237 
13 
175 
24 
46 
134 
251 
Also present in: 
B. taurus 
B. taurus 
B. taurus 
B. taurus. N. crassa 
Β. taurus 
Β. taurus 
Β. taurus, Ν. crassa 
Β. taurus, Ν. crassa 
Β. taurus 
Β. taurus, Ν. crassa 
Β. taurus 
Β. taurus, Ν. crassa. E. coli 
Β .taurus, Ν. crassa 
Β. taurus, Ν. crassa 
Β. taurus 
Β. taurus 
Β. taurus. Ν. crassa, E. coli 
B. taurus, N. crassa 
B. taurus 
B. taurus. N. crassa 
-
B. taurus. N. crassa 
N. crassa 
B. taurus 
B. taurus. N. crassa 
B. taurus. N. crassa 
Casein kinase II phosphorylation 
NDUFS6 site 
USkDa) (SEVE) 
N-myristoylation site 
(GGGGAL; GGALGH) 
7S 
89 
91 
B. taurus 
B. taurus 
Table 6.3 Amino acid consensus patlcms were searched with PROSITE. A consensus amino acid sequence 
pattern was titled conserved when in multiple alignment a similar consensus pattern was present. All data listed in 
this Table concern the human suhunits. 
In order to speculate about functional properties of the human NDUFS2, NDUFS3 and 
NDUFS6 subunit we searched for conserved consensus amino acid patterns among eu- and 
prokaryotes. For this search we included besides man the subunit equivalents of B. taurus, 
N. crassa and E. coli, since complex 1 has been almost completely characterised in these 
organisms. The Swissprot accession numbers for B. taurus, N. crassa and E. coli are: 
NDUFS2: P17694, P22142, P33600; NDUFS3: G163416, P23710, P33599; NDUFS6: 
P23934. NDUFS2 and NDUFS3 are represented in man, B. taurus, N. crassa, and E. coli, 
while the NDUFS6 is not present in N. crassa, and E. coli. Since E. coli contains a complex I 
consisting of only 14 suhunits, a large amount of the nuclear encoded suhunits of human 
complex 1 have no representative in bacteria. The N. crassa complex 1 contains about 35 
S3 
Chaptei 6 
subunits, and yet there is no representative present of the NDUFS6 Subumts with no obvious 
equivalent present in lower life forms could have emerged late in evolution when these 
species had already diverged or they diverged fast so that detection of homology is impossible 
In multiple alignment we considered besides identical patterns, a pattern with different amino 
acids coding for the same consensus motif conserved The pattern search performed with 
PROSITE revealed for each subunit several consensus amino acid motif patterns (Table 6 3), 
but only two were conserved among all four species The NDUFS2 subunit contains a 
conserved SLR protein kinase C phosphorylation site at the C terminus of the protein The 
NDUFS3 transcript contains a conserved casein kinase II phosphorylation site (TAVD) at 
amino acid position 115 This high conservation among eukaryotes and prokaryotes is 
suggestive for lunclional significance The NDUFS6 subunit has a conserved N-
mynstoylation site between amino acid 89 and 96 In the past suggestions were made that the 
NDUFS2, and NDUFSl subunit could contain Fe-S clusters (Preis et al 1990, Fearnley and 
Walker 1992), which are commonly reflected by consensus cysteine patterns The human 
NDUFS2 contains seven cysteine residues, six of which are conserved in Β taurus, and three 
in Ν crassa The NDUFS3 has two cysteine residues, both conserved in Β taurus, but none in 
Ν crassa The human NDUFS6 transenpt contains six cysteine residues, lour are conserved in 
Β taurus Considering the consensus patterns lor Fe-S clusters, none of the three subunits 
seems to meet the criteria, but further experimental studies are warranted 
The average hydropathy was calculated using the OMIGA molecular biological software 
package (Hitachi) All subunits express an overall hydrophilic pattern The NDUFS2 subunit 
contains a hydrophobic segment of about 25 amino acids, which is long enough to torm a 
transmembrane α helix Bovine NDUFS2, NDUFS3 and NDUFS6 are located in the la 
fraction of complex I (which is likely to be the part protruding into the mitochondrial matrix) 
(Finel el al 1992), which is in accordance to the overall hydrophilic pattern of the human 
equivalents In addition, the NDUFS2 has been localised by immuno-labelling on the 
peripheral arm (protruding into the mitochondrial matrix) of complex I in Ν crassa 
(Guenebaut et al 1997) 
Mammalian NADH ubiquinone oxidoreductase has proven to be a very large and complicated 
protein complex The NDUFS2 and NDUFS3 subunits are highly conserved in prokaryotes 
and eukaryotes, since homologues are found in many species and even in chloroplast 
(Fearnley et al 1989, Dupuis et al 1991) Furthermore they contain highly conserved 
phosphorylation sites which might be involved in regulatory function We therelore consider 
the NDUFS2 and NDUFS3 strong candidates tor mutation detection studies in isolated 
complex I deficient patients 
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CHAPTER 7 
cDNA OF EIGHT NUCLEAR ENCODED SUBUNITS OF NADH:UBIQUINONE 
OXIDOREDUCTASE: HUMAN COMPLEX I cDNA CHARACTERISATION 
COMPLETED? 
Biochemical and Biophysical Research Communications 1998 253:415-422 
Abstract. 
NADH:ubiquinone oxidoreductase (complex I) is an extremely complicated multi-protein 
complex located in the inner mitochondrial membrane. Its main function is the transport of 
electrons from NADH to ubiquinone, which is accompanied by translocation of protons from 
the mitochondrial matrix to the intermembrane space. Human complex I appears to consist of 
forty-one subumts of which thirty-four are encoded by nDNA. Here we report the cDNA 
sequences of the hitherto uncharacterised eight nuclear encoded subunits, all located within 
the Hydrophobic Protein (HP) fraction of complex I. Now all currently known forty-one 
proteins of human NADH:ubiquinone oxidoreductase have been characterised and reported in 
literature, which enables more complete mutational analysis studies of isolated complex ί 
deficient patients. 
so 
Chapter 7 
Introduction. 
NADH ubiquinone oxidoreductase ol the mitochondrial respiratory chain is one of the most 
complicated multi-protein enzyme complexes present in the human cell (Smeitink el al 
1998a) Its main function is transport of electrons by oxidation of NADH followed by 
reduction of ubiquinone This process is accompanied by the translocation of protons from the 
mitochondrial matrix to the intermembrane space, a process of which much has to be learned 
Several prosthetic groups catalyse these electron transport reactions, which are hypothesised 
to be at least one Flavin Mononucleotide (FMN) and six to eight Iron-Sulphur clusters 
(Albracht et al 1996, Ohnishi 1998) One of the most extensively studied mammals with 
regard to complex I is ßov taurus Bovine complex 1 consists of about forty-one subunits, 
which have mainly been characterised by the research group of Walker (Walker 1992 and 
references therein) Seven are encoded by mitochondrial DNA (ND1-ND6, ND4L, (Chomyn 
et al 1985 and 1986), the remainder are nuclear encoded and imported into mitochondria 
By using chaotropic agents, complex I can be fragmented into three different fractions 
(Galante and Hatefi 1978 and 1979) The Flavoprotein (FP) fraction contains three subunits 
all of which have been characterised in man on complementary DNA (cDNA) as well as 
nuclear DNA (nDNA) level, namely NDUFV1 (5/ kDa), NDUFV2 (24 kDa) and NDUFV3 
(10 kDa) (Spencer et al 1992, Ali et al 1993, de Coo et al 1995, Hatton et al 1995, de Coo et 
al 1997, Schuelke et al 1998) The NADH binding site of complex I has been assigned to the 
NDUFV1 subumt (Chen and Guillory 1981, Deng et al 1990) In addition, the NDUFV1 
contains the FMN and a lelranuclear Iron-Sulphur cluster (Pilkington et al 1991) The 
NDUFV2 subumt contains a binuclear Iron-Sulphur cluster (Pilkington and Walker 1989), 
while the NDUFV3 does not contain any known redox centres The second fraction is the so-
called Iron-Sulphur Protein (IP) fraction The IP fraction contains at least seven subunits all of 
which are fully characterised on cDNA level, namely the NDUFSl (75 kDa), NDUFS2 (49 
kDa), NDUFSl (30 kDa), NDUFS4 (18 kDa), NDUFS5 (15 kDa), NDUFS6 (13 kDa) and 
NDUFA5 (ß/3) (Chow et al 1991, Pala et al 1997, Loeffen et al 1998, van den Heuvel et al 
1998, Loelfen et al 1999) Several functional properties have been postulated concerning the 
IP subunits The NDUFS1 contains a tetra-nuclear and probably also a bi-nuclear Iron-Sulphur 
cluster (Runswick et al 1989) Furthermore, an active cAMP consensus phosphorylation site 
has been encountered in the NDUFS4 subumt (Papa et al 1996) 
The final subgroup ol complex I is the Hydrophobic Protein (HP) fraction This is a large 
group containing 24 nuclear encoded subunits, ol which in man the cDNA has been 
characterised for 16 subunits NDUFA1 (MWFE), NDUFA2 (B8), NDUFA4 (MLRQ), 
NDUFA6 (ß/4), NDUFA8 (PG1V), NDUFA9 (39 kDa), NDUFAB1 (SDAP), NDUFB1 
(MNLL), NDUFB3 (BI2), NDUFB5 (SGDH), NDUFB6 (BIT), NDUFB7 (B18), NDUFB9 
(ß22), NDUFS7 (PSST), NDUFS8 (TYKV), and NDUFC1 (KFYl) (Wong et al 1990, Baens et 
al 1994, Zhuchenko et al 1996, Gu et al 1996, Hyslop et al 1996, Ton et al 1997, Kim et al 
1997, Procaccio et al 1997, Tnepels et al 1998a, Tnepels et al 1998b, Smeitink et al 1998) A 
complete list of Genbank accession numbers for all human complex I subunits is presented in 
Table 7 1 The complete nDNA structure of subunits present in the HP fraction has only been 
elucidated for the NDUtSS and NDUtAl gene (Zhuchenko et al 1996, de Sury et al 1998) 
90 
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Electron Paramagnetic Resonance (EPR) spectroscopy studies performed with bovine 
complex I revealed that all known Iron-Sulphur clusters are located in the extra membranous 
part (Finel et al 1992), which accommodates the FP and IP subfractions Little is understood 
about functional properties of the individual subunits of the HP fraction, which also accounts 
for functional properties ol this traction as a unit Worth mentioning are the two consensus 
tetranuclear Iron-Sulphur cluster patterns present in NDUFS8 (Dupuis et al 1991a), a 
consensus binuclear Iron-Sulfur cluster pattern in NDUFS7 (Arizmendi et al 1992) and 
NDUFA8 (Dupuis et al 1991b) and the NDUFAB1 subumt being an acyl-carrying protein 
(Runswick et al 1991) 
Up to now, isolated complex I deficiency has been mostly connected to mutations in mtDNA, 
of which several have been described (Zeviani et al 1998) Yet, in our isolated complex I 
deficient patient group (measured in cultured skin fibroblasts) consisting of mainly young 
children, common mtDNA mutations and major mtDNA rearrangements cannot be found It is 
therefore likely, that many defects of respiratory chain disorders will be at nuclear level As a 
prerequisite to mutational analysis studies of nuclear encoded subunits of complex I in our 
patient group, we cloned all remaining uncharactensed complex I subunits 
Here we report the cDNA sequences of these remaining eight uncharactensed subunits, which 
are all part of the HP fraction Now all known mammalian complex I cDNAs have been 
cloned in man Furthermore we examined to what extend these subunits are conserved in 
evolution and speculate about functional properties 
Material and methods. 
Commercial purchased materials 
Oligonucleotide primers, Taq DNA polymerase, Superscript II RNAse H reverse transcriptase 
were purchased from Life Technologies Ine (Breda, The Netherlands), the dRhodamine Dye 
Terminator Sequencing kit was purchased from Perkin Elmer (Wamngton, England), PCR 
purification systems were purchased from Qiagen (Leusden, The Netherlands), RNAzol was 
purchased from Biosolve BV (Watford, England), and a human heart poly A+ RNA pool was 
purchased from Clontech (Palo Alto, USA) 
Software 
Homology searches in protein and nucleotide databases were performed with the Basic Local 
Alignment Search Tool (BLAST) on the internet at the server of the National Centre for 
Biotechnology Information (NCBI) (Altschul et al 1990) Hydropathy was plotted using 
methods based on the procedures described by Kyte and Doohttle (1982) Computer soltware 
was used from the National Centre for Computer Aided Chemistry and Bioinformatics 
(CAOS/CAMM, Nijmegen, The Netherlands) 
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H. sapiens I 
Bos taunis 
NDUFVi/SlkDa 
NDUFV2 / 24 kDa 
NDVFV3/ lOküa 
NDUFA1 / MWFE 
NDUFA2/B8 
NOUFA3/B9 
NDUFA4 / MLRQ 
NDUFA5/BI3 
NDUFA6/B14 
NDUFA7/B14.5A 
NDUFA8/PGIV 
NDUFA9/ 39 Wa 
NDVFAlO/42kDa 
NDUFAB1 / SDAP 
NDUFBl / MNLL 
NDUFB2 / AGGG 
NDUFB3/BI2 
NDUFB4/B15 
NDUFB5 / SGDH 
NDUFB6/B17 
NDUFB7/BI8 
NDUFBS/ASHI 
NDUFB9/B22 
NDUFBIO / PDSW 
NDUFS1175 kDa 
NDUFS2/49kDa 
NDUFS3 / 30 kDa 
NDUFS4/ IHkDa 
NDUFS5/ ISkDa 
NDUFS6/13kDa 
NDUFS7 / PSST 
NDUFSH/TYKY 
NDUFCl/KFYI 
NDUFC2 / BÌ4.5B 
Genbank accession no. 
AF053070 
M25484 
X99726-8 
X81900 
AF047185 
AF044955 
U94586 
U53468 
AF047182 
AFÜ50637 
AF044953 
G189048 
AF087661 
AF087660 
AF054181 
AF050639 
AF047183 
AF044957 
AF047I8I 
AF035840 
M33374 
AF044958 
S82655 
AF044954 
X61100 
AFÜ50640 
AF067139 
AF020351 
AF020352 
AF044959 
U65579 
AF047I84 
AF087659 
Reference 
Schuelkeetal 1998 
De Coo et al 1995, Hattorl et al 1995 
DeCooetal 1997 
Zhuchenko et al 1996 
Ton et al 1997 
CP 
Kim et al 1997 
Patactal 1997 
Τοπ et al 1997 
CP 
Triepels et al 1998b 
Baensetal 1994 
CP 
Triepels et al 1998a 
CP 
Ton et al 1997 
CP 
Ton et al 1997 
Smeitinketal 1998 
Wong et al 1990 
CP 
Guet al 1996 
CP 
Pilkington et al 1991 
Loeffen et al 1998, Procaccio et al 1998 
Loeffenetal 1998 
Van den Heuvel et al 1998 
Loeffenetal 1999 
Loeffen et al 1998 
Hyslopetal 1996 
Procaccio et al 1997 
Ton et al 1997 
CP 
Table 7.1 Complete list of all published human nuclear encoded complex 1 subunit cDNAs. CP = current paper. 
In case of the NDUFV3 and NDUFS7, an accession no. of the cDNA sequence could not be retrieved. We listed 
the exon accession no. of the NDUFV3 subunit instead. The NDUFBl cDNA sequence is not published, but has 
been submitted to Genbank. 
cDNA cloning. 
200 ng heart poly A+ RNA obtained from a pool of twelve healthy male and female 
Caucasians, age range 20-78 years, was reverse transcribed to cDNA by superscript II RNAse 
H" reverse transcriptase in one hour at 420C (Ploos van Amstel et al 1996). Bovine cDNA 
sequences of the remaining eight nuclear encoded subunits of complex I were BLASTed in 
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cDNA of eight nuclear encoded subunits of NADH: ubiquinone oxidoreductase. 
human complex I cDNA characterisation completed': 
the NCBI human Expressed Sequence Tags (EST) database, which revealed for each subunit 
several hits. Oligonucleotide primers were chosen (when possible) in the 5' and 3' 
untranslated region (UTR) in order to clone the complete open reading frame (ORF). Primers 
used for cloning of the cDNAs as well as for direct sequencing reactions are listed in Table 
7.2. PCR reactions were performed in a reaction volume of 50 μΐ, after addition of Ιμΐ cDNA 
template, 5 μΐ lOx PCR buffer, 100 ng Forward and Reverse primer, 0.25 mM dNTPs, 1.5 
mM MgCl:, and 1 U Taq DNA polymerase. PCR products were purified using the QIAquick 
PCR purification kit. Both strands were analysed by direct sequencing (ABI Prism, model 377 
version 2.1.2), using the ABI Prism1"1 dRhodamine terminator cycle sequencing ready 
reaction kit. 
Subunits 
NDUFA3 
B9 
NDUFA7 
BI4.5A 
SDVFAIO 
42kDa 
Forward oligonucleotides Reverse oligonucleotides 
NDUFA3F 
NDUFA7P 
NDUFA10F1 
NDUPA10F2 
NDUFA10F3 
NDUFA10F4 
NDUFA10F5 
N
™™
2
 NDUFB2F ACGG 
NDVFB4 NDUFB4F1 
ß/5 NDUFB4F2 
NDUFB8 NDUFB8F1 
ASHI NDUFB8F2 
NDUFBIO NDUFBIOFI 
PDSW NDUFB10F2 
NDUFC2 NDUFC2F1 
I4.5B NDUFC2F2 
NDUFA3R 
NDUFA7R 
NDUFAIORI 
NDUFA10R2 
NDUFA10R3 
NDUFA10R4 
NDUFA10R5 
NDUFB2R 
I1DUFB4R1 
NDUFB4R2 
NDUFB8R1 
NDUFB8R2 
NDUFB8R3 
AGGCCCGGGACCCGGACGG NDUFB10R1 
CAGTACCGCCGCGTGCCAG NDUFB10R2 
CCCGCCGCGGAGACAAAG 
CGCGGACGGAAGATGGC 
TCCTGAGCTGACCGGGTAG 
GTGGCATTTCCTACTTGGGG 
CTGGTTGTACAGCAGTCGCC 
AGGCGGATTCAGAAGAAAGG 
CAGGATAAGTTTGAGGTGCTG 
GAAGCGAAGTAGGCAGGGGC 
GCTCCCAAGATGTCGTTCCC 
CATGGGAGCTCTGTGTGGATTTG 
GGCATGTGGAAGAAGGTG 
TAGGACCCCAGAAGAACGG 
TCGTCGTGGTTTTCCTTGTAG 
CTACCTGTATGCTGTGAGGG 
NDUFC2R1 
NDUFC2R2 
GGCCGCCTCTGTCAGTGGAG 
GAGGAAATCCAAGGAGGCAAAGTAG 
TGTCTGGATAATGAATCCCC 
GGTTGTACATCGCCTCCAGG 
TTTTCACTCATCTCAGGGAG 
CTGAACTGATGTAAGACACGG 
TGGCCTTTCACAGCAGACC 
CCTTGAAATTCTCACCTGGCTCTTG 
GGCAGGATTTTCGATGAGC 
GGCAGGAATACATATAGTCATCATTG 
CAGGGAGCTTCGGGTAGTC 
AAGCCAGGAAACCGAAGAGC 
TTCTAGGAATGAGGGAGTCC 
GTTGATAATTTCTTGGTCGACTTTG 
CAGTCATACAGAGCCACACAGCAG 
GGCCGTAATATATAGAAGCTGG 
CAAATTCAGAAACAGCAGGTATCAG 
Table 7.2 List of oligonucleotide primers used in PCR amplification and direct DNA sequencing reactions of all 
eight nuclear encoded complex I cDNAs presented in this study. 
Results and discussion. 
NADH:ubiquinone oxidoreductase has been fully characterised on cDNA level in several 
species like B. taurus (Walker 1992), Neurospora crassa (Weiss et al 1991) and Escherichia 
coli, (Weidner et al 1993). The complexity of this multi-protein complex varies from a 
minimal structural unit of fourteen subunits present in many bacteria like E. coli to the 
currently known maximum of at least 41 subunits present in cow. With the additional eight 
cDNAs presented in this study, all known 41 subunits of human NADH:ubiquinone 
oxidoreductase have been characterised, which clears the way for more complete mutational 
analysis studies of nuclear encoded subunits in isolated complex I deficient patients. 
The HP fraction to which all eight presented subunits belong is a precipitate, which remains 
after fragmentation with chaotropic agents. At least 31 subunits belong to this fraction 
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including the seven, which are mitochondrially encoded. Little is known about the retained 
functional integrity of this precipitate. There is speculation that the HP fraction participates in 
the transfer of protons from the mitochondrial matrix to the intermembrane space (Belogrudov 
andHatefi 1994). 
Human 
subunit 
NDUFA3 
NDUFA7 
NDUFA10 
NDUFB2 
NDUFB4 
NDUFB8 
NDUFB10 
NDUFC2 
Size 
ORF 
255 
342 
1068 
318 
390 
561 
519 
360 
No. 
a.a. 
84 
113 
355 
105 
129 
186 
172 
119 
Mr 
(kl)a) 
9.3 
12.6 
40.8 
12.1 
15.2 
21.8 
20.8 
14.2 
Leader 
peptide 
inB 
-
-
+ 
+ 
-
+ 
-
H/B 
identity 
{a.a.) 
83.3% 
88.5% 
80.2% 
83.8% 
73.6% 
84.9% 
82.4% 
73.9% 
Homology 
Bos laurus 
Bos taurus 
Caenorhahditis elegans 
Bos taurus 
Caenorhahditis elegans 
Bos taurus 
Caenorhahditis elegans 
Bos taurus 
Gallus gallus 
Bos taurus 
Bos taurus 
Caenorhahditis elegans 
Bos laurus 
Table 7.3 Molecular characleristics of the prescnled eight human complex I subunits. ORF = open reading frame, 
M
r
 = calculated molecular weight, a.a. = amino acids, H = Homo sapiens, Β = Bos taurus. Homology between 
man and other species was investigated with use of BLAST search at the server of NCB1. 
PCR amplification with subunit specific oligonucleotide primers revealed the complete Open 
Reading Frame (ORF) of all eight remaining subunits: NDUFA3 (B9) 255 bp, NDUFA7 
{B14.5A) 342 bp, NDUFAW {42 kDa) 1068 bp, NDUFB2 (AGGG) 318 bp, NDUFB4 (5/5) 
390 bp, NDUFB8 (ASHI) 561 bp, NDUFBIO (PDSW) 519 bp and NDUFC2 (BI4.5B) 360 bp 
(Fig. 7.1). Molecular characteristics of these subunits are listed in Table 7.3. Several of the 
eight subunit amino acid chains are different in length in man compared to B. laurus. The first 
three amino acids of the bovine NDUFB2 (AGGG) subunit are not present in man, in case of 
the NDUFBIO {PDSW) subunit, man misses six amino acids on the N-terminal side whereas 
there are an extra two at the C-terminal side, the NDUFA10 {42 kDa) of man is twelve amino 
acids longer (situated at the N-terminal side) and finally, bovine NDUFC2 {BI4.5B) starts 
with two methionine residues, whereas man contains only one. The identity on amino acid 
level between man and B. taurus ranges between 73% and 89%. These identity percentages 
arc slightly less than seen in nuclear encoded subunits located in the minimal structural unit as 
e.g. present in E. coli, where identity percentages between man and Bos taurus vary from 90% 
to 97%. Yet, for many subunits of NADH:ubiquinone oxidoreductase the interspecies 
conservation is extremely high, which underlines the functional importance of this complex. 
Average hydropathy calculation using a range of 17 amino acids revealed an overall 
hydrophilic pattern for five subunits {NDUFA7. NDUFAW, NDUFB2, NDUFB4 and 
NDUFBIO). The other three subunits contain one or more continuous hydrophobic parts of at 
least twenty amino acids. The presence of hydrophilic proteins in the insoluble hydrophobic 
fraction of complex 1 has been reported previously for Bos taurus (Walker 1992). One can 
speculate that the hydrophilic proteins present in the HP fraction contribute to the outer 
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sections of the membranal part of complex I which communicate with mitochondrial matrix 
or intermembrane space, while the purely hydrophobic proteins present in this fraction like the 
mtDNA encoded ND genes are actually in the lipid bilayer In cow, three ol eight subumts 
presented in this paper appear to have a leader peptide It is reasonable to assume that these 
Mitochondrial Targeting Sequences (MTS) will also be present in man Interestingly, in cow 
all FP fraction subumts and five of seven IP fraction subumts (71%) appear to have an N-
terminal targeting sequence whereas this applies for only nine of twenty-four (38%) of the HP 
fraction subumts 
EPR spectroscopy studies of bovine, Ν crassa and E colt complex I revealed several Iron-
Sulfur redox centres (Ohmshi 1998) Six nuclear encoded subumts contain conserved cysteine 
patterns corresponding with consensus Iron-Sulfur clusters as listed in the introduction Three 
of those cysteine-nch subumts are present in the HP fraction, namely NDUFS7, NDUFS8 and 
NDUFA8 Of all eight subumts presented in this paper, the NDUFA10 and NDUFB10 are the 
only two with more than two cysteine residues among its amino acids The NDUFA10 subunit 
contains six cysteine residues and the NDUFB10 five, all of which are conserved in Β taurus, 
with the exception of the first NDUFA10 cysteine residue Yet, the cysteine residues are not 
grouped resembling a consensus Iron-Sulfur cluster pattern 
When three-dimensional structures of Ν crassa (at least 35 subumts) and E colt (14 subumts) 
are compared, the mam difference appears to be the size (Guenebaut et al 1998) The core of 
fourteen proteins seems to be equal, higher species appear to have more subumts moulded 
around this core The eight characterised cDNAs presented in this study do not appear to be 
highly conserved among species A BLAST search with the amino acid sequences of these 
subumts revealed (apart from the obvious matches with bovine subumts) only matches 
(although weak in some occasions) in Caenorhabditts elegans (NDUFA7, NDUFA10, 
NDUFB2 and NDUFB10) and Gallui gallus (NDUFB4) 
Isolated complex I deficiency is a major cause of abnormalities in the energy generating 
system present in mitochondria Great efforts have been made in the past to link a genetic 
cause to this enzyme defect Several mtDNA mutations have been described, but these 
certainly cannot explain all isolated complex I deficiencies, especially not the most frequently 
observed phenotype which presents in infancy, expressing a highly progressive lethal course 
Therapeutic possibilities regarding complex I deficiency are out of reach for the time being 
Therefore, mutational analysis offers the possibility for early detection and if desired for 
prenatal diagnosis We presented the remaining eight nuclear encoded complex I cDNAs, 
which completes human complex I on cDNA level 
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NDUFA3F 75 
CCCgccgcggagacaaagATGGCTGCGAGAGTCGGCGCCTTCCTCAAGAATGCCTGGGACAAGGAGCCAGTGCTG 
H A A R V G A F L K N A W D K E P V L 
150 
GTCGTGTCCTTCGTCGTCGGGGGCCTCGCTGTAATTCTGCCCCCATTGAGCCCCTACTTCAAGTACTCCQTCATG 
V V S F V V G G L A V I L P P L S P Y F K Y S V M 
225 
ATCAACAAGGCCACGCCCTACAACTACCCAGTGCCCGTCCGTGATGATGGGAACATGCCCGACGTGCCCAGCCAC 
I N K A T P Y N Y P V P V R D D G N H P D V P S H 
NDUFA3R 300 
CCCCAGGACCCTCAGGGCCCCAGCCTGGAGTGGCTGAAGAAACTGTGAgcacctccactgacagaggcggcccct 
P Q D P Q G P S L E W L K K L * 
340 
cccacggctcccaaCaaaaatgtgaaaaccaaaaaaaaaa 
poly A signal poly A s i t e 
Fig 7.1 (conunued) cDNA and amino acid sequence ol the NDUFAS subunil 
NDUFA7F 75 
CgcggacggaagATOeCGTCCGCCACCCGTCTCATCCAGCGGCTGCGGAACTGGGCGTCCGGGCATGACCTGCAG 
H A S A T R L I Q R L R N W A S G H D L Q 
150 
GGGAAGCTGCAGCTACGCTACCAGGAGATCTCCAAGCGAACTCAGCCTCCTCCCAAGCTCCCTGTGGGTCCTAGC 
G K L Q L R Y Q E I S K R T Q P P P K L P V G P S 
225 
CACAAGCTCTCCAACAATTACTATTGCACTCGCGATGGCCGCCGGGAATCTGTGCCCCCTTCCATCATCATGTCG 
H K L S N N Y Y C T R D G R R E S V P P S I I M S 
300 
TCGCAGAAGGCGCTGGTGTCAGGCAAGCCAGCAGAGAGCTCTGCTGTAGCTGCCACTGAGAAQAAGGCGGTGACT 
S Q K A L V S G K P A E S S A V A A T E K K A V T 
375 
CCAGCTCCTCCCATAAAGAGGTGGGAGCTGTCCTCGGACCAGCCTTACCTGTGAc actgcacccCcacggccacc 
P A P P I K R W E L S S D Q P Y L * 
NDUFA7R 450 
cgactactttgcctccttggatttcctccagggagaatgtgacctaatttatgacaaatacgtagagctcaggta 
500 
tcacttctagttttactttaaaaaataaaaaaatagagacagaaaaaaaa 
poly A signal poly A site 
Figure 7.1 (continued) cDNA and amino acid sequence of the NDUFA7 subunil 
NDUFB2F 75 
gaagcgaagtaggcaggggcgaggcggctggggaccgcggggcggacgggagcgagtATGTCCGCTCTGACTCGG 
H S A L Τ R 
150 
CTGGCGTCTTTCGCTCGCGTTGGAGGCCGCCTTTTCAGAAGCGGCTGCGCACGGACTGCTGGAGATGGTGGAGTC 
L A S F A R V G G R L F R S G C A R T A G D G G V 
225 
CGTCATGCCGGTGGTGGTGTGCACATTGAGCCCCGGTATAGACAGTTCCCCCAGCTGACCAGATCCCAGGTGTTC 
R H A G G G V H I E P R Y R Q F P Q L T R S Q V F 
300 
CAGAGCGAGTTCTTCAGCGGACTCATGTGGTTCTGGATTCTCTGGCGCTTTTGGCATGACTCAQAAQAGGTGCTG 
Q S E F F S G L M W F W I L W R F W H D S E E V L 
375 
GGTCACTTTCCGTATCCTGATCCTTCCCAGTGGACAOATGAAGAATTAGGTATCCCTCCTGATGATGAAGACTGA 
G H F P Y P D P S Q W T D E E L G I P P D D E D * 
NDUFB2R 450 
aggcgtagactcagcctcactctgtacaagagccaggtgagaatttcaaggattatcgacctcatattgcacatt 
490 
a a a g t t a c a a a t c a a a g t g g c t c g g t c a a g a a t g a a a a a a 
poly A signal poly A site 
Figure 7.1 (continued) cDNA and amino acid sequence of the NDUFB2 subunil 
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NDUFA10F1 75 
tCCtgagCtgaccgggtagccATGGCCTTGCGGCTCCTGAAGCTGGCAOCGACGTCCGCGTCCGCCCGGGTCGTG 
M A L R L L K L A A T S A S A R V V 
150 
GCGGCGGGCGCCCAGCGCGTGAQAGGAATTCATAGCAGTGTGCAGTGCAAGCTGCGCTATGGAATereaCATTTC 
A A G A Q R V R G I H S S V Q C K L R Y G H W H F 
NDUFA10F2 2 2 5 
CTaCTTaOaaATAAAGCAAGCAAAAGACTGACAGAACGCAGCAGAGTGATAACTGTAGATGGCAATATATGTACT 
L L G D K A S K R L T E R S R V I T V D G N I C T 
NDUFA10R1 3 0 0 
GGAAAAGGCAAACTTGCAAAAGAAATAGCAGAGAAACTAGGCTTCAAGCACTTTCCTGAAGCOeOOATTCATTAT 
G K G K L A K E I A E K L G F K H F P E A G I H Y 
3 7 5 
COmOGTACCACAGGAGATGGGAAGCCCCTCGCCACCGACTATAATGGCAACTGTAGTTTGGAGAAATTTTAC 
P D S T T G D G K P L A T D Y N G N C S L E K F Y 
NDUFA10F3 4 5 0 
GATGATCCGAGAAGCAATGATGGCAACAGirACCGCCTGCAGTCCTWeTTOTACAeCAOTCQCCTGCTGCAGTAC 
D D P R S N D G N S Y R L Q S W L Y S S R L L Q Y 
5 2 5 
TCAGATGCCTTGGAGCACTTGCTGACCACAGGACAAGGTGTTGTGTTGGAGCGCTCCATCTTCAGTGACTTTGTG 
S D A L E H L L T T G Q G V V L E R S I F S D F V 
NDUFA10R2 600 
TTCCTOaiUlQCaft.TOrakCAACCAGGGATTCATCCGAAAGCAGTGTGTGGACCACTACAACGAGGTGAAGAeCGTC 
F L E A M Y N Q G F I R K Q C V D H Y N E V K S V 
6 7 5 
ACCATCTGCGATTACCTGCCCCCCCACCTGGTGATTTACATCGATGTGCCCGTTCCAGAGGTCCAGAaeCeOAirP 
T I C D Y L P P H L V I Y I D V P V P E V Q R R I 
NDUFA10F4 7 5 0 
Q K K G D P H E M K I T S A Y L Q D I E N A Y K K 
NDUFA10R3 8 2 5 
ACCTTTCTCCCTOIbGKTaASiaUAAATGTGAGGTTTTACAGTATTCTGCAAGGGAAGCTCAAGATTCAAAAAAG 
T F L P E M S E K C E V L Q Y S A R E A Q D S K K 
9 0 0 
GTGGTAGAGGACATTGAATACCTGAAGTTCGATAAAGGGCCGTGGCTCAAGCAGGACAATCGCACTTTATACCAC 
V V E D I E Y L K F D K G P W L K Q D N R T L Y H 
NDUFA10F5 9 7 5 
CTGCGATTACTGGTTCAaaATAAeTTTOAeOtOCTaAAT^ACACAAGCATTCCTATCTTTCTCCCGGAAGTCACC 
L R L L V Q D K F E V L N Y T S I P I F L P E V T 
NDUFA10R4 1050 
ATTGGAGCTCATCAGACTGACqgrgK^TACATCAOTTCAQAGAGCTGCCGGGCCGCAAGTACAGCCCTGGGTAC 
I G A H Q T D R V L H Q F R E L P G R K Y S P G Y 
1125 
AACACCGAGGTGGGAGACAAGTGGATCTGGCTGAAGTGAacgggccgccttctgctccagctgcatcacagtgat 
N T E V G D K W I W L K * 
1200 
ggccaagctgcatcagccgcactctcctggacgccatatagctttaagatcgggggagggtaaataatgcaaaaa 
1275 
ttgcacagtggaagaaggggtctcacaaaaagcaatccatcctgtagtataggtaatggagttgggggaagcagc 
1350 
ttccattctggatgtttggaaccctttagctttgttttggaatggcccaccattctcactggaaaacagtggtct 
NDUFA10R5 1425 
gctgtgaaaggccagctctcggcagcccctgtggtttcagcgtgccgctctgtgccattcaggttgtgcacattg 
1475 
t t t t t c t t c t g a c t t c c a g a a a t a a a a g t g t t t c c a t g g g a a a a a a a a a a 
poly a signal poly A sice 
Figure 7.1 (continued) cDNA and amino acid sequence of the NDUFA10 subunil. 
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NDUFB4F1 75 
M S F P K Y K P S S L R T L P E T L D P A E 
1 5 0 
TACAACATATCTCCGGAAACCCGGCGGGCGCAAGCCGAGCGGTTGGCCATAAGAGCCCAGCTGAAACGAGAGTAC 
Y N I S P E T R R A Q A E R L A I R A Q L K R E Y 
NDUFB4R1 2 2 5 
CTGCTTCAGTACAACGATCCCAACCGCCGAGGaCTCXTCOftAJMXCCTaCCTTeCTTCGTTGGGCCTATGCAAGA 
L L Q Y N D P N R R G L I E N P A L L R W A Y A R 
NDUFB4F2 3 0 0 
ACAATAAATGTCTATCCTAATTTCAGACCCACTCCTAAAAACTCACTCJLTOaaiUKVCTOTOTataT^raGGCCC 
T I N V Y P N F R P T P K N S L M G A L C Q F G P 
3 7 5 
CTCATCTTCATTTATTATATTATCAAAACTGAGAGGGATAGGAAAGAAAAACTTATCCAGGAAGGAAAATTGGAT 
L I F I Y Y I I K T E R D R K E K L I Q E G K L D 
NDUFB4R2 4 5 0 
C G A A C A T T T C A C C T C T C A T A T T A A g t c t g g c a a t g a t g a c t a t a t g t a t t c c t g c c t a a a c a a a c c a t c t a t t a a 
R T F H L S Y * poly A signal 
465 
t c a t t a a a a a a a a a a 
poly A s i t e 
Figure 7.1 (continued) cDNA and amino acid sequence of the NDUFB4 subumt 
NDUFB8F1 75 
ggea tgtggaagaaggtga agATGGCGGTGGCCAGGGCCGGGGTCTTGGGAGTCCAGTGGCTGCAAAGGGCATCC 
M A V A R A G V L G V Q W L Q R A S 
1 5 0 
CGGAACGTGATGCCGCTGGGCGCACGGACAGCCTCCCACATGACCAAGGACATGTTCCCGGGGCCCTATCCTAea 
R N V M P L G A R T A S H M T K D M F P G P Y P R 
NDUFB8F2 2 2 5 
ACCCC>a*»aAACqaGCCGCCGCCGCCAAGAAGTATAATATGCGTGTGGAAGACTACQAACCTTACCCGGATGAT 
T P E E R A A A A K K Y N M R V E D Y E P Y P D D 
NDUFB8R1 3 0 0 
GGCATGGGGTATGGCOACTACCCQAAGCTCCCTaACCGCTCACAGCATGAGAGAGATCCATGGTATAGCTGGGAC 
G M G Y G D Y P K L P D R S Q H E R D P W Y S W D 
3 7 5 
CAGCCGGGCCTGAGGTTGAACTGGGGTGAACCGATGCACTGGCACCTAGACATGTACAACAGGAACCGTGTGGAT 
Q P G L R L N W G E P H H W H L D H Y N R N R V D 
NDUFB8R2 4 5 0 
ACATCCCCCACACCTGTTTCTTGGCATGTCATGTGTATGCAaCTCTTCae^fTCCTOOCTTTCATGATATTCATG 
T S P T P V S W H V M C M Q L F G F L A F M I F M 
5 2 5 
TGCTGGGTGGGGGACGTGTACCCTGTCTACCAGCCTGTGGGACCAAAGCAGTATCCTTACAATAATCTGTACCTG 
C W V G D V Y P V Y Q P V G P K Q Y P Y N N L Y L 
6 0 0 
GAACGAGGCGGTGATCCCTCCAAAQAACCAGAGCGGGTGGTTCACTATGAGATCTGAggaggc t t e g t g g g c t C t 
E R G G D P S K E P E R V V H Y E I * 
NDUFB8R3 675 
t g g g t c c t c t a a c t a g g a c t c c c t c a t t c c t a g a a a t t t a a c c t t a a t g a a a t c c c t a a t a a a a c t c a g t g c t g t 
poly A signal 
688 
gttaaaaaaaaaa 
poly A site 
Figure 7.1 (conunued) cDNA and amino acid sequence of the NDUHB8 subumt 
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cDNA oj eight nuclear encoded subumts of NADH:ubiquinone oxidoredutluse. 
human complex I cDNA characterisation completed' 
NDUFB10F1 7 5 
a g g c c c g g g a c c c g g a c g g a g g t a g a g g c c a g g g c a g c g c g t c c g g g a g c g g a g t c c g c g c c c g c c g c c g c c A T G 
H 
1 5 0 
CCGGACAGCTGGGACAAGGATGTGTACCCTGAGCCCCCGCGCCGCACGCCGGTGCAGCCCAATCCCATCGTCTAC 
P D S W D K D V Y P E P P R R T P V Q P N P I V Y 
2 2 5 
ATGATGAAAGCGTTCGACCTCATCGTGGACCGACCCGTGACCCTCGTGAGAGAATTTATAGAGCGGCAGCACGCA 
M M K A F D L I V D R P V T L V R E F I E R Q H A 
NDUFB10F2 3 0 0 
AAGAACAGGTATTACTACTACCACCGGaUÄACCOCCaCOTaCCAOACATCACTGAGTGCAAGGAGGAGGACATC 
K N R Y Y Y Y H R O Y R R V P D I T E C K E E D I 
NDUFB10R1 3 7 5 
ATGTGCATK3TATGAAGCCGAAATGCAGTGGAAGAGGGACTAaUUUJTa»CC*AaAAATTATCAACATTATGCAG 
M C M Y E A E M Q W K R D Y K V D Q E I I N I H Q 
4 5 0 
GATCGGCTCAAAGCCTGTCAGCAGAGGGAAGGACAGAACTACCAGCAGAACTGTATCAAGGAAGTGGAGCAGTTC 
D R L K A C Q Q R E G Q N Y Q Q N C I K E V E Q F 
5 2 5 
ACCCAGGTGGCCAAGGCCTACCAGGACCGCTATCAGGACCTGGGGGCCTACAGTTCTGCCAGGAAGTGCCTGGCC 
T Q V A K A Y Q D R Y Q D L G A Y S S A R K C L A 
6 0 0 
AAACAGAGGCAGAGGATGCTGCAAGAGAGAAAAGCTGCAAAAGAGGCCGCCGCTGCCACCTCCTGAggcagc t g t 
K Q R Q R M L Q E R K A A K E A A A A T S * 
NDUFB10R2 6 7 0 
g g g t g c c c c t g c t g t g t g g c t c t g t a t g a c t g t t g c t g a a a t a t a a a g c c c t g c a a c c t g a a a a a a a a a a 
poly A si te 
F i g u r e 7.1 ( cont inued) c D N A and amino acid s equence of the N D U F B 1 0 subunil . 
NDUFC2F1 7 5 
t c g t c g t g g t t t t c c t t g t a g t t c g t g g t c t g a g a c c a g g c c t c a a g t g g a a a c g g c g t c a c c A T G A T C G C A C G G 
M I A R 
1 5 0 
CGGAACCCAGAACCCTTACGQTTTCTGCCGGATGAGGCCCGGAGCCTGCCCCCGCCCAAGCTGACCGACCCGCGG 
R N P E P L R F L P D E A R S L P P P K L T D P R 
2 2 5 
CTCCTCTACATCGGCTTCTTGGGCTACTGCTCCGGCCTGATTGATAACCTGATCCGGCGGAGGCCGATCGCGACG 
L L Y I G F L G Y C S G L I D N L I R R R P I A T 
NDUFC2R1 3 0 0 
GCTGGTTTGCATCGCCAOC^rK^ATATATTACGaCCTTTTTTTTTGCTGGATATTATCTTGTAAAACGTGAAGAC 
A G L H R Q L L Y I T A F F F A G Y Y L V K R E D 
NDUFC2F2 3 7 5 
TACCTGTATGCTOTOAjGeaACCGTGAAATGTTTGGATATATGAAATTACATCCAGAGGATTTTCCTGAAGAAGAT 
Y L Y A V R D R E M F G Y M K L H P E D F P E E D 
4 5 0 
AAGAAAACATATGGTGAAATTTTTGAAAAATTCCATCCAATACGTTGAagtct t e a a a a t g e t t g c t c c a g t t t c 
K K T Y G E I F E K P H P I R * 
NDUFC2R2 5 0 0 
a c t g a t a c c t g c t g t t t c t g a a t t t g a t g g a a c a t g t t t c t t a t g a c a g t 
F i g u r e 7.1 ( cont inued) c D N A and amino acid s equence ot the N D U F C 2 subunit 
Primers used for P C R and sequence réactions are shaded Primers are a l so listed in Table 7 1 
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CHAPTER 8 
DEMONSTRATION OF A NEW PATHOGENIC MUTATION IN HUMAN 
COMPLEX I DEFICIENCY: A 5-bp DUPLICATION IN THE NUCLEAR GENE 
ENCODING THE NDUFS4 (18 kDa) SUBUNIT 
American Journal of Human Genetics 1998 62:262-268. 
Abstract. 
We report the cDNA cloning, chromosomal localisation, and a mutation in the human nuclear 
gene encoding the NDUFS4 (18 kDa) subunit of the mitochondnal respiratory chain complex 
I The cDNA has an open reading frame of 175 amino acids and codes lor a protein with a 
molecular mass ot 20 1 kDa Its gene was mapped to chromosome 5 A homozygous 5-bp 
duplication, destroying a consensus phosphorylation site, in the NDUFS4 cDNA was found in 
a complex I-deficient patient The patient showed normal muscle morphology and a 
remarkably non-specific fatal progressive phenotype without increased lactate concentrations 
in body fluids The child's parents were heterozygous for the mutation In 19 other complex I-
deficient patients, no mutations were tound in the NDUFS4 gene 
Chapter 8 
Introduction. 
Among the inborn errors of metabolism, disturbances in the mitochondrial energy metabolism 
form a quantitatively major group, occurring in 1 10,000 live births (Bourgeron et al 1995) In 
case of a defective pyruvate oxidation, skeletal muscle and brain tissue are olten involved In 
these mitochondrial encephalomyopathies (OMIM 251900), the most frequently observed 
enzyme deficiencies are located in the pyruvate dehydrogenase complex and complexes I 
(OMIM 252010) and/or IV of the respiratory chain (Wallace 1992, Ruitenbeek et al 1996) 
Numerous patients with isolated complex I deficiency have been reported (Korenke et al 
1990, DiMauro and Moraes 1993, Shoffner and Wallace 1994) Their clinical presentation in 
general is that of a very severe, often fatal, multisystemic disorder frequently dominated by 
brain and skeletal muscle abnormalities Less severe phenotypes have also been described 
(Wallace 1992, Tnjbels et al 1996) Until now, only one mutation in a nuclear gene has been 
described in a patient with a defective respiratory chain enzyme complex a point mutation in 
the flavoprotein (FP) subunit ot complex Π (Bourgeron et al 1995). No mutations in the 
nuclear genome of one of the other respiratory chain complexes have been reported The 
relatively high frequency of complex I-deficient patients prompted us to investigate the 
molecular cause of this enzyme deficiency Complex I or NADH.ubiquinone oxidoreductase, 
the first multisubunil enzyme complex of the mitochondrial respiratory chain, plays a vital 
role in cellular ATP production, the primary source of energy for many crucial processes in 
living cells (Walker 1992, Pilkington et al 1993, Tnjbels et al 1996) It removes electrons 
from NADH and passes them via a series of different protein-coupled redox centres (FMN 
and FeS clusters) to the electron acceptor ubiquinone (Yamaguchi and Hatefi 1993) In well-
coupled mitochondria, the electron flux leads to ATP generation via the building of a proton 
gradient over the inner membrane 
Complex I is composed of >41 subunits, of which 7 are encoded by the mitochondrial genome 
(NDI-6, ND4L) and the remaining by nuclear genes (Feamley and Walker 1992) Limited 
information is available concerning the precise location and function of the individual 
subunits Very recently, a low-resolution three-dimensional structure of complex I from 
Neurospora crassa has been elucidated (Guenebaut et al 1997) A number of different 
subunits contribute to binding sites for FMN, NADH, and 4Fe-4S and 2Fe-2S centres (Walker 
1992, Pilkington et al 1993) It is hypothesised that subunits of the FP fraction play a role in 
FMN and NADH binding Proteins in the IP (iron-sulphur protein) fraction likely function in 
reduction-oxidation reactions via different iron-sulphur clusters Very recently, it has been 
shown that the nuclear-encoded 18-kDa subunit of bovine heart complex I can be 
phosphorylated by a mitochondrial cyclic adenosine 5'-monophosphate (cAMP)-dependent 
protein kinase (Papa et al 1996) It is well established that the 18-kDa (AQDQ) subunit is in 
the extrinsic domain of complex I (Walker 1992) 
In some patients (i e in Leber hereditary optic neuropathy) a mutation in the ND4 subunit of 
the mitochondrial genome has been established (Brown et al 1997) So far, the human cDNA 
sequences of seven nuclear-encoded subunits (eg NDUFV1, NDUFV2, NDUFS1, NDUFS7, 
NDUFA1, NDUFA5, NDUFB9) have been published (Chow et al 1991, Spencer et al 1992, 
de Coo et al 1995, Hattori et al 1995, Gu et al 1996, Hyslop et al 1996, Zhuthenko et al 1996, 
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A 5 hp duplication in the nuclear gene encoding the NDUFS4 (18 kDa) subunit 
Fata et al 1997) The availability of the bovine cDNA sequence for the 18-kDa (AQDQ) 
protein (Walker et al 1992) enabled us to apply a PCR-based strategy for generating the 
cDN A for the human NDUFS4 ( 18-kDa) protein from human heart 
In this article, we present the human cDNA sequence of the nuclear-encoded NDUFS4 
subunit, the chromosomal localisation of the gene, and the results of mutation detection in 20 
complex I-deficient patients all exhibiting a multisystem disorder Detailed information is 
presented about the clinical symptoms of one patient in whom we found a 5-bp duplication in 
the NDUFS4 gene This is the first report of a pathological mutation in a nuclear complex I 
gene of the mitochondrial respiratory chain 
Patient, material and methods. 
Case history 
A male patient, born after an uncomplicated pregnancy as the second child of healthy 
nonconsanguineous Caucasian parents, was first admitted at the age of 8 mo with severe 
vomiting, failure to thrive, and hypotonia Despite supportive care, his clinical condition 
deteriorated in the following months At the age of Π mo, he showed severe psychomotor 
retardation, convulsions, bradypnoea, cyanosis, hypotonia, and depressed tendon reflexes 
Results of routine clinical chemical blood and urine investigations, as well as amino acid and 
organic-acid analyses in blood and unne, were normal Lactic acid concentrations in blood 
and cerebrospinal fluid were within the range of controls Electromyographic parameters were 
normal Cerebral magnetic resonance imaging revealed generalised brain atrophy and 
symmetrical basal ganglia abnormalities When the patient was 14 mo of age, a skeletal 
muscle biopsy (musculus quadriceps femori) was performed to investigate the mitochondnal 
energy-generating system (see Biochemical methods) Light and electron microscopy and 
histochemistry did not reveal abnormalities No ragged-red fibres were present The child's 
condition deteriorated severely, and he died of cardiorespiratory failure at the age of 16 mo 
The family history is normal for neuromuscular disorders A younger brother and older sister 
of the proband are healthy 
Cloning of the human NDUFS4 cDNA 
Human NDUFS4 cDNA was obtained by reverse transcription using oligo(dT) and random 
hexamer primers on poly A+ RNA isolated from human heart (Clonetech) PCR amplification 
was performed with cDNA as template according to the protocol for Taq polymerase (Life 
Technologies) by use of oligonucleotides 5 -ATGGCGGCGGTCTCAATGTC t and 
5 CTATTTTGTGGATACTCTTGTTC Ί Oligonucleotide sequences were based on homology with 
bovine 18-kDa cDNA sequence (Walker et al 1992) and known human expressed sequence 
tags (ESTs) The PCR product was purified for direct DNA sequencing DNA sequence 
analysis of both DNA strands was performed using the dyedeoxy-terminators on an automated 
ABI 377 sequencer according to a protocol provided by the manufacturer (Applied 
Biosystems) 
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Chromosomal lotalisalion of the NDUFS4 gene 
Genomic DNA was isolated from human-rodent somatic cell hybrids containing all 24 human 
chromosomes (Conell Cell Depositories) digested with EcoRl, tractionated, and blotted to 
Hybond nylon membrane The blot was hybridised with α "P-dCTP-labeled human NDUFS4 
cDNA probe (of 528 bp) Binding of the probe was visualised by autoradiography 
Mutation detection 
Total RNA was extracted (Chomczynski and Sacchi 1987) from cultured skin fibroblasts 
(Bentlage et al 1996) and stored as ethanol precipitate at -80°C A 5^g sample ol RNA was 
reverse transcribed to cDNA in 1 h at 420C with 200 U of Superscript II reverse transcriptase 
(RT) (Life Technologies), using oligo(dT) and random hexamer primers One microliter ol 
cDNA was subjected to PCR amplification By PCR we generated one fragment covering the 
entire coding region, using the synthetic oligonucleotide primers descnbed belore The PCR 
program consisted of 35 cycles of 30 s at 940C, 30 s at 550C, and 1 mm at 72°C The cycles 
were preceded by an initial denaturation step of 3 mm at 95°C and were followed by a final 
extension of 10 mm at 72°C The PCR reaction was analysed on a 1 0% agarose gel with 0 5 
μg/ml ethidium bromide in lx Tnsborate EDTA The nucleotide sequences ot the PCR 
products were analysed by direct sequencing using the Taq Dye Deoxy terminator cycle 
sequencing kit according to the manufacturers recommendations (Applied Biosystems) 
To confirm the mutation at the genomic DNA level, a fragment consisting of 96 bp was 
amplified in the same PCR buffer as descnbed above, using forward primer 
5 TATGACATTGAAGAGAGGAAGG 3 and reverse primer as descnbed above PCR fragments 
were resolved in a 20% Polyacrylamide gel Ethidium bromide was used to visualise the PCR 
fragments, and the presence of the duplication could be checked by size 
Results. 
Biochemital results 
From the decreased activity of NADH femcyanide oxidoreductase as well as 
NADH cytochrome c reductase, a deficiency in complex I in skeletal muscle mitochondria can 
be concluded (see Table 8 1) The NADH Qi oxidoreductase assay revealed a complex I 
deficiency in cultured skin fibroblasts also The activities of the other respiratory chain 
enzyme complexes and Mg"+-ATPase were all normal 
Cloning of the human NDU^S4tDNA 
We obtained a 528-bp cDNA Iragment of the human nuclear-encoded NDUFS4 subunit by 
RT-PCR using human heart RNA and oligonucleotide primers based on the NDUl·S4 cDNA 
sequence from cow (Walker et al 1992) and known human ESTs (Adams et al 1995) 
Sequence analysis ol the human ΝθυΡ54 cDNA clone revealed an open reading frame which 
encodes 175 amino acids (Fig 8 1) The amino acid sequence showed 9 1 % homology with the 
bovine 18-kDa amino acid sequence (data not shown) The calculated molecular weight of the 
protein encoded by the human NDUFS4 cDNA is 20 1 kDa As in the cow, the protein 
contains a leader sequence (amino acids 1-42) for import into the mitochondria In the cow. 
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Enzyme activity 
Patient 
7.2' 
1.16b 
2 7 c 
100c 
1.28b 
634d 
18.3e 
0.075' 
0.23e 
1.22e 
239.0e 
311.0e 
Control ranj 
2.8-11.8a 
1.7-4.1b 
63-529c 
39-249c 
1.0-2.1h 
213-553* 
27-61e 
0.11-0.28e 
0.21-0.44e 
1.25-2.62c 
147-252' 
144-257' 
this signal peptide is removed after import. There is a phosphorylation consensus site (RVS) 
at amino acid positions 171-173 (Pearson and Kemp 1991, Kemp et al 1994). The human 
protein has no cysteine residues. 
Skeletal muscle 
• cytochrome c oxidase 
• NADH:ferricyanide oxidoreductase 
• NADHxylochrome c oxidoreductase 
• succinatexyt c oxidoreductase 
• citrate synthase 
• Mg2+-ATPase 
• pyruvate dehydrogenase complex 
Fibroblasts 
• NADH:Q| oxidoreductase 
• Succinatexyt c oxidoreductase 
• decylubiquinohcyt c oxidoreductase 
• cytochrome r oxidase 
• citrate synthase 
Table 8.1 Respiratory chain enzyme activities in index patient's tissue specimens. Patient's individual 
respiratory-chain enzyme and PDHc activities measured in skeletal muscle tissue and cultured skin fibroblasts. 
Complex I activity is reduced in both tissue specimens. 
' = in k/mg protein;h = in U/mg protein; ' = in mU/mg protein; ^ = in mll/g protein;e = in mU/mU cytochrome c 
oxidase. 
Chromosomal localisation of the human NDUFS4 gene. 
A Southern blot with genomic DNA from human-rodent somatic cell hybrids containing all 
human chromosomes has been used for hybridisation with human NDUFS4 cDNA as probe. 
A specific hybridisation signal was detected only for chromosome 5, indicating that the 
nuclear-encoded NDÜFS4 ( 18 kDa) gene maps to this chromosome (Fig. 8.2). 
Mutation detection in the human NDUFS4 subunit. 
A template of human cDNA was produced by first-strand synthesis of human fibroblast RNA 
originating from 20 patients with a complex 1 deficiency enzymatically established in 
fibroblasts and, when available, also in skeletal muscle and other tissues. One set of 
oligonucleotide primers enabled us to amplify the entire coding region of the NDUFS4 cDNA. 
Direct sequencing of this region revealed a novel homozygous 5-bp duplication of the cDNA 
sequence at positions 466-470 (AAGTC) in one patient (Fig. 8.3a). No other sequence 
aberrations could be detected in the NDUFS4 cDNA of all other patients. The 5-bp 
duplication results in a frameshift at codon K158 and destroys a phosphorylation site present 
at the carboxy-terminus of the NDUFS4 protein. Furthermore, the duplication changes the 
amino acid sequence of the NDUFS4 protein from amino acid 158 to the carboxy terminus 
and expands the length of the protein by 14 amino acids (Fig. 8.3b). The mutation was 
1(17 
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confirmed on the genomic DNA level by PCR combined with PAGE. Both parents appeared 
to be heterozygous for the mutation (Fig. 8.3c). The segregation of this mutation in the family 
is consistent with an autosomal recessive mode of inheritance. The duplication was not 
present in 100 control alleles and the 19 other complex I-deficient patients. 
75 
gcagcaagATGGCGGCGGTCTCAATGTCAGTGGTACTGAGGCAGACGTTGTGGCGGAGAAGGGCAGTGGCTGTA 
M A A V S M S V V L R Q T L W R R R A V A V 
150 
GCTGCCCTTTCCGTTTCCAGGGTTCCGACCAGGTCGTTGAGGACTTCCACATGGAGATTGGCACAGGACCAGACT 
A A L S V S R V P T R S L R T S T W R L A Q D Q T 
225 
CAAGACACACAACTCATAACAGTTGATGAAAAATTGGATATCACTACTTTAACTGGCGTTCCAGAAGAGCATATA 
Q D T Q L I T V D E K L D I T T L T G V P E E H I 
300 
AAAACTAGAAAAGTCAGGATCTTTGTTCCTGCTCGCAATAACATGCAGTCTGGAGTAAACAACACAAAGAAATGG 
K T R K V R I F V P A R N N M Q S G V N N T K K W 
375 
AAGATGGAGTTTGATACCAGGGAGCGATGGGAAAATCCTTTGATGGGTTGGGCATCAACGGCTGATCCCTTATCC 
K H E F D T R E R W E N P L M G W A S T A D P L S 
450 
AACATGGTTCTAACCTTCAGTACTAAAGAAGATGCAGTTTCCTTTGCAGAAAAAAATGGATGGAGCTATGACATT 
N M V L T F S T K E D A V S F A E K N G W S Y D I 
525 
GAAGAGAGGAAGGTTCCAAAACCCAAGTCCAAGTCTTATGGTGCAAACTTTTCTTGGAACAAAAGAACAAGAGTA 
E E R K V P K P K S K S Y G A N F S W N K R T R V 
600 
TCCACAAAATAGgttggcactgactatatctctgcttgactgtgaataaagtcagctatgcagtatttatagtcc 
S Τ Κ * 663 
a t g t a t a a t a a a t a c a t c t c t t a a t c t c c t a a t a a a t t g g a c c t t t a a a c t a c a a a a a a a a a a 
poly a signal poly a site 
Figure 8.1 cDNA and amino acid sequence of the human NDUFS4 subunit. The cDNA and amino acid sequence 
are submitted to Genbank (accession no. NM002495). 
M H tH #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 #11 #12 *13 #14 #15 #16 #17 #1« #19 #20 #21 #22 #X #Y 
Figure 8.2 Chromosomal localisation of the human NDUFS4 ( 18 kDa) gene. The NDUFS4 gene was localised to 
chromosome 5 by chromosomal somatic cell hybrid analysis. Genomic DNA was isolated from a panel of mouse 
or hamster/human cells, each containing a single human chromosome. The DNA was digested with EcoRI, 
fractionated, transferred to Hybond nylon, and probed with a 528-bp NDUFS4 cDNA. A positive signal was 
observed in the sample of total DNA of human origin (left arrow). Mouse (M) and hamster (H) genomic DNA 
showed no NDUFS4 signal. A strong signal for the NDUFS4 was seen only on hybrids containing chromosome 5 
(right arrow). 
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Wildtype 
C A A G 
Figure 8.3a DNA sequence of the NDUFS4 cDNA segments for wild type (top) and patient with the mutation 
(bottom) In case of the patient, a 5 bp duplication (AAGTC) was observed, resulting in a frameshift and 
extension of the C terminus of the NDUFS4 protein 
Wildtype NGWSYDIEER KVPKPKSKSY GANFSWNKRT RVSTK* 
Patient NGWSYDIEER KVPKPKSSPS LMVQTFLGTK EQEYPQNRLA LTISLLDCE* 
150 160 170 180 190 
Figure 8.3b Pnmary C-terminal amino acid sequence of wild-type and patient's NDUFS4 protein 
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Figure 8.3c Molecular analysis ol the NDUFS4 (18 kDa) gene Segregation ot the S-bp duplication in the 
NDUl·S4 gene in the family, delected by PCR on genomic DNA and by PAGE Mutant and wild-type alleles are 
101 bp and 96 bp. respectively Lane I contains ihe molecular sue marker, lane 2 brother, lane 3 father, lane 4 
mother and lane 5 index patient. 
Discussion. 
Complex I deliciencies, whether or not as part of multiple enzyme deficiencies, are a major 
cause of mitochondrial cnccphalomyopathies. So far, no mutation in a nuclear gene of one of 
the numerous complex I subumts has been described. The mulli-sysiemic progressive clinical 
presentation of our patient was highly suggestive for a mitochondriocytopathy (Munnich et al 
1992, DiMauro and Moraes 1993, Shoffner and Wallace 1994, Ruitenbeek et al 1996). 
Despite normal clinical chemical features, biochemical analyses indeed revealed a reduced 
complex 1 activity both in skeletal muscle and cultured skin fibroblasts. In addition, a 5-bp 
duplication in the cDNA and genomic DNA encoding the nuclear-encoded NDUFS4 (18 kDa) 
subunit of complex I of the respiratory chain could be demonstrated. Both parents were 
heterozygous for this mutation. 
We started our mutation analysis in complex 1-deficient patients with examination of the 
NDUtS4 gene, because Papa et al (1996) found that the bovine 18-kDa subunit can be 
phosphorylated. A mitochondrial inner membrane-bound kinase acts via a cAMP-depcndenl 
mechanism. The presence ol a phosphorylation/dephosphorylation site is frequently associated 
with regulation of biological processes. In the case of phosphorylation of the NDUFS4 
subunit, one can hypothesise an influence on complex 1 activity or a role in posttranslational 
processes The cDNA, encoding the 18-kDa subunit of bovine complex I, had already been 
cloned. We cloned the human NDUFS4 subunit by RT- PCR, using human heart mRNA as 
template. The protein encoded by the human NDUFS4 gene is 175 amino acids long, and its 
calculated molecular mass is 20.1 kDa. The amino acid sequence ol the human NDUFS4 
protein is highly conserved. There is ~9\r/r identity between the human and bovine 
counlerparls. The bovine consensus phosphorylation site (RVS) is also present in the human 
subunit. As in the cow, the human NDUFS4 subunit has a leader sequence for import into the 
mitochondria. Although the human, like the bovine, NDUFS4 protein is supposed to be part 
of the IP fraction (Walker et al 1992), it has no cysteine residues thai might provide ligands 
no 
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for iron-sulphur centres A Blast search ior homologous sequences revealed two different EST 
clones (AA258924 and N29566) originating from different human tissues 
We have included in this study 20 patients with a complex I deficiency in fibroblasts and, in 
most patients, in at least one other tissue as well Direct sequencing ol the entire NDUFS4 
cDNA of these patients revealed in one patient a homozygous 5-bp duplication A mistake 
made by the RT or Taq DNA polymerase in the RT-PCR was excluded by repeating the RT-
PCR and DNA sequencing of this patient, all of which revealed the homozygous duplication 
in the patient's cDNA The presence of the duplication in the patient was confirmed on the 
genomic DNA level The 5-bp duplication causes a shift in the translational reading frame 
The shift results in (1) an elongation of the mature protein by 14 amino acids and (2) destroys 
the phosphorylation consensus site Although the gene product belongs to the IP fraction and 
therefore is probably involved in crucial redox reactions, its relation to the adjacent subunits 
and its exact function are still obscure Our results, a mutation with an autosomal recessive 
mode of inheritance, associated with a fatal multisystemic complex I deficiency biochemically 
established in two different tissue types, stress the physiological importance of this subunit in 
humans Because the phosphorylation site in the NDUFS4 subunit is disrupted in the patient, 
we speculate that the mutation in this vital site for regulation of protein function in eukaryotic 
cells is responsible for the observed complex I deficiency Alternatively, the obviously 
changed C-terminus of the NDUFS4 subunit of the patient has caused the complex I 
deficiency The protein has been elongated by 14 amino acids, and amino acids 158-175 have 
been modified A proper transport and/or folding and orientation of the NDUFS4 protein in 
the enzyme complex or in the mitochondrial inner membrane may be hindered Perhaps the 
alterations in the patient NDUFS4 subunit also lead to instability and premature breakdown of 
the protein 
In conclusion, we present the first mutation in a nuclear gene of one ol the subunits of 
complex I of the human respiratory chain Although the frequency ol the described mutation 
must be further established, the finding improves the potentials for genetic counselling and 
prenatal diagnosis These preventive tools are of utmost importance, because therapeutic 
intervention is unsuccessful in the majority ol complex I deficient patients Mutation analysis 
of other nuclear genes in patients with a complex I deficiency is in progress 
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CHAPTER 9 
THE FIRST NUCLEAR-ENCODED COMPLEX I MUTATION IN A PATIENT WITH 
LEIGH SYNDROME 
American Journal of Human Genetics 1998 63:1598-1608 
Abstract. 
Nicotinamide adenine dinucleotide (NADH):ubiquinone oxidoreductase (complex I) is the 
largest multi-protein enzyme complex of the respiratory chain. The nuclear-encoded NDUFS8 
(TYKY) subunit of complex I is highly conserved among eukaryotes and prokaryotes and 
contains two 4Fe4S ferredoxin consensus patterns, which have long been thought to provide 
the binding site for the iron-sulphur cluster N-2. The NDUFS8 cDNA contains an open 
reading frame of 633 bp, coding for 210 amino acids. Cycle sequencing of amplified NDUFS8 
cDNA of 20 patients with isolated enzymatic complex I deficiency revealed two compound 
heterozygous transitions in a patient with neuropathologically proven Leigh syndrome. The 
first mutation was a C236T (P79L), and the second mutation was a G305A (R102H). Both 
mutations were absent in 70 control alleles and co-segregated within the family. A progressive 
clinical phenotype proceeding to death in the first months of life was expressed in the patient. 
In the 19 other patients with enzymatic complex I deficiency, no mutations were found in the 
NDUFS8 cDNA. This article describes the first molecular genetic link between a nuclear-
encoded subunil of complex I and Leigh syndrome. 
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Introduction. 
The oxidative phosphorylation (OXPHOS) system of mammals consists of five complicated 
multi-protein complexes (complexes I-V) Complexes I and II accept electrons from the 
reduced coenzymes nicotinamide adenine dinucleotide (NADH) and flavin adenine 
dinucleotide (FADI-l·), respectively These electrons are transported along the electron 
transport chain, and coupled to this transport a proton gradient is created by complexes 1, III, 
and IV across the inner mitochondrial membrane ATP synthase (complex V) couples proton 
movement down its electrochemical gradient with the synthesis ol ATP from adenosine 
diphosphate and P, 
Complex I has been widely studied in prokaryotes as well as eukaryotes Genetic 
characteristics of NADH ubiquinone oxidoreductase are best documented in Bos taurus 
(Walker 1992), Neurospora crassa (Weiss et al 1991), and Escherichia coli (Weidner et al 
1993, Friedrich 1998) E coli complex I consists ol the 14 subunits that together are 
considered to be the minimal structural unit for enzymatic activity In humans, the exact 
number of complex I subunits is unknown (for a review see Smeitink et al 1998a) Β taurus is 
the mammal nearest to humans whose complex I has been structurally elucidated (Walker 
1992, Gngoneff 1998) It contains -42 subunits (Walker 1995, Walker et al 1995), 35 of 
which are encoded by the nucleus and the remaining 7 by mlDNA (Chomyn et al 1985 and 
1986) Complex I contains several redox centres to facilitate electron transport These are 
hypothesised to be one non-covalently bound flavin mononucleotide and 6-8 iron-sulphur 
clusters (Yamaguchi and Hatefi 1993, Albracht et al 1996, Ohnishi 1998) 
One of the most frequently encountered syndromes associated with defects of the OXPHOS 
system was named after the man who first described a young patient suffering from a 
progressive neurodegenerative disorder with characteristic neuropathology, namely, Leigh 
syndrome (MIM 256000, Leigh 1951) The estimated incidence of Leigh syndrome is 
~1 40,000 live births (Rahman et al 1996) Several inheritance patterns can be differentiated 
in Leigh syndrome (DiMauro and De Vivo 1996) autosomal recessive, with defects described 
in biotimdase (Baumgartner et al 1989), pyruvate dehydrogenase complex (PDHc), OXPHOS 
complex II (Bourgeron et al 1995) and complex IV (Willems et al 1977), X-linked recessive, 
with defects in the E|
a
 subunit of PDHc (Matthews et al 1993), and maternal, with delects in 
subunit 6 of ATP synthase (Shoffner et al 1992, Tatuch et al 1992), tRNA(Lys) (Hammans et 
al 1993), tRNA(Trp) (Santorelli et al 1997), tRNA(Val) (Chalmers et al 1997), and 
tRNA(Leu) (Graeber and Muller 1998), MERFF mutation A8344G (Berkovic et al 1991), and 
A3243G (Rahman et al 1996) Recently, respiratory-chain enzyme assays performed in 
patients with Leigh syndrome revealed that complex I deficiency (MIM 252010) is a major 
contributor to this disease entity (Moms et al 1996, Rahman et al 1996), but until now 
molecular genetic defects have not been described 
The NDUFS8 (TYKY) is a highly conserved nuclear-encoded complex I subunit with 
equivalents present in many species, best documented in humans (Procaccio et al 1997), Β 
taurus (Walker 1992), Ν crassa (Duarte et al 1996), E coli (Weidner et al 1993), and 
Rhodobacter capsulatus (Chevallet et al 1997) The position of the NDUFS8 subunit in 
dillerent fractions of complex I (flavoprotein [FP] Iraclion, iron-sulphur protein [IP] fraction. 
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and hydrophobic protein [HP] fraction) has not been firmly established Masui et al (1991) 
located the bovine TYKY subunit in the IP fraction, but it is also considered to belong to the 
HP fraction (Walker 1992) The amino acid sequence contains two 4Fe4S ferredoxin 
consensus patterns (PROSITE pattern P500198 CIACKLCEAICP and CIYCGFCQEACP) 
Whether these consensus patterns provide the binding site for iron-sulphur cluster N-2 is still 
under debate (Dupuis et al 1991, Albracht et al 1997, Duarte et al 1997) Albracht and 
coworkers proposed in 1997 that the NDUFS8 subunit has tunctional sigmhcance in the 
reduction of ubiquinone coupled to the pumping of protons Recently, homologous 
recombination studies performed with the Nuol subunit of Λ capsulatus (equivalent to human 
NDUFS8) showed that Nuol plays an important role in the assembly of complex I, which 
emphasises the importance of this subunit (Chevallet et al 1997) 
Herein we report the results of a mutational analysis study of the NDUFS8 subunit performed 
in 20 patients with isolated complex I deficiency Our study revealed two new compound 
heterozygous transition mutations in one patient with Leigh syndrome Detailed information 
concerning the clinical characteristics ot this patient is presented This is the first molecular 
genetic link between Leigh syndrome and a nuclear-encoded subunit of NADH ubiquinone 
oxidoreductase In addition, we studied the mRNA tissue distnbution of the NDUFS8 subunit 
and discuss possible connections between tissue expression and the clinical phenotype of the 
patient 
Patients, material, and methods. 
Case report 
In May 1990, a 5-wk-old male infant presented with poor leeding and episodes of apnoea and 
cyanosis The symptoms, which had existed since the first day of life, escalated in the course 
of an acute gastro-ententis He was the second child of healthy, non-consanguineous parents 
of Dutch origin Pregnancy, birth, and first hours oi lite were uneventful The family history 
was negative for major neurological disorders At admission, the main symptoms were mild 
cyanosis, severe hypercarbia, a cardiac murmur (grade 2/4), drowsiness with absent optical 
and acoustical blink, eye flutter, intense hypotonia, brisk tendon reflexes with ankle clonus, 
and erratic seizures A weak cry, rudimentary sucking and primitive reflexes were still present 
The occipitofrontal circumference was normal Dysmorphic features or hepatomegaly were 
absent Cardiac investigation revealed a moderate hypertrophic obstructive cardiomyopathy 
Computed tomography of the brain showed extensive white-matter hypodensity, mild 
ventricular enlargement, and, at a later occasion, also hypodense symmetric lesions in 
putamen and mesencephalon Evoked potentials were delayed for all modalities tested 
Blood tests showed increased lactate (3 4 mmol/1, normal range 0 6-2 1 mmol/1) and pyruvate 
(167 μιηοΐ/ΐ, normal range 30-80 μπιοΐ/ΐ) levels Cerebrospinal fluid (CSF) lactate and 
pyruvate levels were elevated to 5 6 mmol/1 (normal range 14-19 mmol/1) and 191 μιτιοΐ/ΐ 
(normal range 96-145 μπιοΐ/ΐ), respectively The CSF lactate/pyruvate ratio was also increased 
(29 0, normal range 11 7-16 5), and the CSF protein content was slightly increased (504 mg/1, 
normal range 245-460 mg/1) 
On the basis of these findings, a clinical diagnosis of subacute necrotising 
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encephalomyelopathy, or Leigh syndrome, was made Light microscopy studies of a 
quadriceps femoris muscle biopsy sample obtained when the infant was 10 wk of age showed 
a reduced number of small type I fibres (16%, normal 50%), ragged red fibres were not seen 
Electron microscopy (EM) studies were not performed At the age of 11 wk, the infant died of 
cardiorespiratory failure Biochemical examinations performed on skin fibroblasts, skeletal 
muscle, heart muscle, and liver and brain tissue, obtained at autopsy performed <l h after 
death, revealed severely reduced activity of NADH ubiquinone oxidoreductase (39% residual 
activity of the lowest reference value in muscle tissue, see Table 9 1), whereas all other 
complexes of the respiratory chain expressed normal activity PDHc activity was slightly 
reduced in muscle In cultured skin fibroblasts, an isolated NADH ubiquinone oxidoreductase 
deficiency was observed (69% residual activity of the lowest reference value, see Table 9 1) 
Biochemical studies of heart, liver, and brain tissue (also obtained at autopsy) revealed an 
overall reduced activity of NADH ubiquinone oxidoreductase, with respectively, virtually 0%, 
53%, and 3% residual activity of the lowest reference value (Table 9 I) The completely 
deficient complex I activity in heart tissue was repeatedly confirmed Macroscopically, the 
brain had a normal appearance Microscopic investigation of the brain showed extensive 
bilateral symmetrical degeneration, predominantly in the rostral and caudal brain stem, 
diencephalon, and central nuclei, but also elsewhere, including the spinal cord and semioval 
centre The lesions consisted of spongiform degeneration, capillary proliferation with 
endothelial swelling, demyelination, and gliosis Neuronal damage was variable in different 
brain slides, partly because there was a relative sparing of neurons in comparison to the 
surrounding tissue EM studies of heart and liver tissue were not performed On the basis of 
data obtained at autopsy, the patient was neuropathologically diagnosed with Leigh syndrome 
Paiieni group 
Twenty patients with isolated complex I deficiency (4 females and 16 males) were included in 
this study Concise clinical characteristics have been published elsewhere (Loeffen et al 
1998), and a detailed report of our complex I deficient patient group will be published 
elsewhere (Loeffen et al 2000) In this patient group the NDUFAI, NDUFS4, NDUFSS, and 
NDUtBó cDNA were previously examined by direct DNA sequencing (Loeffen et al 1998, 
Smcitink et al 1998b, van den Heuvel et al 1998, Loeffen el al 1999) In one patient a 
mutation was found in the NDUFS4 gene Neither major mitochondrial DNA rearrangements 
nor common pathogenic mtDNA mutations (A3243G [MELAS], T3271C [MELAS], A4317G 
[MELAS], A8344G [MERRF], T8993G/C [NARP/Lcigh syndrome]) were present in this 
patient group 
Commercialh purchased materials 
Molecular size markers, laq DNA polymerase. Superscript II RNAse H reverse transcriptase, 
Bal\ restriction cndonuclcase, and custom-made oligonucleotide primers were obtained from 
Life Technologies, PmM restriction cndonuclcase from Promega, a d-Rhodamine DyeDeoxy 
Terminator Sequencing Kit from Perkin Elmer, gel purification systems from Qiagen a poly 
A+ RNA pool and a Poly A+ RNA master blot from Clontech, and RNAzol from Biosolve 
BV 
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Software 
Consensus-pattern searches in the NDUFS8 ammo acid sequence were performed with 
PROSITE Sequence alignments were performed with Sequence Navigator (Perkin Elmer) 
Hydropathy and secondary structure were plotted by means of methods based on the 
procedures described by Chou and Fasman 1978, Kyte and Doohttle 1982, and Nishikawa 
1983 Computer software was obtained from the National Centre for Computer-Aided 
Chemistry and Bioinformatics (CAOS/CAMM) 
Tissue culture and enzyme measurements 
In our patient group, biochemical enzyme measurements of respiratory-chain complexes were 
performed on skin fibroblasts cultured according to standard procedures Enzyme assay 
procedures were slightly modified from those used for muscle tissue (Bentlage et al 1996) 
The autopsy tissue materials of the patient described in this article were obtained <1 h after 
death and immediately deep frozen in liquid nitrogen and kept at -80oC until enzyme assays 
were performed The enzyme assays described in this paper were based on the following 
methods (slightly modified) NADH ubiquinone oxidoreductase according to Fischer et al 
(1986), succinate cyt c oxidoreductase according to Fischeret al (1985), cytochrome c oxidase 
according to Cooperstein and Lazarow (1951), citrate synthase according to Srere (1969), and 
PDHc according to van Laack et al (1988) Control tissue specimens were handled and stored 
under conditions similar to those of the patient In our expenence, loss of respiratory-chain 
enzyme activities in deep-frozen tissue samples obtained <2 h after death is negligible 
Control values and number of controls are listed in Table 9 1 Values in fibroblasts are 
expressed on cytochrome c oxidase base (cytochrome c oxidase and citrate synthase are 
expressed on a protein base) We chose cytochrome c oxidase as a marker instead of citrate 
synthase, because in the presented patient enzyme activities were measured in fibroblasts 
mitochondria enriched fractions In our expenence, citrate synthase can be artificially 
decreased in mitochondria enriched fractions, since it is a mitochondrial matrix enzyme 
Mutational analysis of the NDUFS8 cDNA 
Patient RNA was extracted from cultured skin fibroblasts according to methods described by 
Chomczynski and Sacchi 1987 Wild-type RNA was commercially obtained and consisted of 
pooled poly A+ RNA from 12 healthy Caucasian males and females, age range 12 78 years 
The RNA was reverse transenbed to cDNA by supersenpt II RNAse H reverse transcriptase 
with oIigo(dT) and random hexamer primers (Ploos van Amstel et al 1996) 
Oligonucleotide primers were designed according to the NDUFS8 cDNA sequence published 
by Procaccio et al (1997, GenBank accession number U65579) The primer oligonucleotides 
F(orward)l Ci TGGCCGAATGGCAGCGTC 3 ) and R(everse)3 (5 TTTTATTGGGCAGCAGGGGC 3 ) 
were applied in PCR to amplify the complete open reading frame (ORF) PCR was performed 
in a reaction volume of 25 μΐ containing 1 μΐ of cDNA template, 0 5 unit of Taq DNA 
polymerase, 2 5 μΐ of lOx PCR buffer, 1 5 mM of MgCb, 50 ng of Fl and R3, and 2 5 mM of 
dNTPs PCR parameters were 35 cycles of 1 mm denaturation at 940C, 1 mm annealing at 
58°C, and 1 mm extension at 72°C The cycles were preceded by an initial denaturation step 
of 1 mm at 94CC and were followed by a final extension step of 10 mm The amplification 
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product was purified from a 2% agarose gel. Sequence reactions using the DyeDeoxy 
Terminator Sequencing Kit were performed with oligonucleotide primers Fl, 
F2 (S'-CCTACAAGTATGTGAACATGC-.T), F3 (.V-CATTGCCTGCAAGCTCTGCG-3'), 
Rl (5'-AGTTGATGGTGGCCGGTTCC-3'), R2 (S-GATGTCATAGCGGGTGGTCC-.T), and R3 (Fig. 9.1). 
The cDNA sequence analysis was performed on the automated ABl 377 sequencer according 
to the protocol provided by the manufacturer. 
F l 7 5 
c g c t g g c c g a a t g g c a g c g t c c t a c a g t g t a g c c t c c g c c t c c c g a t t g a c t g g c c t g c t t g g c a a g g c a a g t a g 
1 5 0 
cggcggcgcttcaagATGCGCTGCCTGACCACGCCTATGCTGCTGCGGGCCCTGGCCCAOGCTQCACGTGCAGGA 
M R C L T T P M L L R A L A Q A A R A G 
F2 2 2 5 
CCTCCTGGTGGCCGGAGCCTCCACAGCAGTGCAGTGGCAGCCACCTACAaUJTATaTQAACATaCAGGATCCCGAG 
P P G G R S L H S S A V A A T Y K Y V N M Q D P E 
3 0 0 
ATGGACATGAAGTCAGTGACTGACCGGGCAGCCCGCACCCTGCTGTGGACTGAGCTCTTCCGAGGCCTGGGCATG 
M D M K S V T D R A A R T L L W T E L F R G L G M 
Τ RI 3 7 5 
ACCCTGAGCTACCTGTTCCGaOAÄCCOaCCACCATCAACTACCCGTTCGAGAAGGGCCCGCTGAGCCCTCGCTTC 
T L S Y L F R E P A T I N Y P F E K G P L S P R F 
A L F3 450 
CGTGOGGAGCATGCGCTGCGCCGGTACCCATCCGGGGAGGAGCGTTGCATTOCCTaCAAaCTCTeCOAGGCCATC 
R G E H A L R R Y P S G E E R C T A C J T I i C E A T 
Η R2 5 2 5 
TGCCCCGCCCAGGCCATCACCATCGAGGCTGAGCCAAGAGCTGATGGCAGCCGCCaOACCACCCOCTATOACATC 
C Ρ A Q A I T I E A E P R A D G S R R T T R Y D I 
600 
GACATGACCAAGTGCATCTACTGCGGCTTCTGCCAGGAGGCCTGTCCCGTGGATGCCATCGTCGAGGGCCCCAAC 
D Μ Τ Κ C i y C G f C g E A C P V D A I V E G P N 
675 
TTTGAGTTCTCCACGGAGACCCATGAGGAGCTGCTGTACAACAAGGAGAAGTTGCTCAACAACGGGGACAAGTGG 
F E F S T E T H E E L L Y N K E K L L N N G D K W 
750 
GAGGCCGAGATCGCCGCCAACATCCAGGCTGACTACTTGTATCGGTGAcgccccaccggcccgcagcccctgctg 
E A E I A A N I Q A D Y L Y R * 
R3 787 
cccaataaaaccactccgaccccacggaaaaaaaaaa 
poly a signal poly a site 
Fig. 9.1 Human NDUFSH cDNA and amino acid sequence (Procaccio et al 1997) Primers used for amplilicalion 
ο Γ Ihc ORF were Fl and R3; all primers were used in DNA sequence reactions. The ORF is pnnled bold and is 
capitalised, and both consensus 4Fe4S ferredoxin clusters are in italic and underlined Mutalions arc shown 
above the cDNA sequence, substilulions below the amino acid sequence. 
Restriction enzyme endonuclease analysis. 
Both mutations were confirmed by restriction endonuclease analysis of the NDUFS8 cDNA 
fragment obtained with oligonucleotide primers Fl and R3. C236T was cleaved with 
restriction enzyme Ball (recognition site 5'-TGG/CCA-3') and G305A with Pin M (recognition 
site 5'-A/CCGGT-3') (The forward slash [/] indicates the break point as created by the 
restriction enzymes). The transition mutations present in our patient (position underlined in 
the digestion recognition site) introduce the restriction sites. For both digestions, conditions 
were used as recommended by the manufacturer. 
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Tissue distribution of the NDUFS8 mRNA. 
A human RNA master blot was used to quantify the expression of NDUFS8 mRNA m a range 
of human adult and foetal tissues The quantity of RNA spotted for each tissue onto the master 
blot was normalised using eight different housekeeping gene transcripts as probes (nbosomal 
protein S9, ubiquitin, 23 kDa highly basic protein, hypoxanthine guanine phosphonbosyl 
transferase, tubulin, ß-actin, phospholipase, and glyceraldehyde triphosphate dehydrogenase) 
Using a standard hybridisation solution (Sambrook et al 1989), we hybridised the master blot 
with an a[12P]-dCTP-labelled cDNA probe The blot was washed twice with 2x SSC, 1% 
SDS, at (i5°C and was subjected to autoradiography 
Results. 
Biochemical measurements 
In our patient group (n=20), residual complex I activity measured in cultured skin fibroblasts 
was 24%-73% of the lowest reference value (expressed on a cytochrome c oxidase base) The 
other respiratory-chain complexes showed normal activities in all patients In most patients, 
respiratory-chain complex activities were also measured in other tissues apart from 
hbroblasts In the case of the patient with two compound heterozygous transition mutations in 
the NDUFS8 gene, enzyme activities were measured in a quadriceps muscle biopsy specimen, 
in cultured skin fibroblasts, and in liver, brain, and heart tissue In all of these tissues complex 
I activity was markedly reduced, whereas other complexes of the electron transport chain were 
essentially within the normal range (Table 9 1) 
Mutational analysis of the NDUFS8 cDNA 
PCR with oligonucleotide primers Fl and R3 produced a cDNA fragment of 757 bp, including 
the complete ORF of the NDUFS8 subunit Direct DNA sequence analysis of amplified 
pooled control NDUFS8 cDNA confirmed the published wild-type cDNA sequence 
Amplified NDUFS8 patient cDNA was then cycle sequenced and analysed In one patient this 
revealed two heterozygous transitions The first mutation, a C—>T at bp position 236, resulted 
in an amino acid change of proline into leucine (amino acid position 79) In the second 
mutation, a G—>A at bp position 305, arginine had been replaced by histidine (amino acid 
position 102). The presence of the first and second mutation in the common population was 
checked by restnction endonuclease analysis In 35 controls (70 alleles), C236T and/or 
G305A were not present The other 19 patients with enzymatic complex 1 deficiency all 
displayed the wildtype NDUFS8 cDNA sequence 
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Complex 1 
Complex 
IV 
Suc. cyi c 
oxidored. 
Citrate 
synthase 
PDHc 
Muscle 
tissue 
PAT 
1.7a 
170" 
24" 
87a 
2.5a 
CON 
4.4-19 
(31) 
73-284 
(21) 
22-78 
(39) 
48-146 
(43) 
2.8-8.0 
(15) 
Skin 
fibroblasts 
PAT 
0.069b 
181a 
0.33" 
154a 
-
CON 
0.11-0.28 
(14) 
147-252 
(14) 
0.21-0.44 
(14) 
144-257 
(14) 
-
PAT 
± 0 a 
174a 
26.3a 
316a 
9.1a 
Heart 
tissue 
CON 
4.5-41 
(6) 
73-412 
(7) 
11.2-62 
(7) 
208-490 
(7) 
2.3-21 
(6) 
PAT 
2.5a 
53a 
14a 
37" 
1 Γ 
Liver 
tissue 
CON 
4.7-9.2 
(7) 
13.9-108 
(11) 
6.0-51 
(9) 
13.7-96 
(10) 
0.38-7.4 
(24) 
PAT 
0.16·' 
58" 
14a 
216" 
-
Brain 
tissue 
CON 
5.1-19 
(5) 
26-181 
(14) 
11-40 
(6) 
53-207 
(10) 
-
Table 9.1 Respiratory chain enzyme activities in index patient's tissue specimens. Patient's individual 
respiratory-chain enzyme and PDHc activities measured in skeletal muscle tissue, cultured skin fihrohlasts, heart 
tissue, liver tissue, and brain tissue. Complex I activity is severely reduced in all tissue specimens. Numbers in 
parentheses denote how many controls were used for each enzyme assay. Sue. cyt e oxidored. = 
succinatexytochrome c oxidoreductase." = mU/mg protein;b = mU/mU cytochrome c oxidase. 
Confirmation of mutations by restriction endonuclease analyses. 
RNA isolated from whole blood of both parents and three healthy siblings (two boys, one girl) 
was reverse transcribed to cDNA. Oligonucleotide primers used for cloning of the complete 
ORF of the NDUFS8 subunit were applied in PCR. The PCR fragment was digested with 
restriction enzymes Ball (C236T) and PinM (G305A). The results were visualised on a 4% 
agarose gel. Since both restriction endonucleases cut in the region containing the mutation, the 
wild-type NDUFS8 cDNA fragment remained intact. In the patient both mutations were 
heterozygous, and after cleavage with Ball they expressed three bands (a wild-type cDNA 
fragment, one fragment of 325 bp, and one fragment of 432 bp). Incubation with Pin Al again 
revealed three fragments (a wild-type cDNA fragment, one band of 365 bp, and one band of 
392 bp). When Ball and PinAl were added simultaneously, the corresponding four digestion 
fragments were seen, which implies that the two mutations are on different alleles (data not 
shown). Three bands corresponding to the patient's were expressed in the father's cDNA after 
incubation with Ball, and a single wild-type band was expressed when P/«AI was applied. 
The mother's cDNA showed an undigested wild-type band after incubation with Ball and three 
bands (similar to the patient's) when PinAl was used. An older brother had the same digestion 
pattern as the father, a younger sister the same fragment pattern as the mother, and the 
youngest son showed only wild-type bands after digestion with Ball and PÎVÎAI (Fig. 9.2). 
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Father Mother Sib 1 Patient Sib 2 Sib 3 Wild type 
B P B P B P B P B P B P B P 
m m 
Fig. 9.2 Restriction endonucleasc analysis pattern. Wild-type and Sib 3 NDUFSti cDNA is undigested; patient is 
a carrier of C236T and ΟλΟίίΛ. father and sib 1 are carriers of C236T. and mother and sib 2 are carriers of 
G3Ü5A. The marker (m) is Lambda Pstl. For each person, the first lane conlains the fragments after digestion 
with Ball (B). and the second lane the fragments after PinAI (?) was applied. 
Tissue distribution of the NDUFS8 mRNA. 
Hybridisation of the I^PI-dCTP-labelled NDUFS8 cDNA probe to the RNA master blot 
revealed a ubiquitous expression pattern in human adult and foetal tissues. Adult tissue dots 
with relatively higher intensities are, in decreasing order, heart, skeletal muscle, pituitary 
gland, adrenal gland, kidney, caudate nucleus, putamen, substantia nigra, and lung. Among 
foetal tissues, heart expressed the highest dot intensity (Fig. 9.3). 
Discussion. 
The clinically, biochemically, and genetically heterogeneous group of OXPHOS disorders 
(estimated incidence 1:10,000 live births (Bourgeron et al 1995) has a main contributor in 
Leigh syndrome combined with isolated complex I deficiency. In the late 1980s and early 
1990s, several mtDNA mutations associated with complex 1 deficiency were identified 
(Wallace et al 1988, Holt et al 1989, Poulton and Gardiner 1989, Zeviani et al 1989, Goto et al 
1990, Holt et al 1990, Tanaka et al 1990, Zeviani et al 1991, Shoffner et al 1992). Yet, in 
many patients with isolated complex 1 deficiency, mtDNA mutations cannot be found 
(Buddiger et al 1997, Loeffen et al 1999). Recently, we found the first mutation (a 5-bp 
duplication in the NDUFS4 (18 kDa) gene to be identified in a nuclear-encoded subunit of 
complex I (van den Heuvel et al 1998). These findings make further studies of mutations in 
nuclear-encoded subunits of complex 1 necessary. 
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whole 
brain 
occipital 
lobe 
heart 
testis 
kidney 
amygdala 
putamen 
aorta 
ovary 
liver 
caudate 
nucleus 
substantia 
nigra 
skeletal 
muscle 
pancreas 
small 
intestine 
cerebel-
lum 
temporal 
lobe 
colon 
pituitary 
gland 
spleen 
cerebral 
cortex 
thalamus 
bladder 
adrenal 
gland 
thymus 
frontal 
lobe 
subthal. 
nucleus 
uterus 
thyroid 
gland 
peripheral 
leukocyte 
hippo-
campus 
spinal 
cord 
prostate 
salivary 
gland 
lymph 
node 
medulla 
oblongata 
stomach 
mammary 
gland 
bone 
marrow 
f appendix lung trachea placenta 
foetal 
brain 
yeast 
RNA 
100 ng 
foetal 
heart 
yeast 
tRNA 
100 ng 
foetal 
kidney 
E. coli 
rRNA 
100 ng 
foetal 
liver 
E. coli 
DNA 
100 ng 
foetal 
spleen 
poly r(A) 
100 ng 
foetal 
thymus 
human 
Coti DNA 
100 ng 
foetal 
lung 
human 
DNA 
100 ng 
human 
DNA 
500 ng 
Fig. 9.3a Multiple tissue master blot. The type and position of poly(A+) RNAs and controls dotted on the 
positively charged nylon membrane. 
Figure 9.3b Tissue distribution of NDUFS8 mRNA with a poly A+ RNA master blot. NDUFS8 is ubiquitously 
expressed in human tissues, with a relatively higher expression in the human heart, skeletal muscle, gland 
tissue, kidney, caudate nucleus and putamen. 
124 
The first nui leur entoded complex I mutation in a patient with Leigh midrome 
We chose the NDUFS8 subumt for mutational analysis studies for several reasons In the first 
place, the NDUFS8 subumt is highly conserved among species, with, for example, 93% amino 
acid identity between humans and Β taurus It is also one of the 14 subunits that together 
constitute the minimal structural unit for enzymatic activity, as found in E coli, which stresses 
its possible functional significance Finally, it contains two consensus 4Fe4S terredoxin 
patterns, which have long been considered to be binding sites for iron-sulphur cluster N-2 
These findings make this protein a strong candidate gene lor isolated complex 1 deficiency 
Cycle sequencing of the NDUFSS cDNA in our complex I-deficient patient group revealed 
two compound heterozygous mutations in a patient neuropathologically diagnosed with Leigh 
syndrome The clinical phenotype of this patient and the results of additional laboratory and 
imaging studies are highly suggestive of an OXPHOS disorder, and diagnosis (isolated 
complex I deficiency) was biochemically confirmed in muscle tissue, cultured skin 
fibroblasts, and heart, liver, and brain tissue The first transition (C236T) resulted in an 
amino acid substitution of leucine for proline It is well known that proline markedly 
influences protein architecture A Chou-Fasman plot comparison of NDUFS8 wild types and 
NDUFS8 containing this specific mutation clearly revealed the disturbance of an α helix by a 
ß-sheet Although it remains purely speculative which conformation the NDUFS8 protein 
will have when incorporated in the entire complex, proline is very important for secondary 
and tertiary structure, and thus the disappearance of this amino acid will likely disturb the 
protein structure The second mutation (G305A) replaced arginine with histidinc Histidine 
contains an imidazole side chain that can readily switch between uncharged and positively 
charged to catalyse the making and breaking of bonds A Basic Local Alignment Search Tool 
(BLAST) search at the server of the National Centre for Biotechnology Information with the 
human NDUFS8 amino acid sequence revealed an extremely strong conservation of the 
region containing the arginine, which is mutated in the patient This region of 24 amino acids 
is + 100% conserved in, among others, Β taurus, Ν crassa Paracoccus demtnfìtam, 
Rhodobacter capsulatus and Nicotiana tabacum This stresses the possible significance of 
this region, which is located just prior to the first cysleine-nch 4Fe-4S ferredoxin consensus 
pattern (eight amino acid residues between the mutated arginine and the consensus cluster) 
An arginine-to-histidine mutation is the main genetic cause in another disease associated with 
complex I deficiency, namely, Leber hereditary optic neuropathy (Wallace et al 1988, Singh 
et al 1989) Although both amino acids are basic, they are clearly not, in all cases, 
exchangeable Since neither mutation is present in 70 control alleles and in the remaining 19 
complex I-deficient patients, it is unlikely that these mutations represent population 
polymorphisms These two mutations with an autosomal recessive inheritance pattern, 
combined with the lethal clinical course within the early months of life, provide further 
evidence for the functional importance of this iron-sulphur cluster binding pattern containing 
nuclear-encoded complex I subumt 
Restriction endonuclease analysis periormed on NDLIFS8 cDNA of all members of the 
patient's family showed that mutation C236T was inherited from the father and mutation 
G305 A from the mother In the oldest son (carrier of C236T), the activity of respiratory chain 
enzyme complexes was measured in a skeletal muscle biopsy specimen, and that of each 
125 
ClwpK r 9 
complex was within the normal range While the mother was pregnant with the younger sister 
(earner of G105A), chorionic villi were obtained for biochemical measurements of the 
respiratory-chain complex activities, which were again within normal limits (no muscle 
biopsy was performed in the younger sister) It seems likely, therelore, that both mutations arc 
necessary to reduce the enzymatic activity of NADH ubiquinone oxidoreductase 
Leigh syndrome has been linked, by biochemical enzyme assays to several single enzyme and 
enzyme complex deficiencies, including deficiencies in biotmidase, PDHc, 
NADH ubiquinone oxidoreductase, succinate dehydrogenase, cytochrome c oxidase, and ATP 
synthase However, molecular genetic defects have been described in only a few subumts of 
PDHc, the FP subunit of succinate dehydrogenase, subunit 6 of ATP synthase, and some 
mitochondrially encoded tRNAs Recent mutational analysis of all 10 nuclear encoded 
subumts ol cytochrome c oxidase (complex IV of the OXPHOS system) in a Leigh syndrome 
patient with cytochrome c oxidase deficiency revealed no mutations (Adams et al 1997) The 
patient described in the present article provides the first genetic link between a nuclear-
encoded subunit ol complex I and Leigh syndrome Since complex I deficiency is a large 
contributor to Leigh syndrome, other patients with isolated complex I deficiency in whom a 
similar clinical phenotype is expressed should be screened for NDUFS8 mutations as well 
The tissue expression of the NDUFS8 cDNA showed dots with relatively high intensity in 
heart, skeletal muscle, kidney, pituitary gland, adrenal gland, caudate nucleus, putamen, and 
lung All of these tissues have a relatively high energy demand and are therelore likely to be 
alfected by reduced energy availability The patient with Leigh syndrome reported here had 
symptoms that strongly correlate with the high-intensity dots present on the NDUFS8 master 
blot, such as hypertrophic cardiomyopathy hypotonia, convulsions and episodes of 
respiratory distress The specific neuropathology seen in Leigh syndrome can be hypothesised 
to be the result of oxidative stress caused by a diminished activity of complex I It would be 
reasonable to assume that oxygen radicals are generated in the vicinity of an iron sulphur 
cluster A defective NDUFS8 subunit. as seen in our patient, is a likely source of 
malfunctioning electron transport and therelore a possible source of free radicals The review 
by Robinson (1998) concerning oxygen free radicals and human complex I deficiency stales 
that NDUFS8 would be a prime candidate for an electron donor lor superoxide formation 
Future research is necessary to investigate the possible relationship between the specific 
neuropathology present in Leigh syndrome and malfunction of the NDUFS8 subunit 
In conclusion, we have described herein the first mutations identified in the nuclear-encoded 
NDUFS8 subunit of complex I (possible binding site for iron-sulphur cluster N-2) in a patient 
with isolated complex I deficiency whose condition was neuropalhologically diagnosed as 
Leigh syndrome Our analysis of these compound heterozygous transitions is the second report 
of genetic delects in nuclear-encoded subumts of complex I The frequency of these mutations 
in complex I deficient patients in general and, more specifically, in patients diagnosed with 
Leigh syndrome must be further established These findings contribute to possibilities for 
genetic counselling and prenatal diagnosis, which are of utmost importance since therapeutic 
intervention in complex I disease is very unsatisfactory We will continue to search for other 
candidate genes for complex 1 deficiency 
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MUTATIONS IN THE COMPLEX I NDUFS2 GENE ARE ASSOCIATED WITH 
HYPERTROPHIC CARDIOMYOPATHY AND ENCEPHALOMYOPATHY 
Submitted 
Abstract. 
Human complex 1 is built up and regulated by genes encoded by the mitochondrial DNA 
(mtDNA) as well as the nuclear DNA (nDNA) In recent years, attention mainly focussed on 
the relation between complex I deficiency and mtDNA mutations However, several aspects of 
our isolated complex I deficient patient group make a nuclear-genetic cause likely (high 
percentage of consanguinity, aulosomal-recessive mode of inheritance, absence of common 
mtDNA mutations) The nuclear encoded NDUFS2 (49 kDa, NuoD) protein is part of 
complex I of many pro- and eukaryotes Hypothesised tunctions of the NDUFS2 are 
participation in proton translocation and ubiquinone binding The gene coding for the 
NDUFS2 protein is therefore an important candidate for mutational detection studies in 
enzymatic complex I delicicnt patients Screening of patient NDUFS2 cDNA by RT-PCR in 
combination with direct DNA sequencing revealed three missense mutations resulting in the 
substitution of conserved amino acids in three families 
Chapter IO 
Introduction. 
The genetic causes of oxidative phosphorylation (OXPHOS) disorders in general and more 
specific of isolated complex I deficiency (OMIM 252010) remain largely to be elucidated The 
mitochondrial DNA encodes for several structural components of the OXPHOS system ( 13 
polypeptides which are incorporated in complex I, III, IV and V) as well as 22 tRNAs and 2 
rRNAs (Anderson et al 1981) The nucleus however, encodes for the majority of the structural 
complex components, but also for all non-structural OXPHOS system proteins, like e g 
transcription and translation factors, chaperone proteins and assembly proteins This dual 
genetic control makes adequate genetic counselling in OXPHOS disorders difficult Several 
mtDNA mutations have clearly been linked to important OXPHOS system disorders, but in 
the majonty of adult patients (60%) and children (>90%) common mtDNA mutations are not 
encountered (Shoffner 1996) 
Isolated complex I deficiency is a serious inborn error of metabolism, often presenting in 
infancy or early childhood A diversity of clinical phenotypes has been described to occur in 
complex I deficient patients like Leigh(-like) syndrome, fatal infantile lactic acidosis, 
cardiomyopathy and lactic acidosis with or without cataract, macrocephaly with 
leukodystrophy and hepatopathy with tubulopathy (Rahman et al 1996, Pitkanen et dl 1996, 
Kirby et al 1999, Loeffen et al 2000) The common divisor in these patients is the prominent 
place of symptoms of central nervous system and muscular disease The mean age of 
presentation encountered in our patient group is -5 months (Loeffen et al 2000) The 
inheritance pattern in the majonty of families (no affected children in the maternal lineage, 
high percentage of consanguinity) makes autosomal-recessive inheritance and therefore a 
nuclear-genetic cause likely 
Human complex I consists of at least 42 different proteins (-35 nuclearly encoded, seven 
mitochondnally encoded (Chomyn et al 1986), which makes it one of the most complex 
multi-protein constructions in the human cell (Smeitink and van den Heuvel 1999) The main 
function of complex I is oxidation of NADH Electrons, which are freed by this oxidation, are 
transported to free-moving ubiquinone This electron transport is coupled to a yet unknown 
mechanism, by which protons are translocated from the mitochondrial matrix into the 
intermembrane space Several important aspects of these functions have (partly) been 
elucidated NADH binds to the NDUFVI subumt of complex I (Chen and Guillory 1981, 
Deng et al 1990), electrons are then transported through the flavin mononucleotide (FMN, 
Pilkington et al 1991) and at least six Iron-Sulphur (Fe-S) clusters which have been detected 
by electron paramagnetic resonance studies (Ohmshi 1998) The proton translocation process 
as well as the ubiquinone binding and reduction process remain poorly understood 
The NDUFS2 (49 kDa, OMIM 602985) subumt of complex I is a highly conserved protein, 
with homologues present in many pro- and eukaryotes In Neurospora crassa, the 49 kDa 
subumt has been located in the peripheral part of complex I near the membrane domain 
(Guenebaut et al 1997) This is further illustrated by characterisation studies performed with 
Escherichia coli complex I which showed that NuoD (the equivalent of NDUFS2 in 
prokaryotes) is situated in the connecting part, which possibly functions as a bridge between 
the NADH dehydrogenase Iragment and the membrane fragment (Braun et al 1998) The 
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following two findings concerning the NDUFS2 subunit are indicative for possible functions 
of this protein At first, there may be an evolutionary relationship between the NDUFS2 and 
hydrogenases thought to function as proton translocators, which is suggestive for the NDUFS2 
subunit to play a role in the proton translocation process (Friedrich 1998) Secondly, 
Darrouzet and colleagues presented a piencidin-resistant mutant of the bacterium 
Rhodobacter capsulata!,, which contained a V407M substitution in the highly conserved 
C-terminal part of NuoD (Darrouzet et al 1998) The complex I inhibiting properties of 
piencidin probably result from antagonism of the ubiquinone binding site (Degli Esposti 
1998) It is therefore well possible that NuoD participates in the binding of ubiquinone 
Hence, the NDUFS2 subunit is a major candidate gene for mutational analysis studies in 
isolated complex I deficient patients 
In this study we present the results of mutational detection studies performed with cDNA of 
isolated complex I deficient patients in whom major mtDNA rearrangements and eleven 
common mtDNA mutations have been excluded This revealed missense mutations in four 
patients (three lamihes) These findings increase our possibilities for adequate genetic 
counselling and prenatal diagnostics and in the future may also result in more information 
concerning the proton translocation and ubiquinone binding process 
Patients, Material and Methods. 
Famil\ A Family A consists of three children whose parents are consanguineous (Fig 10 1). 
Two of these children suffered from an isolated complex I deficiency The oldest child in this 
family is healthy and currently alive (Al, female) The early neonatal period of the second 
child (A2, male) was normal, but after six months neurological regression was noted He 
stopped smiling and holding objects and was unable to track moving items Investigation of 
the eyes revealed a fine horizontal nystagmus and bilateral optic atrophy Muscle tone was 
axially decreased while this was increased in all extremities with brisk tendon reflexes An 
EEG was normal, while a brain CT scan revealed bilateral hypodensities in basal ganglia An 
echocardiogram showed left ventricular hypertrophy Lactate levels were severely increased in 
blood (9 9 mM, normal 0 6-2 1 mM) and CSF (7 8 mM, normal 14-19 mM) The patient's 
neurologic condition detenorated steadily and he became gradually lethargic with episodes of 
apnoea eventually leading to death at the age of 24 months The third child (A3, female) 
expressed a phenotype resembling her brother's, though the age of presentation was earlier 
and the course of deterioration faster The blood lactic acid level was found elevated at the 
second day of life (12 mM) She suffered from severe neurological regression, axial hypotonia 
with pyramidal signs and failure to thrive. Prolonged latencies seen in Visual Evoked 
Potentials (VEP) and an abnormal electroretinogram (ERG) pointed towards optic atrophy and 
problems with the photoreceptors, respectively Brainstem Auditory Evoked Potentials 
(BAEP) showed prolonged conduction in the brain stem region The cerebral CT scan 
disclosed marked generalised atrophy with ventnculomegaly An echocardiogram made at 
birth was normal, but at the age of three months a hypertrophic cardiomyopathy was 
demonstrated. She died at the age of 18 months due to cardiorespiratory failure Both patients 
expressed an isolated complex I deficiency in cultured skin fibroblasts (Table 10 1) Enzyme 
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assays were also performed in skeletal muscle tissue of patient A2 which again revealed 
isolated complex I deficiency (muscle tissue of patient A3 was not available). 
I 
A T ^ A3^ 
Ï 
Figure 10.1 Family tree of family A The oldest child is not affected (Al). Patient A2 and A3 suffered from a 
complex 1 deficiency and were homozygous for the G683A mutation while both parents are heterozygous 
Family B. There were no signs of genetic diseases within this family. Patient Bl (male; family 
tree Fig. 10.2) exhibited respiratory insufficiency during the first day of life. Lactic acid was 
severely increased in blood (24 mM) leading to acidosis (pH 6.9). Echocardiography 
performed in the early neonatal period showed a hypertrophic cardiomyopathy, which was 
confirmed at autopsy. The child died after four days due to cardiorespiratory failure. 
Biochemical investigation of the OXPHOS system revealed an isolated complex I deficiency 
in cultured skin fibroblasts and skeletal muscle tissue (Table 10.1). 
Figure 10.2 Family tree of family Β The complex I deficient patient is homozygous for the C686A mutation 
while both parents arc heterozygous 
Family C. Family C (consanguineous parents (Fig. 10.3), negative family history for 
neuromuscular disorders) consists of four children, three of whom died of a clinical phenolype 
resembling an OXPHOS disorder. Measurement of enzyme activities of the respiratory chain, 
PDHc and citrate synthase revealed an isolated complex I deficiency in the second child (C2) 
in cultured fibroblasts as well as muscle tissue (Table 10.1). Unfortunately, tissue specimens 
of patient CI and C3 were not available. The first patient (CI ; male) presented at 7 months 
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with repeated vomiting and failure to thrive Physical examination showed horizontal 
nystagmus, mild ataxia, muscle hypotonia and pallor of the optic discs Cognitive 
development was age appropriate, yet motor delay was prominent Lactate level was increased 
in blood (4 2 mM) A brain CT scan disclosed areas of white matter hypodensities The 
patient died at the age of 18 months The second index patient (C2, male) presented at the age 
of 10 months with a phenotype strongly resembling the phenotype of his brother Recurrent 
vomiting, failure to thrive, nystagmus and generalised hypotonia with mild cognitive 
impairment but marked motor delay were present Lactic acid was elevated in blood (5 0 
mM), as well as in CSF (3 3 mM) From the age of 2 5 years he developed recurrent episodes 
of sleep apnoea Brain CT scan and MRI revealed progressive hypodensity of basal ganglia 
and midbrain The course deteriorated steadily necessitating mechanical ventilation The child 
died at the age of 3 years The third patient (C3, male) presented at birth with severe 
metabolic acidosis (lactic acid 12 5 mM) The clinical characteristics and course were similar 
to the phenotype of his brothers and he died at the age of two years The fourth child of this 
family was born after egg cell donation and is alive and healthy 
yU s i y . JT 
CI C2 C3 C4 
Figure 10 3 Family tree of family C The first three sons died of complex I deficiency The fourth son was bom 
after egg cell donation and is alive and healthy Patient C2 is homozygous for the T1217C mutation while both 
parents are heterozygous Unfortunately DNA and RNA from CI CI and C4 were not available 
Biochemical enzyme assays 
The respiratory chain enzyme complex activities, PDHc and citrate synthase in skeletal 
muscle tissue and skin fibroblasts (culture) were assayed using the following methods 
(slightly modified) NADH ubiquinone oxidoreductase and succinate cytochrome c 
oxidoreductase as described by Fischer et al 1985 and 1986, cytochrome c oxidase by 
Cooperstein and Lazarow 1951, citrate synthase by Srere 1969 and PDHc according to van 
Laack et al 1988 In case of cultured fibroblasts, enzyme measurements were performed in 
mitochondria enriched fractions (Bentlage et al 1996), while in case of muscle tissue 600xg 
supernatant of crude homogenates was used 
Mutational analysis 
Patient total RNA isolated from cultured fibroblasts was reverse transenbed to cDNA by 
superscnpt II RNAse Η reverse transcriptase after addition of oligo(dT) and random hexamer 
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primers (Ploos van Amstel et al 1996) Wildtype and patient NDUFS2 cDNA was amplified 
and sequenced as published previously (Loeffen et al 1998a) All patients have been screened 
for major mtDNA rearrangements by a previously developed long template PCR technique (Li 
et al 1995) Furthermore, the following common pathogenic mtDNA mutations have been 
excluded in fibroblasts in our patient group by a combination of PCR and RFLP 14484T—>C 
(ND-6), 14459G->A (ND-6), 11778G->A (ND-4), 8993T->G/C (ATPase 6), 8356T->C 
(tRNAL y s), 8344A->G (tRNAL y s), 4317A->G (tRNAG l n); 4160T->A (ND-1); 3460G->A 
(ND-1), 3271T^C (tRNA^"), 3243A^G (tRNA l j : u) Procedures were followed as 
recommended by the restriction enzyme manufacturer 
Restriction Fragment Length Polymorphism (RFLP). 
An NDUFS2 nDNA fragment of 294 base pairs (Genbank accession no AFI 83172) of all 
members of family A and Β was amplified using oligonucleotides 
5'-AAGATGTTTGAGTTCTACGAGCG-V (forward) en S -ACTGATAAATGTCATCCATAAGCC-V 
(reverse) The 683G—»A mutation destroys an Mspl restriction site (recognition site C\CGG), 
while the 686C—»A mutation destroys an Haelll restriction site (recognition site GG\CC) In 
case of the parents of family C as well as patient C2 a nDNA fragment of 342 base pairs was 
amplified (Genbank accession no AF183173) using oligonucleotides 
5'-AGACCATATGTAGAGTAGGTAGC-V (forward) and V-TTAGTTAAGACTTGCAAGGTGGG-V 
(reverse) The 1237T—»C mutation introduces a Ban\ restriction site (recognition site 
G\GYRCC) In all RFLP assays, conditions were used as recommended by the manufacturer 
Northern blot and multiple tissue dot blot 
In order to check the specificity of an a[ "P]-dCTP-labelled NDUFS2 cDNA probe, we 
hybridised the probe to a multiple tissue Northern blot commercially purchased from 
Clontech, USA (heart, brain, placenta, lung, liver, skeletal muscle, kidney, pancreas), using a 
standard hybridisation solution based on procedures described in Sambrook et al 1989 The 
blot was washed twice with 2x SSC, 0 1% SDS, at 65 0C and was subjected to 
autoradiography. To visualise the distribution of NDUFS2 mRNA in a large range of human 
adult and foetal tissues, the same probe was hybridised to a multiple tissue RNA Master blot 
The quantity of RNA spotted for each tissue on the Master blot was normalised using eight 
different housekeeping gene transcripts as probes (ribosomal protein S9, ubiquitin, 23 kDa 
highly basic protein, hypoxanthine guanine phosphonbosyl transferase, tubulin, ß-aclin, 
phospholipase, and glyceraldehyde triphosphate dehydrogenase) 
Results. 
Biochemical enzyme assays 
The enzyme assays of citrate synthase and respiratory chain enzymes were performed in 
cultured skin fibroblasts of all patients and additionally in fresh muscle tissue in case of 
patient Β and C2 and in muscle tissue which has been stored in liquid nitrogen of patient A2 
(in muscle tissue of patient A2 and Β PDHc activity was also measured and found normal) 
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This revealed in all cases an isolated complex I deficiency (complex I enzyme activities of all 
patients are listed in Table 10.1). 
Patient A2 
Patient A3 
Patient Β 
Patient C2 
NADH:ubiquinone oxidoreductase 
(complex I) 
Fibroblasts 
0.11-0.28" 
0.043 
0.060 
0.040 
0.045 
(14) 
Muscle 
70-250b (20) 
101-389c (13) 
40e 
-
17" 
48b 
Table 10.1 Residual complex I activity of the patients in cultured fibroblasts and muscle tissue. All patients 
expressed an isolated complex 1 deficiency. Complex 1 activity is referred to cytochrome c oxidase base in case 
of fibroblasts" (mU/mU cytochrome c oxidase), to citrate synthase (mU/U citrate synthase) when measured in 
fresh muscle tissue11 and to cytochrome c oxidase (U/mU cytochrome c oxidase) when measured in 600χ^ 
supernatant of muscle tissue which has been deep frozen in liquid nitrogen0. Numbers of controls used for each 
assay are listed in parentheses. 
Mutational analysis studies. 
RT-PCR followed by direct DNA sequencing of the NDUFS2 cDNA revealed missense 
mutations in four patients (three families). In family A we found a homozygous G—>A 
transition at position 683 in both complex I deficient patients (A2 and A3). As a consequence 
of this mutation a conserved arginine is substituted into a glutamine (Table 10.2). The 
NDUFS2 cDNA of the index patient in family Β contained a homozygous 686C—>A 
transversion, which leads on protein level to the substitution of a conserved proline into a 
glutamine (Table 10.2). Finally, in patient 2 of family C, we encountered a homozygous T—>C 
transition at position 1237. This mutation results in the replacement of a conserved serine 
residue by a proline (Table 10.2). 
Restriction Length Polymorphism (RFLP) analysis. 
We confirmed the presence of the mutations found in the index patients on nDNA by means 
of RFLP analysis (Fig. 10.4). To prove the presence of the mutation found in patient A2 and 
A3, we amplified and sequenced an NDUFS2 nDNA fragment of the region containing the 
mutation (294 base pairs; Genbank accession no. AFI 83172), which revealed two recognition 
sites for Msp\ in control cDNA, one of which is destroyed by the 683G—)A mutation. 
Complete digestion with Mspl results in three bands in the control and the healthy sib Al 
(203, 57 and 34 base pairs), confirming the presence of two wildtype alleles. Two bands were 
found in both patients (203 and 91 base pairs), who contain two mutated alleles and finally 
four bands were seen in case of the heterozygous parents (203, 91, 57 and 34 base pairs). 
The same wildtype NDUFS2 nDNA fragment as generated for all members of family A 
(Genbank accession no. AFI83172) contains three HaeWl recognition sites. Since one HaeWl 
site is destroyed by the 686C—>A mutation, only two cleavage sites remain in patient Bl. 
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Complete digestion of control NDUFS2 nDNA therefore results in four bands (161, 60, 57 
and 16 base pairs. Fig 10 4), in case of our patient three bands are seen (161, 117 and 16 base 
pairs, two mutant alleles), while the heterozygously mutated parents express five bands (161, 
117, 60, 57 and 16 base pairs) The 60 and 57 bands are not separated from each other and the 
16 base pair band is not visible. 
The 1237T—>C mutation found in patient C2 introduces a Ban\ restriction site A control 
NDUFS2 nDNA fragment (342 base pairs, Genbank accession no AF183173) remains 
therefore undigested, while the nDNA fragment of the patient is cleaved in two fragments of 
175 and 167 base pairs The nDNA fragment of both parents is partly digested resulting in 
three bands of 342, 175 and 167 base pairs The 175 and 167 bands are not separated 
Unfortunately, nDNA as well as cDNA of patient CI and C3 are not available. 
All three mutations have been excluded in nDNA fragments of 85 controls (170 alleles) 
226 227 228 229 230 
683β->λ Y I R Ρ G 
Wildtype tat ate egg cca gga 
Patiente λ tat ate cag cca gga 
Y I Q Ρ G 
227 228 229 230 231 
686C->A I R Ρ G G 
Wildtype ate egg cca gga gga 
Patient Β ate egg caa gga gga 
I R Q G G 
411 412 413 414 415 
1237T-K: L V S D G 
Wildtype ctg gtg tet gat ggc 
Patient C ctg gtg eet gat ggc 
L V Ρ D G 
Table 10.2 NDUFS2 wildtype and patients cDNA and amino acid sequence of the regions containing the 
mutations 
RNA tissue distribution 
Hybridisation ot the radioactively labelled NDUFS2 cDNA probe to the multiple tissue 
Northern blot revealed a single band for each tissue present on the blot, which confirms the 
specificity of the probe (data not shown) In order to evaluate the NDUFS2 RNA distribution 
in a vanety of tissues, we hybridised the same probe to a multiple tissue Master blot (Fig 
10 5) This revealed a similar pattern (slight differences) as seen for other nuclear encoded 
complex I subumts The NDUFS2 cDNA probe is ubiquitously expressed, with a relative 
higher expression in the following tissues adult and foetal heart, kidney, skeletal muscle, 
adrenal gland and liver Also the human and E coli DNA dots (H4, H7 and H8) were positive 
Π8 
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Fa Β Mo Co M 
Figure 10.4 Top: RFLP pattern of family A after digestion with Mspl. Complete digestion results in three bands 
in the control and Al (203, 57 and 34 bp (latter band faint), two bands in the index patients (203 and 91 bp) and 
four in case of their parents (203, 91, 57 and 34 bp). Middle: The family Β nDNA RFLP pattern after digestion 
with Waelll. Complete digestion results in four bands when control DNA is used as template (161, 60, 57 and 16 
bp), three bands in case of our index patient (161, 117 and 16 bp) and five when nDNA of the parents is used as 
template (161, 117, 60, 57 and 16 bp). The 60 and 57 bands are not separated from each other, the 16 bp band is 
not visible). Bottom: The 1237T—>C mutation introduces a Banl restriction site. The control NDUFS2 nDNA 
fragment (342 bp, Genbank accession no. AFI 83173) remains therefore undigested, while the nDNA fragment of 
the index patient is cleaved in two fragments of 175 and 167 bp. Nuclear DNA fragments of both parents are 
partly digested resulting in three bands of 342, 175 and 167 bp. The 175 and 167 bands are not separated. The 
DNA size marker (M) is PuclS/Haclll (band sizes are listed right from the image). Mo = mother. Fa = father, Co 
= control, bp = base pairs. 
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Figure 10.5a Multiple tissue Master blot. The type and position of poly(A+) RNAs and controls dotted on the 
positively charged nylon membrane, subthal. = subthalamic. 
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Figure 10.5b Tissue distribution of NDUFS2 mRNA visualised on a poly A+ RNA master blot. The NDUFS2 
cDNA probe is ubiquitously expressed in human tissues, with a relatively higher expression in the human and 
foetal heart, kidney, skeletal muscle, adrenal gland tissue, whole brain and liver tissue. 
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Discussion. 
Mitochondnocytopathies have an incidence of about 1 in 10,000 live births (Bourgeron et al 
1995) The exact prevalence of one of the mitochondrial disorders, complex I deficiency, is at 
the moment unknown However, we know that complex I deficiency is one of the most 
frequently occurring OXPHOS enzyme disorders in children (Loeffen et al 2000) 
The clinical phenotype observed in patients with complex I deficiency, often develops 
devastating, with early onset, rapid progression and death within a few years after birth 
Successful therapeutic possibilities are currently not available It is therefore important to 
locate the genetic causes of this disease to offer at least the possibility of adequate genetic 
counselling and prenatal diagnostics In previous years, several nuclear mutations resulting in 
deficient activity of one of the respiratory chain complexes, have been found These genes 
concerned structural genes in case of complex I deficiency (van den Heuvel et al 1998, 
Loeffen et al 1998b, Schuelke et al 1999, Tnepels et al 1999), and complex II deficiency 
(Bourgeron et al 1995), but also mutations in assembly genes have been described (in relation 
to complex IV deficiency, Zhu et al 1998, Tiranti et al 1998, Coenen et al 2000, Smeitink et al 
2000) Yet, for a large part of our complex I deficient patients, gene defects remain to be 
identified 
The NDUFS2 subunit is the third largest complex I subunit Its mRNA contains an open 
reading frame of 1392 base pairs, coding for 463 amino acids. Electron microscopy studies 
performed in Ν crassa using Fab fragments of antibodies directed against the 49 kDa subunit 
located this protein in the extramembraneous part of complex I, near the membrane domain 
(Guenebaut et al 1997) Disruption of this subunit results in the complete absence of the 
peripheral arm of complex I (Guenebaut et al 1997) Recent studies revealed interesting 
aspects of the NDUFS2 subunit The identification of a R capsulatus mutant containing a 
V407-»M substitution in NuoD (prokaryotic equivalent of NDUFS2), which is partially 
resistant to piencidin, is an indication for a possible role of NuoD in ubiquinone binding 
(Darrouzet et al 1998) This amino acid substitution is located in the conserved C-terminal 
part of the protein. The structure of piencidin is similar to the structure of ubiquinone, both 
containing a polar and an aliphatic part It is thereiore possible, that the inhibiting function of 
piencidin results from antagonism of the ubiquinone-binding site Darrouzet and colleagues 
hypothesise that NuoD interacts with the polar part of piencidin while the aliphatic 
component interacts with NuoH, which is located in the membranous part of complex I The 
piencidin resistant mutants are also partially resistant to rotenone. It seems likely that 
piencidin and rotenone share at least partially a common binding site This was also seen in 
competition expenments performed by Okun and co-workers, which showed that the 
hydrophobic part of piencidin and rotenone share a common binding domain with partially 
overlapping sites (Okun et al 1999) 
The NDUFS2 protein is highly conserved in many species (95% in Bos taurus, 62% in 
Neurospora crassa and 38% in Escherichia coli) which indicates its overall functional 
importance (Loeffen et al 1998a) The NDUFS2 subunit has also weak homology with several 
proteins involved in the transport of protons, like HycE (subunit of formate hydrogenlyase) 
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and HyfG (subunil of Ni-Fe hydrogenase), so there might be an evolutionary relationship 
between these proteins. This implicates that there might be a role for the NDUFS2 subunit in 
proton transport (Friedrich and Weiss 1997). 
Hybridisation of the NDUFS2 cDNA probe to the RNA Master blot showed spots at all adult 
and foetal tissues present on the blot. Dots with a relative higher intensity are tissues with a 
high metabolic activity like heart, kidney and skeletal muscle tissue. Hybridisation of the 
probe to the multiple tissue Northern blot confirmed the probe's specificity. The human DNA 
dots (H7 and H8) were also positive on the RNA Master blot. This can be caused by the 
presence of relatively large exons, which hybridise to a substantial part of the probe or the 
presence of pseudogenes. Also the E. coli dot (H4) showed a faint signal. This can be caused 
by the high percentage of homology between the NDUFS2 subunit and NuoD. The 
hybridisation of the probe to the DNA dots is however not a problem for the interpretation of 
the RNA dots, since the RNA dots on the blot contain virtually no DNA (guaranteed by the 
manufacturer). 
The amino acid substitution present in family A (R228Q) is located just prior to the amino 
acid, which has been changed in family Β (P229Q). These substituted amino acids are 
conserved in many pro- and eukaryotes (Table 10.3). The high conservation of the bases 
flanking these substituted amino acids (RPGGV) is reflected by their conservation (partially) 
in some proteins, which are involved in proton pumping like e.g. HycE of Mycobacterium 
tuberculosis. However, functional aspects of such an amino acid pattern have not been 
described. Chou-Fasman plots (Chou and Fasman 1978) calculated with the NDUFS2 
wildtype and mutated proteins (R228Q as well as P229Q), show replacement of α-helix by β-
sheet in the region prior to the proline at position 229. When this region is functionally 
important, it is thinkable that conformational peptide changes alter the overall function of the 
NDUFS2 protein. The amino acid which is substituted in family C (S413P) is also conserved 
in many species (Table 10.3). The biochemical characteristics of the substituted amino acids 
clearly differ from those of their substitutes. These different characteristics can have serious 
consequences for the functionality of the NDUFS2 protein and therefore on the overall 
complex I activity. It is unlikely that the missense mutations encountered in our index patients 
are population polymorphisms since they were not encountered in 170 control alleles. In 
addition, a BLAST search in the human EST database of the National Centre for 
Biotechnology Information (NCBI) with a cDNA fragment containing the mutations, only 
revealed wildtype EST fragments (5 ESTs were present containing the region which is 
mutated in family A and B, and 30 in the region which is mutated in family C). Definite proof 
of the pathogenicity of the mutations found in our index patients has to come from rescue of 
the complex I activity by introducing a vector containing the wildtype NDUFS2 cDNA into 
our patient fibroblasts. These experiments are however rather difficult and time consuming 
since we need up to 10 million cells to perform our enzyme assays accurately. 
Several clinical aspects of the phenotypes found in the patients described in this article are 
worth discussing. The patients of family A (A2 and A3) and the patient in family Β suffered 
from a hypertrophic cardiomyopathy. In patient Β the cardiomyopathy was present at birth, 
while in patient A3 it developed in the first months of life (in case of patient A2 the presence 
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or absence of the cardiomyopathy at birth was not investigated). The multiple tissue dot blot 
autoradiograph showed the highest expression of NDUFS2 mRNA in cardiac tissue. 
Cardiomyopathy is not an uncommon clinical finding in patients with mitochondrial 
encephalomyopathies. In our group of isolated complex I deficient patients, 30% suffered 
from cardiomyopathy (mainly hypertrophic). Besides the cardiomyopathy, ocular symptoms 
were frequent among our index patients. Both patients in family A (A2 and A3) as well as 
patient CI showed signs of optic atrophy. Horizontal nystagmus was seen in patient A2, A3, 
CI, C2 and C3. Since patient Bl died four days after birth, time was too short to detect 
possible visual defects. 
Species 
PT 
Y/T 
BT 
NC 
Y/T 
MT 
SM 
PD 
EC 
222 
222 
187 
237 
153 
183 
151 
169 
165 
Mutation A 
(R228Q) 
I 
MHAAYIQPGGVHQ 
MHAAYIRPGGVHQ 
MHÄÄYVRPQGVHQ 
LHÄÄYVRPGGVHQ 
MHASFIRPGGVAQ 
MNSAYIRBGGVAQ 
MHAAYFRPGGVHQ 
LHAMTFRPGGVHQ 
MHPAWFHIGGVAH 
234 
234 
199 
249 
165 
195 
163 
181 
177 
223 
223 
188 
238 
154 
184 
152 
170 
166 
Mutation Β 
(P229Q) 
i 
HAAYIRQGGVHQD 
HÄAYIHPGGVHQD 
H A A S V U O G V H Q D 
HÄAYVRPGGVHQD 
H&SFïRPGGVAQD 
NSAYÏRPGGVAQD 
RAAYFRPGGVHQD 
HÄÄYFRPGGVHQD 
HPAWFRIGGVAHD 
235 
235 
200 
250 
166 
196 
164 
182 
178 
407 
407 
372 
422 
338 
384 
340 
357 
544 
Mutation C 
(S413P) 
i 
FGVYLVPDGSSRP 
FGVYLVSDGSSRP 
FGVYLVSDGSSRP 
MGVYWSDGSERP 
FGVFLVSNGSNRP 
LGVHMVSDGGTRP 
PGVYLVSDGTNKP 
FGVYLVADGTNKP 
NSYYLTSDGSTMS 
419 
419 
384 
434 
350 
396 
352 
369 
556 
Table 10.3 The extent of conservation of the substituted amino acids (R228Q, P229Q and S413P) in several pro-
and eukaryotes (PT = patient; WT = wildtype human; BT = Bos taurus; NC = Neurospora crassa; 
WT = Wood tobacco; MT = Mycobacterium tuberculosis; SM = Sinorhizobium meliloti; PD = Paracoccus 
denitriftcans; EC = Escherichia coli). 
In summary, we found missense mutations in the highly conserved NDUFS2 mRNA in four 
isolated complex I deficient patients (three families). The identification of this gene as a 
possible host for mutations causing complex I deficiency increases our possibilities for genetic 
counselling and prenatal diagnostics. Future cellular studies with fibroblasts of these patients 
might increase our insight in the binding and reduction of ubiquinone by complex I as well as 
the hypothesised proton translocating function of the NDUFS2 subunit. 
Electronic database information. 
Genbank accession numbers NDUFS2/49 kDa /NuoD: 
Homo sapiens NP_004541, 075306; Bos taurus P17694; Neurospora crassa P22142; Wood 
tobacco S57332; Mycobacterium tuberculosis CAB06291; Sinorhizobium meliloti 
CAB51623; Paracoccus denitriftcans P29916; Escherichia coli P33600. 
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CHAPTER 11 
MUTATIONAL ANALYSIS STUDIES OF FOUR NUCLEAR ENCODED SUBUNITS 
OF THE COMPLEX I IRON-SULPHUR PROTEIN (IP) FRACTION: 
WHICH GENES NEXT? 
Submitted 
Abstract. 
Human complex I consists of at least 42 different proteins, of which 35 are encoded by 
nuclear genes With the use of chaotropic agents, complex I can be subdivided in a 
Flavoprotein (FP), Iron-Sulphur protein (IP), and Hydrophobic protein (HP) fraction The IP 
fraction is situated in the part of complex I, which protrudes into the mitochondrial matrix and 
contains together with the FP fraction almost all known redox groups 
We performed mutational analysis studies on cDNA level of four IP subunits (NDUFS1, 
NDUFS3, NDUFS6 and NDUFA5) in 20 isolated complex I deficient patients, which revealed 
no pathological mutations With the results presented in this study, all 35 known nuclear 
encoded complex I subunits have been checked for mutations in our initial patient group 
Altogether these mutational analysis studies revealed mutations in genes of five diflerent 
subunits (NDUFVl, NDUFS2, NDUFS4, NDUFS7, NDUFS8), in seven out ol eighteen 
pedigrees (29%) Three of these subunits (four pedigrees) belong to the IP Iraclion 
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Introduction. 
Isolated complex I deficiency is one of the main enzyme defects of the mitochondrial 
respiratory chain found in children clinically presenting with a mitochondrial 
encephalomyopathy (Loeffen et al 2000a) Various drugs and combinations of drugs have 
been supplied to complex I deficient patients such as riboflavine (precursor FAD), 
nicotinamide (precursor NAD) and succinate (complex II substrate) (Scholle et al 1995) 
These therapies have only been described to benefit individual or small number of patients 
Elucidation of the genetic cause(s) in complex I deficient patients, the main aim of our current 
investigations, may be worthwhile in this context for several reasons In the first place it will 
give us the opportunity to offer adequate genetic counselling and prenatal diagnostics 
Secondly, pathophysiological studies performed with tissues of patients in whom the genetic 
defect has been elucidated may enhance our understanding of the cell biological consequences 
of complex I deficiency and eventually may contribute to accurate disease models, necessary 
for developing adequate therapy strategies 
Studies of the genetics of complex I deficiency are complicated by the fact that this complex 
is under double genomic control in eukaryotes (Walker 1992) Seven of the -42 subunits ot 
human complex I are encoded on the mitochondrial DNA (mtDNA, Anderson et al 1981) 
This implicates that the remaining 35 subunits are encoded by nuclear genes The last two 
years, we searched for mutations in the nuclear encoded subunits ol complex I in a group of 
isolated complex I deficient patients Pre-screening for major rearrangements (long template 
PCR technique (Li et al 1995)) and for eleven common mtDNA mutations in these patients 
revealed no abnormalities (Loeffen et al 2000a) 
The cDNA and amino acid sequence of unidentified human complex I subunits were 
elucidated using the high percentage of identity with bovine complex I subunits Recently the 
35'h nuclear encoded bovine complex I subunit has been identified (Skehcl et al 1998) 
Equivalents of these 35 subunits have been lound in humans (Loellen et al 1998a, Tnepels et 
al 2000) Strikingly, mutational analysis studies performed thus far in our patient group 
mainly revealed mutations in those subunits, which are highly conserved in evolution as 
illustrated by their presence in prokaryolic hfeforms (Loeffen et al 2000a) 
In this study we focussed mutational analysis on four subunits of the Iron-Sulphur protein (IP) 
fraction, namely the NDUFS1, NDUFS3, NDUFS6 and NDUFA5 The IP fraction contains -8 
subunits and constitutes the main part of complex I which protrudes in the mitochondrial 
matrix (Galante & Hatefi 1978 and 1979, Belogrudov and Hatefi 1996) The largest subunit of 
the IP fraction is the NDUFS1 (Chow et al 1991) It contains one 2Fe 2S cluster binding site 
(cluster Nib) and probably two 4Fe-4S cluster binding sites (cluster N4 and N5, Ohmshi 
1998) The second largest subunit is the NDUFS2, which is believed to influence proton 
transport and ubiquinone binding (Loeffen et al 2000b) Little is currently known of the 
function of the NDUFS3 subunit, but its high conservation during evolution implicates 
importance (Loeffen et al 1998b) The NDUFS4 subunit contains a cAMP regulated 
phosphorylation site, and probably plays a role in the regulation ol complex I activity (Papa el 
al 1996) Another subunit, which is likely to conlnbute to the electron transport is the 
NDUFS8 This subunit contains highly conserved patterns for two 4Fe 4S cluster-binding 
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sites Of the other three subumts (NDUFS5, NDUFS6 and NDUFA5) is functionally little 
known (Pala et al 1997, Russell et al 1997, Loeffen et al 1998b, Loeffen et al 1999) 
In this study we present the results of mutational analysis studies of four nuclear encoded IP 
subumts (NDUFS1, NDUFSl, NDUFS6 and NDUFA5) in a group of 20 isolated complex I 
deficient patients, which revealed no pathological mutations This study completes mutational 
analysis of the eight subumts present in the IP fraction With the results ot this study, all 
currently known 35 nuclear encoded complex I subumts in our initial complex I deficient 
patient group have been checked for mutations 
Patients, material and methods. 
Patient group 
Twenty isolated complex I deficient patients (age range 0-26 months, measured in all cases in 
cultured skin fibroblasts) were selected for mutational analysis studies of nuclear encoded 
complex I subumts Clinical characteristics ot this patient group have recently been published 
(Loeffen et al 2000a) 
Material 
DNA Taq polymerase, superscript II RNAse H reverse transcriptase and oligonucleotide 
primers were purchased from Life Technologies Ine , gel purification systems from Qiagen, 
dRhodamine Dye Terminator Sequencing Kit from Perkin Elmer, poly A+ RNA pool from 
Clontech and RNAzol trom Biosolve BV 
Tissue culture 
Skin fibroblasts were cultured in a humidified atmosphere of 95% air, 5% CO2 at 37CC in 
medium 199 with Earle's salts supplemented with 10%(v/v) foetal calf serum (FCS) and 100 
IU penicillin/ml and 100 μΟ streptomycin/ml The cells were grown to confluence 
Biochemical measurements 
Fibroblasts were harvested according to standard procedures and suspended in a concentration 
of 1 107 cells/ml 1% Foetal Calf Serum in Phosphate Buffered Saline (FCS-PBS) A 
mitochondnal-ennched fraction was isolated from these fibroblasts as described by Bentlage 
and co-workers in 1996 
All individual enzyme assays have been performed in mitochondrial ennched fractions 
Pyruvate dehydrogenase complex (PDHc) activity is estimated by measurement of the 
production rate of 1 4C02 by PDHc under basal and activated conditions, in presence of 
[l-14C]-pyruvate, CoA and NAD+ according to van Laack et al 1988 Citrate synthase activity 
is estimated by the extent of complex formation between CoA and 5',5'dithiobis-2 
nitrobenzoate (DTNB) which is measured spectrophotometncally at 412 nm according to 
Srere in 1969 NADH O2 oxidoreductase and NADHQl oxidoreductase are measured by 
following NADH oxidation spectrophotometncally at 340 nm in presence of O2 or Ql as 
electron acceptor in presence and absence of rotenone as desenbed by Fischer et al 1986, 
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succinatexytochrome c oxidoreductase is estimated by following the reduction of cytochrome 
c at 550 nm in presence of succinate, rotenone, antimycine A and KCN according to Fischer et 
al 1985. Cytochrome c oxidase activity is determined by measurement of the oxidation rate of 
completely reduced cytochrome c· spectrophotometrically at 550 nm as described by 
Cooperstein and Lazarow 1951. 
Mutational analysis. 
Control RNA was obtained from commercially purchased pooled poly A+ RNA from 12 
healthy Caucasian males and females, age range 12-78 years. Patient RNA was extracted from 
cultured skin fibroblasts according to methods described by Chomczynski and Sacchi 1987. 
cDNA was made by reverse transcription of RNA by superscript II RNAse H" reverse 
transcriptase, with oligo(dT) and random hexamer primers (Ploos van Amstel et al 1996). 
The complete open reading frame (ORF) of the NDUFSl subunit was divided in four 
overlapping fragments, which were separately amplified (F1+R2, F3+R4, F5+R6, F7+R8) in a 
volume of 50 μΙ, containing 2 μΙ cDNA template. 5 μΐ lOx PCR buffer, 100 ng forward and 
reverse primer, 0.25 mM MgCh, 0.25mM dNTPs and 1.0 unit Taq DNA polymerase. In case 
of the NDUFS3 (F1+R3), NDUFS6 (Fl+Rl) and NDUFA5 (Fl+Rl) subunit, one fragment 
containing the complete ORF was amplified in a volume of 25 μΐ, containing 1 μΐ cDNA 
template, 2.5 μΐ lOx PCR buffer, 50 ng forward and reverse primer, 0.25 mM MgCh. 0.25mM 
dNTPs and 0.5 unit Taq DNA polymerase. All reaction conditions and primer sequences used 
are listed in Table 11.1 and 11.2. PCR products were purified using the QIAquick PCR 
purification kit or GEL extraction kit. 
Control and patient PCR fragments were sequenced with the ABl PRISM™ 377 using the 
sequence primers for each individual subunit. which are listed in table 11.1. Procedures were 
followed as recommended by the manufacturer. 
Forward oligonucleotides 
CGGACAGTTTAGCAGAACAG 
GGTTGTCTGTTGCTGGAAAC 
GTGGAAGACAAGAACATTGG 
GATGTAATGGATGCGGTTGG 
GTGGACTCTGACACCTTATG 
GGTGGTTTTAGGCAGTTCTG 
GCTGATGTTATTCTCCCAGG 
CCCACTTGTTCCACCTCAG 
CATCTGAGTAACATGGCGGC 
GTTAGAGGTCTGTATCCATCC 
AGCCAACTGGTATGAAAGGG 
AAATGGCGGCGGCGATGACC 
GTCACCGAGTCGTTGGCG 
Rl 
R2 
R3 
R4 
R5 
R6 
R7 
R8 
Rl 
R2 
R3 
Rl 
Rl 
Reverse oligonucleotides 
GGCACAAGCAGCTACAACC 
CCCAAATCATCTACTCCTGC 
CACTCTTCATTGATGTCCTC 
CAAATCTGTGCCAGCTCCTG 
GAATTGCTGCTCCATCATTTC 
CTCTACCCTCAGTGTTGAC 
GAGGCTCTGCTAATCGAATC 
GGATCACTGCACTACAGTTG 
CTGTGCATTGGTGTGATCCC 
GGATCCTTCTTAGATCAGGG 
GGACACTCAATCATAGATAAGG 
GCACAGAACCAGCGAGCTTCAC 
CAGTTTCCCATGAACACACC 
Tabic 11.1 Sequence of primers used in the PCR reactions and of those used in sequence reactions {all primers) 
Subunits 
NDUFSl 
NDUFS3 
NDUFS6 
NDUFA5 
Fl 
F2 
F3 
F 4 
FS 
F6 
F7 
F8 
Fl 
F2 
F3 
Fl 
Fl 
1^0 
Mutational analysis studies of four nuclear encoded subunits of the 
complex I Iron-Sulphur protein (IP) fraction: which genes next? 
PCR conditions 
NDUFS1F1+R2 920C/1 min.; 920C/1 min., 56 0C/1 min., 72 "C/I min. (40 cycles); 72 oC/10 min. 
NDUFS1F3+R4 920C/1 min.; 920C/1 min., 58 "C/I min., 72 0C/1 min. (40 cycles); 72 "C/IO min. 
NDUFS1F5+R6 920C/1 min.; 920C/1 min., 56 "C/I min., 72 0C/1 min. (40 cycles); 72 oC/10 min. 
NDUFS1F7+R8 92°C/1 min.; 920C/1 min., 58 0C/I min., 72 "C/i min. (40 cycles); 72 oC/l0 min. 
NDUFS3F1+R3 940C/1 min.; 940C/1 min., 60 0C/I min., 72 "C/i min. (34 cycles); 72 oC/10 min. 
NDUFS6F1+R1 940C/1 min.; 940C/1 min., 60 "Ol min., 72 0C/1 min. (34 cycles); 72 oC/10 min. 
NDUFA5F1+R1 94t,C/l min.; 94°C/1 min., 55 "C/I min., 72 0C/1 min. (34 cycles); 72 oC/10 min. 
Table 11.2 Conditions of the PCR reactions used in the amplification of each suhunit. 
Results and discussion. 
Cycle sequencing of the wildtype amplified NDUFS1 cDNA revealed an open reading frame 
(ORF) of 2184 base pairs (including stopcodon) coding for 727 amino acids. We found two 
mutations in the ORF of our wildtype and patient cDNA sequences compared to the published 
NDUFS1 cDNA sequence (Chow et al 1991). It concerned a 1248A->T and 1249T^A, 
which change the published tryptophane residue at position 417 into an arginine (W417R). 
The NDUFS1 subunit has a molecular weight of 79.5 kDa deducted from its amino acid 
sequence. The bovine homologue (75-kDa subunit) contains a presequence of 23 amino acids 
(Runswick et al 1989) and is believed to contain at least two Iron-Sulphur cluster bindings 
sites (4Fe-4S (N4) and 2Fe-2S (Nib); Runswick et al 1989), but probably another 4Fe-4S 
binding site is present (Ohnishi 1998). The presence of these clusters implicates an important 
role for the NDUFS1 in the transport of electrons and is therefore one of the major candidate 
genes in isolated complex I deficiency. Belugrodov and co-workers showed by ligand blotting 
that the bovine 75 kDa subunit has a close interaction with the 51-kDa (NADH binding site, 
FMN, 4Fe-4S) and 24-kDa (2Fe-2S) subunit and therefore likely accepts the electrons from 
the Flavoprotein fraction (FP; Belogrudov and Hatefi 1996). Sequence analysis of patient 
NDUFSI cDNA of 20 isolated complex I deficient patients revealed however no pathological 
mutations. We did encounter several silent mutations, namely a 414T—>C (D138D) 
heterozygously in one patient, a homozygous 966T—>G (A322A) also in one patient (also 
heterozygously in the wildtype) and a 1251G—>A (R417R) in several patients and wildtype 
(homozygous as well as heterozygous). Finally, we found a heterozygous 1291C—>G 
mutation, which leads to the substitution of a leucine into a valine (L431V) in one patient. 
The wildtype NDUFS3 subunit contains an ORF of 795 base pairs coding for 264 amino acids 
(Loeffen et al 1998b). Like the NDUFSI, this subunit is present in the prokaryotic complex 1 
which is indicative for functional importance. Currently nothing is known about the function 
of this subunit. Mutational analysis studies revealed neither mutations nor polymorphisms. 
The NDUFS6 (ORF 375 base pairs) and NDUFA5 (ORF 348 base pairs) wildtype cDNA 
sequence has been published by Loeffen et al in 1998b and Fata et al in 1997, respectively. 
Cycle sequencing of amplified cDNA of all patients again revealed neither mutations nor 
polymorphisms. 
At this moment mutational analysis studies have been performed of all currently known 35 
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nuclear encoded subunits ol complex 1 in an initial group of 20 isolated complex I deficient 
patients (18 pedigrees) In case of subunits present in the fiavoprotein (FP) fraction these 
studies revealed compound heterozygous mutations leading to a nonsense mutation and two 
single amino acid substitutions in the NDUFV1 subumt (R59X and T423M in two brothers 
with an encephalomyopathy and a homozygous mutation resulting in an A341V in a girl with 
macrocephaly and leukodystrophy (Schuelke et al 1999)) Mutational analysis studies 
perlormed with the NDUFV2 and NDUFV3 cDNA revealed no pathological mutations 
(unpublished results) Similar studies performed with subunits of the IP fraction revealed 
amino acid substitutions in the NDUFS2 subumt in three pedigrees (R228Q, P229Q and 
S413P), however the patient in whom the P229Q substitution has been found did not belong 
to the initial patient group (Loeffen et al 2000b) In the NDUFS4 gene a 5-bp duplication was 
found in a boy with Leigh-like syndrome Finally, the NDUFS8 cDNA contained mutations in 
a boy with Leigh syndrome leading to a P79L and R102H amino acid substitution Screening 
of the remaining large group of the Hydrophobic Protein (HP) fraction (24 subunits) revealed 
an amino acid substitution (V122M) in two brothers with Leigh syndrome (Tnepels et al 1999 
and 2000) In summary, mutations were found in 7 of the initial 18 pedigrees (39%), all of 
which co-segregated within the family and were excluded in a large control population 
This study completes the mutational analysis studies of the currently known nuclear encoded 
complex I subunits in our initial complex I deficient patient group (n=20) In contrary to 
cytochrome c oxidase deficiency where no mutations were found in the nuclear encoded 
subunits (Adams et al 1997, Jaksch et al 1998) mutations have been found in those ol 
complex I Since the number of subunits is not definitely determined in cow (now 42 known, 
and one announced, Skehel et al 1998) there might be other mutations present in undetected 
nuclear encoded subunits Similar expenmenls to determine the number of subunits like those 
performed in cow (e.g electrospray mass spectrometry) still have to be performed in humans 
These studies will give the definite number of subunits of which human complex I is 
composed 
The nuclear encoded complex I genes were clear candidates lor mutational analysis studies in 
our complex 1 deficient patient group The elucidation of the gene defects in patients in whom 
no mutations were encountered in the cDNAs ol the nuclear encoded complex I subunits will 
however be more complicated Several approaches can be lollowed to tackle this problem 
One can try to find homologues of human genes, which have been linked to the biogenesis ol 
complex I in lower species and consequently perform mutational analysis studies Good 
candidates for this approach would be the CIA30 and CIA84 complex I chaperone/assembly 
proteins described in Neurospora craaa (Kuffner et al 1998) This method has been 
successfully applied by Papadopoulou and co-workers in 1999 for complex IV deficiency, but 
can lead to many candidates genes. The other more structural approach comprises the 
establishment of complementation groups as has been performed for complex IV deficiency 
(Tiranti et al 1995) This process can be followed by the combination of techniques like 
microcell-mediated chromosome transfer, deletion mapping and positional cloning which led 
to the solution of cytochrome c oxidase deficient patients with Leigh syndrome in whom 
mutations were found in the SURFI gene (Zhu et al 1998, Tiranti et al 1998) 
Mutations might also be present in one of the ND genes or tRNA genes encoded by the 
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mtDNA in our "unsolved" complex I deficient patients. We checked for major rearrangements 
and eleven common point mutations, but this does not cover the complete area At this 
moment it might be wise to exclude or prove mutations in the mtDNA by complementation 
studies with p0 cells as described by King and Attardi in 1989 
In summary, we checked for mutations in the cDNA of four Iron-Sulphur protein fraction 
subumts, namely the NDUFS1, NDUFS3, NDUFS6 and NDUFA5 in our isolated complex I 
deficient patient group This revealed no disease-causing mutations Currently all known 35 
nuclear encoded complex I subumts have been analysed lor mutations in a group of twenty 
isolated complex I deficient patients. This revealed mutations in seven of the eighteen 
pedigrees (39%) Techniques like microcell-mediated chromosome transfer and 
positional/functional cloning should elucidate the genetic delect in the remaining patients 
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CHAPTER 12 
CONSIDERATIONS, CONCLUSIONS AND FUTURE PERSPECTIVES 
Chaptei 12 
Human complex I: structural and functional aspects. 
Over 50 years ago, mitochondria were for the first time identified to host oxidative 
phosphorylation (Kennedy and Lehmnger 1948) Adequate oxidative phosphorylation requires 
synthesis ol a lew rRNAs, tRNAs and proteins by the mitochondrion ilsell (tor a review see 
Taanman 1999) as well as importation of many proteins encoded by the nuclear DNA into 
these mitochondria (Koehler et al 1999) This dual genetic origin demands a delicately tuned 
nuclear and mitochondrial collaboration, which partly has been elucidated (Butow and 
Bahassi 1999) 
Complex I or NADH ubiquinone oxidoreductase is the first, largest and most complicated 
complex of the OXPHOS system (Walker 1992, Smeitink et al 1998) Currently, its subumt 
composition has been elaborately studied in several prokaryotes and cukaryotes Lschemhia 
coMLeifetal 1993, Weidner el al 1993, Leif et al 1995, Friedrich et al 1995, Friedrich 1998), 
Rhodobacter capsulatus (Dupuis et al 1995), Thermits thermophilits (Yano et al 1997), 
Paratoitus ilemt rifu ans (Xu et al 1993), Helicobacter p\lori (Finel 1998), Neurospora 
crassa (Videira 1998), Bos taitrus (Walker et al 1992, Walker 1992) and now also Homo 
sapiens (this thesis, and references therein) 
In general, the number of subunits seems to increase when species ascend the evolutionary 
ladder Prokaryotes are considered to have a fourteen subumt complex I (Leil el al 1993, 
however in some bacteria like E coli, NuoC en D are fused to NuoCD which leaves it with 
thirteen subunits (Braun et al 1998)) Sodium Dodecyl Sulphate (SDS) gel electrophoresis 
revealed that there are at least 35 subunits present in Ν crassa complex I (Weiss el al 1991), 
however at this moment they have not been all genetically characterised It is striking that 
several subunits present in complex I of Ν crassa do not seem to have a homologue in Β 
taurus and Η sapiens and vice versa It could be possible that the genes coding lor these 
subunits diverged very fast, with the result that the interspecies homology is lost The core ol 
lourteen subunits present in prokaryotes is however highly conserved in Ν crassa again 
illustrating the lunclional importance of this part The number ol subumls ol Β taurus was 
believed to be 41 in 1992 (Walker 1992) Eleclrospray mass spectrometry experiments 
however, revealed that there are at least 43 subunits, which is likely to be the final number 
(Skehel et al 1998) The existence ot at least one of these additional proteins in complex I has 
been confirmed with two-dimensional gel electrophoresis and has subsequently been 
characterised on cDNA and amino acid level (Skehel et al 1998) The amino acid sequence of 
the 43 r J subumt has yet to be identihed Similar experiments with human tissue specimens are 
not yet performed, so the final number ol human complex I subunits remains to be elucidated 
At this moment, all 42 amino acid sequences of complex I subunits that have been found in 
cow are also characterised in humans (Table 12 1), of which eighteen have been characterised 
by our research group Gene/protein names were assigned according to the database for human 
gene nomenclature (http //www gene ucl ac uk/nomenclature (White et al 1997)) At present, 
the chromosomal localisation ol 30 nuclear encoded complex I subunits is known, which 
shows a random distribution across the chromosomes (Table 12 1, Spencer et al 1992, Duncan 
et al 1992, All el al 1993, Baens el al 1993, de Coo et al 1995, Hatton et al 1995, Hyslop et al 
1996, Zhuchenko ct al 1996, Russell et al 1997, de Coo et al 1997, Dunbar et al 1997, de Sury 
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et al 1998, Loeffen et al 1998a, Emahazion et al 1998, Triepels et al 1998, Procaccio et al 
1998, Loeffen et al 1999) 
Based on sequence similarity with homologues in lower species, functional aspects can be 
attributed to several human complex I subumts (Table 12 2) Yet, in the lion's share of the 
proteins, the function remains unknown for the time being Especially little is known about 
the additional subumts on lop of the fourteen "minimal" subumts Several theories concerning 
these "plus" subumts have been postulated in literature Alignment of the structure of E tolt 
and Ν crassa complex I revealed that most of the additional proteins are moulded around the 
conserved core (Friedrich 1998) It therefore seems that many of these additional proteins in 
eukaryotes function in stabilising the complex (Guenebaut et al 1997, Friedrich et al 1998) 
and/or shielding the redoxgroups from oxygen, which prevents these groups from premature 
reoxidation by oxygen 
Known exceptions to this are the NDUFAB1 and the NDUFA9 proteins, which both are 
believed to have a biosynthetic function The first shows resemblance to a family of 
acylcamer proteins (ACP) It contains a phosphopantetheine binding site which (when bound) 
can act as docking site for fatty acids and amino acids ACPs are therefore thought to 
participate in fatty acid and polypeptide biosynthesis (Cortes et al 1990, Runswick et al 1991) 
Disruption of the ACP gene in Ν crassa prevents the formation of the extramembranous arm 
(Schneider et al 1995) The NDUFA9 shows homology to a group of isomerases/reductases 
and is thought to have a nucleotide-binding site Furthermore it is proposed to participate in 
the synthesis of a recently discovered new redoxgroup (Schulte et al 1999) 
Studies performed with specimens of LHON patients revealed interesting indications for 
possible functions of the ND subumts Lymphoblasts of LHON patients carrying the 
homoplasmic mtDNA 3460 (ND 1) mutation showed reduced electron transfer capacity in the 
presence of a ubiquinone analogue, but not in presence of femcyanide as electron acceptor 
(Majander el al 1991) LHON patients with a defect in ND-4 (11778 mutation) did not have a 
detective electron transfer, yet did have reduced ATP synthesis when complex I substrates 
were used, but not after usage of complex II substrates (Majander et al 1991, Hofhaus & 
Attardi 1993) ND-2, ND-4 and ND-5 do have some degree of homology, which led to the 
speculation that these subumts participate in proton transport in some way II this assumption 
is correct, mutations in the genes coding for these latter subumts, can result in a decreased 
contribution of complex I to the proton-motive force (PMF), but the electron transport will be 
undisturbed Degli Esposti demonstrated that the 11778 mutation in ND 4 alters the affinity of 
complex I for ubiquinone and reduces the complex I inhibition capacity of rotenone (Degli 
Esposti et al 1994) Photoaffimty labelling studies with |1H]dihydrorotenone indicated that 
ND 1 is probably also involved in the binding of rotenone (Earley et al 1987), while Friedrich 
postulated that the ND-1 subunit is involved in ubiquinone binding (Friedrich et al 1990) 
Based on the results of these studies one may speculate that the possibility exists that not all 
patients with a malfunctioning complex I will be detected with the used complex I enzyme 
assay Whenever complex I is capable of transporting the electrons from NADH to a 
ubiquinone analogue, the results of such assays will be normal, while proton transport may be 
seriously affected 
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Homo sapiens 
Name 
NDUFV1 
NDUFV2 
NDUFV3 
NDUFSI 
NDUFS2 
NDUFS3 
NDUFS4 
NDUFS5 
NDUFS6 
NDUFS7 
NDUFS8 
NDUFA1 
NDUFA2 
NDUFA3 
NDUFA4 
NDUFA5 
NDUFA6 
NDUFA7 
NDUFA8 
NDUFA9 
NDUFA10 
NDUFAB1 
NDUFB1 
NDUFB2 
NDUFB3 
NDUFB4 
NDUFB5 
NDUFB6 
NDUFB7 
NDUFB8 
NDUFB9 
NDUFBIO 
NDUFC1 
NDUFC2 
17.2HUM 
ND-1 
ND-2 
ND-3 
ND-4 
ND-4L 
ND5 
ND-6 
-
-
-
-
-
-
kDa 
51.0 
27.4 
12.0 
79.6 
52.5 
30.2 
20.1 
12.5 
13.7 
18.0 
23.7 
8.1 
10.9 
9.3 
9.4 
13.5 
15.1 
12.6 
20.1 
42.5 
40.8 
17.4 
7.0 
12.1 
11.4 
15.2 
21.8 
15.5 
16.4 
21.8 
21.8 
20.8 
8.7 
14.2 
17.1 
35.7 
39.0 
13.2 
51.6 
10.7 
67.0 
18.6 
Chr . 
Ilql3 
18pll.31-pl1.2 
21q22.3 
2q33-q34 
Iq23 
l lpl l . l l 
Sqll.l 
Ip34.2-p33 
5pter-pl5.33 
19pl3 
Ilql3.1-ql3.3 
Xq24 
5q31.2 
? 
') 
7q32 
22ql3.2-ql3.3l 
19pl3.2 
9q33.2-q34.ll 
I2pl3.3 
12P 
16pl2.3-pl2.l 
14q3l.3 
7q34-q35 
7 
y 
9 
9pl3.2 
19pl3.12-13.11 
10q23,2-q23.33 
8q24-2l 
I6pl3.3 
4q28.2-q28.3 
llh 
0 
mlDNA 
mcDNA 
mlDNA 
mlDNA 
mlDNA 
mlDNA 
mlDNA 
NCBIno. 
human subunit 
NUBM_HUMAN 
NUHM.HUMAN 
>fUOM_HUMAN 
NUAMJHUMAN 
NUCM_HUMAN 
NUGM_HUMAN 
NUYM.HUMAN 
NP_004543 
NUMM_HUMAN 
NUKM_HUMAN 
NU1M_HUMAN 
NP^0O4532 
NP_002479 
NP_004533 
NP.002480 
NUFM_HUMAN 
NP_002481 
N4AM_HUMAN 
ARM4953_1 
NUEM_HUMAN 
NUDM_HUMAN 
NP_004994 
NP_0O4536 
NP_004537 
NP_002482 
NP_0O4538 
NP_œ2483 
NPJX)2484 
AAF17I88 
NP_004995 
NP_004996 
NP_(X)4539 
NP_002485 
NP_004540 
AAF17196 
ND1_12I88 
ND2_12I88 
ND3_I2I88 
ND4_I2188 
NULM_HUMAN 
ND5_12188 
ND6_12188 
Escherichia coli 
Name 
NuoF 
NuoE 
NuoG 
NuoD 
NuoC 
-
-
-
NuoB 
Nuol 
-
-
. 
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
NuoH 
NuoN 
NuoA 
NuoM 
NuoK 
NuoL 
NuoJ 
-
-
-
-
-
-
-
kDa 
49.3 
18.6 
100.3 
68.7' 
68.7' 
25.1 
20.5 
36.2 
45.7 
I6.S 
56.5 
10.S 
66.4 
19.9 
Neurospora 
crassa 
Name 
51 kDa 
24 kDa 
78 kDa 
49 kDa 
31 kDa 
21.3 kDa 
-
-
19.3 kDa 
23 kDa 
-
10.5 kDa 
-
29.9 kDa 
14.8 kDa 
-
20.8 kDa 
40 kDa 
-
9.6 kDa 
-
12 kDa 
-
-
-
-
-
-
_ 
12.3 kDa 
-
-
ND-1 
ND-2 
ND-3 
ND-4 
ND-L·* 
ND-5 
ND-6 
17.8 kDa 
21 kDa 
12 kDa 
21.3 kDa 
9.5 kDa 
21.3 kDa 
18.3 kDa 
kDa 
54.3 
28.8 
81.7 
54.0 
32.3 
24.5 
25.0 
24.9 
10.5 
30.9 
14.8 
20.9 
43.0 
14.5 
12.3 
12.3 
41.6 
65.8 
6.0 
9.8 
79.8 
20.1 
21.0 
12.3 
21.3 
9.3 
21.4 
21.8 
Bot tau 
Name 
51kDa(FP) 
24 kDa (FP) 
lOkDa(FP) 
75 kDa (IP) 
49 kDa (IP) 
30 kDa (IP) 
AQDQ (IP) 
15 kDa (IP) 
13 kDa (IP) 
PSST 
TYKY (IP) 
MWFE 
B8 
B9 
MLRQ 
813 (IP) 
BI4 
B14.5a 
PG1V 
39 kDa 
42 kDa 
SDAP 
MNLL 
AGGG 
B12 
B15 
SGDH 
B17 
BI8 
ASHI 
B22 
PDSW 
KFY1 
Β 14.5b 
BI7.2 
ND-1 
ND-2 
ND-3 
ND-4 
ND-4L 
ND-5 
ND-6 
-
-
-
-
-
rut 
k D a 
50.7 
27.3 
11.9 
79.4 
49.2 
30.3 
19.8 
12.7 
13.4 
23.8 
23.9 
8.1 
11.1 
9.3 
9.3 
13.3 
15.1 
12.7 
20,1 
42.8 
39.3 
10.1 
7.0 
12.3 
11.1 
15.2 
21.6 
15.5 
16.4 
21.7 
21.8 
21.0 
8.8 
14.1 
17.1 
35.7 
39.3 
13.1 
53.8 
I0.X 
68.3 
19.2 
Table 12.1 Complex 1 subunit composition of E. coli, Ν. crassa, Β. taurus and Η. sapiens. ' = STS G29346 
= STS G25213. Genbank accession numbers refer to human subunits. Nuo = NADH:ubiquinone 
oxidorcductase; Sequence similarities between species were found with use of the BLAST program provided by 
the National Centre for Biotechnology Information (Altschul et al 1990). ' NuoC and D arc fused in Escherichia 
coli. 
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Subunit 
NDUFV1/51 kl)a 
NDUFV2/24 kDa 
NDUFS1/ 75 kDa 
NDUFS2/49 kDa 
NDUFS4/ 18 kDa 
NDUFS7/PSST 
NDUFS8/TYKY 
NDUFA9/39 kDa 
NDUFAB1/SDAP 
ND-1 
ND-4 
Function/characteristic 
NADH binding site 
FMN binding site 
4Fe-4S cluster (N3) 
2Fe-2S cluster (Nla) 
G-protein 
2Fe-2S cluster (Nib) 
4Fe-4S cluster (N4) 
4Fe-4S cluster (N5*) 
proton transport 
ubiquinone binding 
phosphorylation site for a cAMP dependent 
protein kinase 
4Fe-4S cluster (N2) 
2x 4Fe-4S cluster 
Family of NAD(P)H 
reductases/isomerases 
acyl carrier protein 
binding site rotenone 
binding site ubiquinone 
binding site rotenone 
binding site ubiquinone 
Reference 
Chen & Guillory 1981, Deng et al 1990 
Patel et al 1991, Schuelke et al 1998 
Ohnishi et al 1985, Ohnishi 1998 
Ohnishi et al 1985, Ohnishi 1998 
Hegde 1998 
Ohnishi 1998 
Ohnishi 1998 
Ohnishi 1998 
Darrouzet et al 1998 
Papaetal 1996 
Ohnishi 1998 
Walker 1992 
Schulteetal 1999 
Runswick et al 1989 
Earleyetal 1987 
Friedrich et al 1990 
Degli Esposti et al 1994 
Table 12.2 Functional aspects of human complex I subunits. Part of this data is based on homology with complex 
1 subunits of lower evolutionary species, from which functional aspects have been studied. 
* The presence of cluster N5 in the NDUFS1 subunit is subject of debate. 
A piericidin A and rotenone resistant mutant of Rhodohacter capsulatus contained a V407M 
amino acid substitution in NuoD. Reintroduction of this amino acid substitution into the 
parental strain resulted in a similar resistance to piericidin A and rotenone as the original 
mutant (Darrouzet et al 1998). The authors propose a model in which NuoD forms the binding 
site for the polar head of piericidin A/ubiquinone and NuoH docks the hydrophobic 
isoprenalyl tail. Okun and colleagues tested members of the three groups of complex I 
inhibitors (piericidin A (class I/A type), rotenone (class Il/B type) and capsaicin (C type), as 
proposed by Degli Esposti and Ghelli in 1994) for competition. They found that the rotenone 
site overlaps with the piericidin A site and the capsaicin site, but the latter two do not seem to 
overlap each other (Okun et al 1999). They suggest a fairly large binding site for ubiquinone 
of complex I, with different points of action for inhibitors. 
Genetic counselling and prenatal diagnostics. 
In our experience, patients suffering from isolated complex I deficiency have a very poor 
prognosis (Loeffen et al 2000a) and currently no widely applicable treatment besides 
supportive, exists. Eventually, in most patients early death will be inevitable. This leaves us at 
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the moment with little more to offer but the opportunity of genetic counselling. Several factors 
make this counselling extremely difficult. Firstly, the genetic cause of the disease can be 
situated in the mtDNA as well as the nDNA. The majority of mtDNA point mutations are 
hcleroplasmic, which results in different amounts of mutated mtDNA between individual 
patients as well as between different tissues within the same patient. In addition, the 
phenotype often has a threshold dependency on the content of mutated mtDNA. Chinnery 
showed that the mutant load of the A3243G mutation present in muscle tissue corresponds 
with the severity of the symptoms, however the mutant load in blood did not (Chinnery et al 
1997). The amount of mtDNA transmitted to the next generation can also be variable. 
According to the bottle neck theory a small number of mtDNA molecules are preferentially 
amplified to repopulate the oocyte (Hauswirth and Laipis 1982). These factors implicate that 
the percentage of mutated mtDNA can vary considerably within families and prediction of 
chance on disease presentation is usually not possible. Some exceptions to this seem to exist. 
Recently, White and colleagues reviewed 56 T8993G/C pedigrees in which they examined the 
relation between the severity of the clinical phenotype and mutant load and predicted clinical 
outcome of individual patients based on their percentage mutated mtDNA (White et al 1999). 
They found a strong positive relation between the mother's blood mutant load and amount of 
heteroplasmy of the 8993 mutation in her offspring. However, there is a wide 95% range of 
predicted probabilities, which indicates variation in mutant load in children of mother's with 
the T8993G/C mutation. Leber's hereditary optic neuropathy (LHON) is usually associated 
with a homoplasmic mutation within the mitochondrially encoded ND genes, which increases 
the accuracy of molecular-genetic prenatal diagnosis performed in chorionic villi. However, 
not all patients carrying an LHON mutation actually become ill. This implicates that 
additional (possibly nuclear) factors must contribute to the phenotype (Shoubridgc 1998). 
Harding and colleagues estimated the recurrence risk of LHON to be 6-10% for female 
offspring and 30-46% for male progeny (Harding et al 1995). Many large deletions and 
duplications within the mtDNA arc sporadic and are therefore not encountered in the mtDNA 
of relatives. 
The majority of isolated complex I deficiencies seen in our centre seems to follow an 
autosomal recessive mode of inheritance (recurrence risk 25%). From the end of the eighties 
until now our centre has gained experience with the measurement of respiratory chain enzyme 
activities in chorionic villi (CV) and amniocytes. These measurements were for years the only 
opportunity for prenatal diagnostics in this patient group. Chorionic villi biopsies are usually 
performed between the IO-12'h week of pregnancy. Enzyme assay procedures used in CV 
(slightly modified) are for NADH:ubiquinone oxidoreductase according to Fischer ci al 1985 
and 1986, cytochrome c oxidase according to Cooperstein and Lazarow 1951, citrate synthase 
as described by Srere in 1969 and PDHc is measured as described by Speri et al in 1990. 
Studies performed in our centre in the early nineties, compared enzymatic findings in CV 
biopsies of 20 pregnancies (18 families). Three respiratory chain deficiencies were found (3x 
cytochrome c· oxidase with Leigh syndrome). Respiratory chain enzyme assays performed in 
fibroblasts of these three infants confirmed the complex IV deficiency which was found in 
CV. None of the other pregnancies resulted in infants with an OXPHOS disorder (Ruitenbeek 
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et al 1992) The last few years however, we encountered some conflicting results when 
complex I activities ol native CV are compared to values obtained from cultured CV of the 
same pregnancy In some cases enzyme measurements in cultured CV reveal a deficient 
complex I activity, while in native chorionic villi complex I activity is normal We have 
currently no explanation for this phenomenon In summary, it is possible to measure 
respiratory chain enzyme activities in CV However, for complex I activity, results are at this 
moment not always conclusive and demand additional investigation 
DNA and RNA are easily extracted from cultured chononic villi and theretore in abundance 
available It is of course necessary to check lor maternal contamination The latter can be 
avoided by careful dissection of the maternal decidua trom the chorionic and by the 
simultaneous amplification of a suitable polymorphism The interpretation of results obtained 
Irom molecular-genetic prenatal diagnostics is considerably easier than those obtained with 
biochemical enzyme measurements Consequently, the search lor molecular-genetic causes of 
complex I deficiency is of utmost importance 
Evidence pathogenicity mutations. 
The complete characterisation of the human complex I subumts on cDNA level made 
mutational analysis studies possible. As described previously, our enzyme assay for complex I 
in fibroblasts is based on measurement of the conversion of NADH to NAD+ in mitochondrial 
enriched fractions in presence of a ubiquinone analogue and in presence/absence of the 
selective complex I inhibitor rotenone Since the peripheral arm of complex I contains all 
known redox centres (Friedrich et al 1998, Skehel et al 1998), the FP and IP traction remain 
the most important candidates for mutational analysis studies in our patient group. We 
focussed these studies on subumts present in the Iron-Sulphur protein fraction, which revealed 
di Itèrent mutations in live pedigrees, which cosegregate within the family (chapter 8, 9 and 
10) Except for the 5-bp duplication found in the NDUFS4 subunil, these mutations concerned 
subumts present m the minimal form of complex I as encountered in prokaryotes The point 
mutations resulted in the substitution of conserved amino acids while the 5-bp duplication 
resulted in a Irameshift with destruction of the C-terminal part of the protein All mutations 
were excluded in a large control population In our patient group, mutations were also found 
in the NDUFV1 subunit present in the FP fraction in two pedigrees (Schuelke et al 1999), and 
in the NDUFS7 subunit of the HP traction in one pedigree (Tnepels et al 1999) At this 
moment all 42 complex I subumts have been checked for mutations on cDNA level in our 
patients (this thesis, Tnepels et al 2000) So ultimately, we lound mutations in 8 of 25 
pedigrees described in chapter 2 (32%) The finding of these mutations offer the parents of 
these patients adequate prenatal counselling during subsequent pregnancies Currently, the 
cDNA ol the subumts in which mutations have been encountered is screened for mutations by 
means of RT-PCR and direct DNA sequencing in new complex I deficient patients presented 
to our centre, in order to investigate the frequency of these and possibly other mutations 
within these subumts Recently, in two new patients frameshift mutations have been found in 
the NDUFS4 subunil (Budde et al 2000) 
Although we believe that the observed mutations are certainly pathogenic, definite prool has 
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to come from complex I deficiency rescue experiments performed with fibroblasts of our 
index patients Rescue experiments were performed with fibroblasts ot the patient described 
m chapter 9 We introduced a plasmid vector containing the NDUFS4 cDNA construct into a 
portion of patient fibroblasts using a multi-component lipid-based transfection reagent 
However, the used transient transfection method failed to result in sufficient cells containing 
the plasmid for complex I measurement Important problems are therefore the large amount of 
transfected fibroblasts needed lor our complex I and cytochrome c oxidase assay (about 10 
million) and the low yield of fibroblasts containing the construct alter transfection Currently 
we are immortalising our patient cell lines, which will be used in a permanent transfection 
procedure The group of Yagi restored complex I activity in two Chinese hamster cell lines, 
which both contained mutations in the NDUFA1 subumt (a deletion and a point mutation) by 
introducing the NDUFA1 cDNA (Seo et al 1999) This procedure restored complex I activity 
to 100% in the cell line with the deletion, while the cell line with the point mutation only 
regained 40% It was suggested that the defective subumt still occupied its position in 
complex I and thereby inhibited complete restoration of the complex I activity This problem 
has to be taken into consideration when we perform our transfection experiments in the future 
Another method to rescue the complex I deficiency is introducing the wildtype chromosome 
on which the mutated gene is situated (or a more accurate reduced part of this chromosome) 
into our patient fibroblasts by microcell-mediated chromosome transfer (Cuthbert et al 1995, 
Zhu et al 1998) Since many complex I deficient fibroblast cell lines do not grow in media 
containing galactose instead of glucose (Robinson 1996), one might observe whether or not 
growth recovers in galactose containing media after introduction of the correct chromosome 
This may be considered as an indirect indication for rescue Other studies like e g 
normalisation of complex 1 subumt distribution visualised with Western blotting could also 
tunclion as indication for rescue 
An important step in order to obtain additional information concerning possible consequences 
of the mutations lound in our patients will be investigating the steady state levels of the 
corresponding mutated transcripts by northern blot or RT-PCR Besides RNA studies, it is 
also possible to analyse consequences of mutations by use of specific antibodies against the 
mutated subumts Both of these approaches are currently investigated 
The quest for new candidate genes. 
Mutational analysis studies of all known 35 nuclear encoded complex I subumts revealed 
mutations in about 40% of our patients, which implicates that in -60% of our patients the 
genetic cause remains unsolved One can consider the possible involvement of mtDNA 
mutations in this residual group As a screening of "unsolved" and new complex I deficient 
patients (but also combined respiratory chain deficiencies) we can investigate a mtDNA 
genetic cause by fusion of patient cell lines with p" cells (cells depleted of mtDNA by long 
term exposure to cthidium bromide (King and Attardi 1989)) Procaccio used ρ0cells, which 
needed undine and pyruvate in the medium to grow and in addition, they were insensitive to 
bromodeoxyuridine (brdU) Cells ot patients and controls do grow in undine and pyruvate 
free medium but are sensitive to brdU After fusion of the p" cells with the patient and control 
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fibroblasts, they were able to select the fused cells by adding brdU to the medium and leaving 
undine and pyruvate out (Procaccio et al 1999) This fusion of patient fibroblasts with p" cells 
should lead to rescue of the complex I deficiency in case of a nuclear cause, while nothing 
will happen in case the mutation is situated in the mtDNA Vice versa introduction of patient 
mitochondria by fusion of enucleated patient fibroblasts with p" cells results in complex I 
deficiency in case of mutations in the mtDNA, while activity remains normal in case of a 
nuclear cause (this latter strategy was used by Raha and colleagues with fibroblasts of a 
patient with hypertrophic cardiomyopathy and a mutation in the mitochondnally encoded 
tRNAGly gene (Raha et al 1999)) After fusion of p" cells with the patient cell lines, several 
aspects like growth characteristics of cells, antibodies against mitochondnally encoded 
subumts and OXPHOS system enzyme measurements can be used to check whether or not 
complementation has occurred The use of p" cells has also been successlully applied in 
demonstrating the nuclear-genetic cause in a cytochrome c coxidase deficient patient (Tiranti 
et al 1995) Since the ND genes strongly contribute to the total amount of mtDNA mutations 
found in complex I deficient patients, it is also possible to search for mutations in these genes 
by means of PCR combined with direct DNA sequencing or Single Strand Conlormation 
Polymorphisms (SSCP) Sequencing of all ND genes in eight complex I deficient patients 
carried out in our centre by de Vries and colleagues in 1994 however, did not reveal any 
mutations (de Vries, thesis) 
One of the most direct methods to find nuclear encoded candidate genes is to search for 
human homologues of genes, which have been linked to the lunction of complex I in lower 
species These genes can code for a diversity of proteins involved in the functioning of 
complex I like transcnption and translation factors of e g complex I subumts, proteins which 
participate in the targeting and importation of complex I subumts into mitochondria, proteins 
which assist in the assembly and incorporation of complex I into the inner mitochondnal 
membrane, proteins which have a lunction in the synthesis of factors associated to complex I 
like ι e the flavin mononucleotide (FMN) and the iron sulphur clusters, but also nuclear genes 
controlling the perpetuation, propagation and expression of the mitochondrial genome The 
approach of candidate gene search in lower species has been successfully applied for complex 
I (Loeffen et al 1998b, van den Heuvel et al 1998, Schuelke et al 1999, Tnepels et al 1999, 
Loeffen et al 2000b) and complex IV (Papadopoulou et al 1999) One of the major problems 
is choosing the right gene lor mutational analysis in the large pool of candidate genes 
available by this approach For complex I, important future candidates are the human 
homologues of complex I intermediate associated proteins (CIA) 30 and 84, which have been 
associated with the large assembly intermediate of the membrane arm ol complex I in Ν 
crassa (Kuffner et al 1998) Deletion of one of these genes in Ν crassa resulted in disruption 
of the assembly process (Kuffner et al 1998) Other important candidate genes involved in the 
biogenesis of complexes of the OXPHOS system obtained via homology searches with yeast 
proteins are BCS1, PETI 12, SCOI, COX15 and COX11 (Petruzzella et al 1998) 
A very elegant step in elucidating the genetic cause in our remaining complex I deficient 
patients would be the investigation of existence of individual complementation groups as has 
been performed for cytochrome c oxidase deficiency by Munaro et al in 1997 First, the 
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existence of a nuclear cause should be proved in the patient group by use ol p 0 cells as 
described belore Subsequently two patient fibroblast cell lines can be fused with ι e 
polyethylene glycol (PEG) Selection of hybrids can be obtained by making each of the two 
cell lines resistant to a different antibiotic before fusion by introducing a recombinant vector 
expressing a resistance-inducing gene (Double-antibiotic selection, Munaro el al 1997) These 
cells can then be cultivated in medium containing both antibiotics until an adequate amount of 
cells is available lor measurement of the enzymes of the OXPHOS system If both patients are 
affected by mutations in the same gene, rescue of the complex I deficiency will not occur, 
while rescue will take place when both patients are affected by diflerenl genes 
Several other methods arc available to categorise our patients in different groups By using 
antibodies directed against different complex I subunits, we can analyse protein expression 
patterns in mitochondrial preparations by Western blotting Procaccio defined two diflerenl 
protein patterns in two complex 1 deficient patients by this approach, one expressing lowered 
amounts ol the NDUFV1 and NDUFV2 subunits while the other tested subunits were 
expressed in normal amounts, and a patient who expressed reduced protein contents of all 
tested subunits (Procaccio et al 1999) Von Kleist-Retzow used this approach of immunoblot 
analysis with antibodies against nine complex IV subunils in 17 cytochrome c oxidase 
deficient patients This revealed mainly patlems with overall decreased protein levels, but in 
individual patients distinct patterns were also found (von Kleist-Retzow et al 1999) This 
approach can be expanded by using the technique of two-dimensional blue native gel 
electrophoresis (Nijtmans el al 1998) Coenen successfully showed with this technique that 
diflerenl two dimensional gel electrophoresis patterns exist for cytochrome c oxidase deficient 
patients with a mutation in the SURF1 gene and those who do not (Coenen et al 1999) 
Specific patterns may well be present among complex I deficient patients 
The finishing touch in elucidating the genetic cause in a complémentation group of complex I 
deficient patients can be provided by the tremendous technique of microcell mediated 
chromosome transfer, successfully applied by Zhu and colleagues who found the link between 
the SURl· J gene and cytochrome c oxidase deficient patients with Leigh syndrome (Zhu et al 
1998) By I using human rodent hybrid cell lines containing single human chromosomes 
(Culhbcrt et al 1995), rescue of the enzyme deficiency will occur after introduction of the 
chromosome on which the gene defect in the patient is situated After establishment ol the 
correct chromosome, one can reduce the size of the fragment on which the candidate gene is 
situated by analysing hybrids with deleted versions of this chromosome Zhu beautifully used 
the tact that introduced chromosomes delete and rearrange after fusion, by choosing 
informative markers in hybrids which compensate and clones which don't compensate to 
narrow the area ol the gene ol interest (deletion mapping, Zhu et al 1998) Finally 
positional/lunctional cloning might reduce the area containing the candidate gene to a 
'reasonable" size for direct DNA sequencing Preparations to introduce this technique in order 
to elucidate the genetic delects in our remaining complex I deficient patients are currently 
undertaken in collaboration with the rcscarchgroup of Eric Shoubndge 
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Pathophysiological aspects of complex I deficiency. 
A decreased production of ATP can be an important pathophysiological consequence of 
complex 1 deficiency Complex I contributes to the proton motif force (PMF) that is used by 
complex V to generate ATP When complex I malfunctions, this can lead to a decrease ot the 
PMF and therefore to less available ATP MERRF and MELAS mutations lead to a generally 
decreased mitochondrial protein synthesis (Chomyn et al 1992, King et al 1992, Masucci et al 
1995), often resulting in a combined complex I and IV deficiency In MERRF cells the 
aminoacyldtion capacity of tRNA1 y s is decreased leading to an impairment ol mitochondrial 
protein synthesis (Enriquez et al 1995) The specific pathophysiological mechanism occurring 
in cells harbouring the A3243G (MELAS) mutation remains unclear for the time being 
Theoretically, the decreased proton pumping by the respiratory chain can result in a decreased 
mitochondrial membrane potential (Δψ,,,) and PMF James et al used the lipophilic cation 
TPMP (which accumulation is related to the membrane potential) to estimate this 
mitochondrial membrane potential This revealed a clear decrease in membrane potential in 
MERFF as well as MELAS fibroblasts (James et al 1996) Moudy and colleagues used 
quantitative fluorescence imaging to measure the membrane potential of individual 
mitochondria of fibroblasts loaded with the dual emission dye JC-1 This revealed 
significantly reduced J aggregates in MELAS fibroblasts (JC-1 specifically labels 
mitochondria and expresses mitochondrial membrane potential as a function ol the state of 
dye aggregation) indicative for reduced mitochondrial membrane potentials in these cells 
(Moudy et al 1995) Moudy also measured the ATP concentration in these cells, which was 
within the normal range James and colleagues hypothesised that once one increases the ATP 
turnover in quiescent fibroblasts, patient fibroblasts have less reserve capacity to replenish this 
ATP compared to control fibroblasts (James et al 1999) They measured ohgomycin-sensitive 
ATP production by fibroblasts permeabihsed with digitonine and found a decreased ability to 
synthesise ATP in cells derived from MERFF and MELAS patients However the amount of 
ATP in MERFF and MELAS fibroblasts (measured with the luciferase luciferm technique) 
was similar to that ol controls, which also counts for the ATP/ADP ratio To increase the ATP 
turnover, gramicidin (Na+ and K+ lonophore) was added which indirectly increases the activity 
of the plasmamembrane Na+/K+ ATPase resulting in an increased ATP turnover They found 
that cells carrying the MELAS and MERRF mutations have problems to maintain their 
ATP/ADP ratio at gramicidin concentrations when control cells have no problems at all 
(James et al 1999) 
Quiescent fibroblasts strongly depend on glycolysis instead of oxidative phosphorylation for 
their ATP production (Robinson 1993, Robinson 1996) James et al found that the culture 
medium of MELAS cells acidified faster compared to controls Measurement ol lactate 
dehydrogenase (referred to citrate synthase activity) revealed increased activity pointing 
towards anaerobic respiration (James et al 1996) Fibroblasts cultured in glucose medium first 
convert glucose into pyruvate and lactate and when glucose is running out, the conversion of 
pyruvate into acetyl-CoA is accelerated which increases the contribution of the OXPHOS 
system to the production of ATP (Robinson 1996) This is further illustrated by the 
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experiment where in fibroblast culture medium glucose is exchanged for galactose in 
equimolar amounts The conversion of galactose to glucose-1-phosphate is limited so cells 
will increasingly depend on the OXPHOS system instead ol glycolysis Complex I deficient 
fibroblasts will therefore grow poorly on galactose containing culture medium (Robinson 
1996) This strong dependence on glycolysis could explain why resting ATP levels were 
lound normal in MELAS and MERRF hbroblasts, since this part of the energy-providing 
system is not affected 
Adequate ATP steady state and production measurements ideally should be performed in 
tissues, which often are affected in complex I deficient patients like brain, heart and skeletal 
muscle tissue A favourable improvement would be the applicability of myoblast cultures 
(Shoubndge et al 1996) in our OXPHOS enzyme assays, but also other pathophysiological 
studies One of the problems we encounter in cultunng myoblasts is their rapid terminal 
dillcrcntiation into multinucleated myotubes This limits the number of culture passages and 
therefore the use of myoblasts in many pathophysiological experiments, including our 
OXPHOS enzyme assays Another major problem in cultunng myoblasts is the contamination 
of these cultures with fibroblasts Myoblast cultures were successfully applied in the 
measurement ol ATP and ADP ol patients with the 3243A—»G (MELAS) mutation, which 
both were found to be decreased (Rusanen et al 2000) 
Last year, Barnentos and Moraes published studies m which they examined 
pathophysiological aspects ol complex 1 deficiency using a model of human ape 
xenomitochondnal hybrids (HXC cells, 40% complex I deficiency) as well as a drug-induced-
model (rotenone, 40% complex I deficiency) (Barnentos and Moraes 1999) These models 
showed similar results as descnbed previously Cells used in both models grew poorly on 
galactose-containmg medium compared to glucose-containing medium They also measured 
Δψη, of individual mitochondria using the JC-1 probe, which revealed a mild decrease ol Δψ
ηι 
in rotenone treated cells as well as in HXC cells 
Another important damage inflicting mechanism possibly involved in complex I deficiency is 
abundant generation of reactive oxygen species (ROS) with as most prominent members 
superoxide (O? ), hydrogen peroxide (HiOi) and the hydroxy! radical (OH ) This process 
probably results trom interaction of oxygen with semiquinone molecules (Robinson 1998) and 
is therefore indirectly the result from the one electron reduction events taking place in 
complex I The first reactive oxygen compound likely to be generated is O2 by interaction ol 
oxygen with semiquinone (in physiological as well as pathophysiological conditions) 
Superoxide dismutase (SOD) scavenges O2 by converting them two at a time to H2O2 and 
O2, which is normally further processed by catalase in peroxisomes and glutathion peroxidase 
in mitochondria and cytosol When H2O2 has a close encounter with free iron or copper, it can 
be converted into the highly reactive OH This latter radical is believed to generate most of 
the damage attributed to biological macromolecules, like lipid peroxidation, protein 
aggregation and DNA hydroxylation One can speculate that malfunctioning of electron 
transport chain complexes leads to excessive escape of electrons from these complexes and 
therefore to a surplus of ROS Much data about involvement ol excessive ROS lormation in 
complex I deficiency has been generated by the research group of Robinson Pitkanen et al 
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showed with Southern blotting that mlDNA isolated trom fibroblasts of complex I deficient 
patients with cataract and cardiomyopathy contains many multiple deletions in contrast to 
control fibroblasts (Pitkanen et al 1996), indicating free oxygen radical damage Furthermore, 
they showed with western blot analysis as well as with an enzymatic assay that the 
mitochondrial Mn-SOD levels were elevated in these patients Later this group used the 
luminometnc probe lucigemn in order to measure the O2 production on addition ot NADH in 
isolated fibroblast mitochondrial membranes of complex I deficient patients Their results 
revealed a spectrum with on one side elevated O2 levels combined with reduced Mn-SOD 
values (phenotype ol cataract and developmental delay) while on the other side patients 
expressed reduced OT levels with increased values of Mn-SOD (phenotype of cataract and 
cardiomyopathy, Pitkanen and Robinson 1996) Measurement of OT production in control 
fibroblasts treated with rotenone revealed increased production rates The authors hypothesise 
that complex I deficiency increases the formation of ROS, though variable induction of Mn-
SOD influences this rate Luo and colleagues demonstrated increased production of OH in 
complex I deficient patients expressing cataract and cardiomyopathy by using the aromatic 
hydroxylation assay with salicylate as a probe (Luo et al 1997) Furthermore Luo showed 
overproduction of aldehydes (indicative ot lipid peroxidation) in fibroblasts of these patients 
Bamentos and Moraes used H2DCF (converted to a fluorescent product alter oxidation by 
H2O2) and found increased ROS formation in cells from the HXC as well as the rotenone 
model (Bamentos and Moraes 1999) Future studies must be performed to entangle the 
influence of excessive ROS formation in the pathophysiology ol complex I deficiency 
An important future topic in the study of the pathogenesis of complex I deficiency will be the 
role of calcium In normal cells, the cytoplasmic calcium concentration ((Ca"+]J is kept 
strictly at 10 7 M Several factors influence cellular calcium homeostasis like Ca 2 + pumping 
(e g insPi receptor in the ER membrane) and leaking mechanisms (Hofer et al 1998) Another 
organelle capable of calcium sequestration is the mitochondrion Despite the low affinity of 
mitochondria for calcium, increases of [Ca"+]L are transmitted into mitochondria because of 
close contact between mitochondria and endoplasmic reticulum (ER) (Rizzuto et al 1998) 
This indicates the importance of the intracellular distribution of the mitochondrion, which can 
be disturbed in OXPHOS disorders The uptake of calcium by mitochondria is strongly 
dependent on the Δψ,,,, which can be reduced in complex I deficiency Moudy monitored the 
cytosolic calcium handling ([Ca2 +]J with conlocal microscopy within single fibroblasts 
loaded with the fluorescent probe FURA-2 of patients with MELAS syndrome (Moudy et al 
1995) They found that MELAS cells have an elevated resting [Ca-*],, and in addition express 
a disturbed sequestration of fCa"+l1. after inositol triphosphate (IP3) mediated stimulation 
Padua and colleagues performed similar experiments with fibroblasts of a patient with a 
pyruvate dehydrogenase complex (PDHc) deficiency (Padua et al 1998) They found equal 
resting [Ca + ]
c
 between controls and patients, however bradykinine stimulated increase of 
[Ca2+]L resulted in reduced [Ca 2 +]m transients in PDHc deficient fibroblasts (-4% of controls) 
indicating that these mitochondria have decreased ability to sequester cytosolic calcium 
We monitored the [Ca2*]^ handling of cultured skin fibroblasts suspensions of 5 complex I 
deficient patients with mutations in nuclear encoded complex I subunits, 3 SURFl patients 
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and 5 controls, with the ratiometric Ca + probe FURA-2 Bradykinine stimulation of lCa"+|t in 
calcium-free medium and calcium containing medium revealed bound FURA-2/unbound 
FURA-2 (140 nm/380 nm) ratio peaks (averaged for each subgroup) which were highest in 
controls, lollowed by complex I deficient fibroblasts and were lowest in SURFl cell 
suspensions (100%, 78%, 67%, respectively, unpublished results) The ascending and 
descending slope of the spike as well as the wide were comparable in all three groups Agonist 
stimulation ol cells in calcium containing medium results in a higher 140/380 ratio after the 
peak, probably due to capacitati ve calcium entry (Berridge 1995) Strikingly, this effect was 
highest in controls, followed by complex I deficient cells and lowest in SURFl fibroblasts 
(unpublished results) In order to study the calcium maintenance more specifically within 
these cells we used the inhibitor ol the endoplasmic reticulum calcium ATPase (SERCA 
lamily) thapsigargin Subsequently, passive leakage of calcium out of the ER results in a 
temporary increase of [Ca"+]
c
 The 340/380 ratio showed a sleeper slope in the ascending as 
well as descending part of the curve in controls compared to complex I and SURFl 
fibroblasts This could be explained by decreased uptake capabilities for calcium of patient 
mitochondria To study this mechanism of different calcium kinetics after thapsigargin 
supplction in controls and complex I and SURFl deficient fibroblasts we want to target the 
ratiometric calcium probe MAG-FURA-2 (low alfinity lor calcium) into the ER after which 
the emptying ot the ER can be studied (Hofer 1999) Landolfi showed in intact cells using this 
technique that uncoupling of mitochondria with CCCP immediately reduces the ER emptying 
(Landolfi et al 1998) The exact mechanism ot this effect is unknown, however the decreased 
slope of the ascending part ol the curve obtained after addition of thapsigargin to the medium 
in our complex I and SURFl deficient fibroblasts could be caused by a similar phenomenon 
Hofer showed that leakage of calcium from the ER after blockage ol the SERCA pump is 
specifically regulated by the ATP concentration (Holer et al 1996) The leakage rate 
diminishes when the ATP concentration is lowered This could explain why the leak of 
calcium Irom the ER after similar SERCA blocking is reduced in our patient fibroblasts 
Recently, Jouaville and colleagues described a powerful technique by which they can measure 
cytosohc and mitochondrial ATP levels with the specifically targeted ATP dependent protein 
luciferase (Jouaville el al 1999) Ri/utto already showed that agonist stimulated calcium 
increase in the cytosol are followed by large calcium increases in the mitochondrial matrix 
(Ri77uto et al 1998) With the combined usage of aequonn (fluorescent protein which can 
visualise calcium fluctuations) and luciferase (reflects ATP content) which both can be 
targeted into mitochondria, Jouaville showed that following agonist stimulation, [Ca"+]L 
increases, which is directly followed by an increase ol mitochondrial calcium concentration 
([Ca"+]
m
) In addition, this increase ol |Ca"+ |
m
 is followed by an increase of ATP production, 
which sustains alter the calcium peak disappeared (Jouaville et al 1999) This phenomenon 
can partly be explained by the fact that several mitochondrial enzymes like PDHc, isocitratc 
dehydrogenase and α ketoglutarate dehydrogenase are regulated by calcium The results of 
these experiments (calcium peaks in mitochondria and subsequent ATP increases in 
mitochondria and cytosol) were more pronounced in myotubes compared to HeLa cells (in 
resting culture conditions) Brim and colleagues subsequently showed with this technique that 
170 
( oiisideratiOHs loniluòionò und future perspetlnes 
IPi stimulated [Ca"+]c increases were equal between controls and 100% mutated MERRF 
fibroblasts, but the consequent nse in [Ca"+lm is severely diminished in the MERRF 
fibroblasts (Bnm et al 1999) They also saw, that ATP increase after IPi stimulation is 
diminished in MERRF fibroblasts 
Several studies performed in the last lew years have shown that excessive (slow) uptake of 
calcium by mitochondria leads to opening of the so-called mitochondrial permeability 
transition pore (MTP), probably leading to calcium induced cell death (Crompton 1999) 
Normally, the [Ca"+lm is kept below 10 μΜ When calcium exceeds a limit of 200 μΜ in the 
presence of ADP, the pore opens Three components have been identified to participate in the 
MT pore formation, namely the Adenine Nucleotide Translocase (ANT), Cyclophilin-D (CyP-
D) and the Voltage Dependent Anion Channel (VDAC) Several processes influence the 
opening and closing of the MT pore like the mitochondrial membrane potential, the redox 
state, matrix pH, reactive oxygen species (ROS) and adenine nucleotides (Fontaine et al 
1998) In vitro, the opening ot the MT pore leads to collaps of PMF, disruption ol ionic 
homeostasis, mitochondrial swelling and ATP hydrolysis by complex V (Fontaine et al 1998) 
Eventually nuclear apoptosis is initialed Fontaine and co-workers summarised several 
mechanisms by which MTP opening can lead to cell damaging pathways like decreased levels 
of cellular ATP, increase of [Ca"+lt, release of apoptosis inducing factor (AIF) and release of 
cytochrome c Interestingly, they saw that the sensitivity ol the MT pore for calcium as 
monitored by a decrease of the mitochondrial membrane potential after calcium loading was 
much higher when complex I substrates were used, compared to complex II substrates This 
increased sensitivity for calcium seemed to depend mainly on the rate of electron flux through 
complex I Barnentos and Moraes showed that rotenone induced cell death is strongly reduced 
by cyclosponne A and the phospholipase AT inhibitor ArA (both act synergislically in 
inhibiting MT pore opening) This indicates that some pathophysiological consequences of 
complex I deficiency eventually lead to MT pore opening and cell death (Barnentos and 
Moraes 1999) 
Therapy for complex I deficiency: utopia or...? 
Isolated complex I deficiency in children often leads to a devastating clinical course, usually 
resulting in death of the child Several therapeutic procedures have been tested in the past, 
usually with little elicci Finding a cure for these patients should however be one ol the main 
goals in future research Schölte and co-workers listed successlul drugs which have been 
supplied to (mainly individual) patients with complex I deficiency Examples are riboflavin, 
succinate, nicotinamide, and menadione + succinate therapy (Schölte et al 1995) In general, 
these forms of therapy have only been described to work in individual cases Additionally, 
little is known about the natural cause of the diverse clinical phenotypes associated with 
complex I deficiency, so benefits are difficult to assign 
A completely dillerent approach has been developed by the research group ol Shoubndge 
Many iRNA point mutations are distributed between tissues in a heleroplasmic way In muscle 
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tissue, high percentages of mutated mtDNA are often found in mature muscle fibres, while 
undifferentiated satellite cells contain undetectable amounts (Shoubndge et al 1997) MtDNA 
analysis of cultured muscle cells obtained from two biopsies taken from the biceps muscle of 
a patient (cytochrome c oxidase deficient) with a point mutation in the milochondnally 
encoded tRNA1'*'11 gene, showed that mature muscle fibres contained 95% mutated mtDNA, 
while this was nearly undetectable in simultaneously cultured satellite cells Fu and co-
workers proposed that elimination of the mutated mtDNA could be achieved by stimulation of 
the regeneration ol muscle tissue (Fu et al 1996) This patient was rebiopsied at the site ol the 
original biopsy and regenerating muscle fibres were stained for cytochrome c oxidase activity 
which was almost invariably positive (Shoubndge et al 1997) Single fibre PCR analysis 
revealed that all regenerating muscle fibres had no detectable mutated mtDNA Clark and 
colleagues had similar results by inducing muscle fibre regeneration chemically in a patient 
with a point mutation in the tRNA1'''" gene (Clark et al 1997) Taivassalo and co-workers 
expanded this approach by inducing a form of gene shifting therapy using concentric muscle 
training to promote muscle fibre regeneration (Taivassalo et al 1999) This approach led to a 
dramatic increase in the wildtype/mutated mtDNA ratio in regenerating muscle fibres 
Taylor and colleagues also try to develop a therapy based on the heteroplasmy aspect of 
mtDNA Their goal is to develop a method to selectively inhibit the replication of mtDNA 
containing a mutation, which subsequently results in propagation of wildtype mtDNA To 
prove the possibility of this approach they synthesised peptide nucleic acids (PNAs) 
complementary to human mutated mtDNA templates (Taylor et al 1997) They showed that 
these antigenomic PNAs inhibited replication of mutated mtDNA but not of wildtype DNA, 
and that these PNAs indeed are taken up by myoblasts 
Since these latter two approaches have their fundament in the principle ol mtDNA 
heteroplasmy, it is not applicable in patients with mutations in nuclear DNA 
A revolutionary approach has been performed by Seo and co-workers who successfully 
introduced the internal NADH quinone oxidoreductase of Saccharom\ces serevuuie 
(rotenone-insensitive) into a complex I deficient hamster cell line In addition, they showed 
that the transfected cell lines had normal complex I activity, while the non-transfected 
remained deficient (Seo et al 1998) In later studies they proved that this enzyme is transcribed 
and translated in human cells, despite the presence of human complex I (Seo et al 1999) This 
tremendous approach might eventually lead to a successful therapy 
Finally, I would to like to focus on one of the ultimate ways to study pathophysiological and 
therapeutical aspects of complex I deficiency, namely an animal model A mouse in which one 
of the nuclear genes coding for a complex I subunit has been knocked out or modified, will 
lead to enormous progress in our understanding of the consequences of complex I deficiency 
Of course this model can also figure as an important lest model to investigate benefits and 
disadvantages of several therapeutic models In addition, such a model provides tissues, which 
are often affected in patients, yet dilficult to obtain like heart, brain en liver tissue 
Much is said by quoting one ol the major energy providers in the world 
complex I is on the move 
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Dutch iumnuin 
Samenvatting. 
Introductie. 
In de humane cel vinden zeer veel biochemische reacties plaats Veel van deze reacties 
verlopen spontaan, omdat de toestand na de reactie energetisch gunstiger is dan voor de 
reactie In dit laatste geval is de vrije energie (AG) van de reactie negatief Veel biochemische 
reacties verlopen echter niet spontaan omdat ze energetisch ongunstig zijn (AG is positief) 
Een biochemisch energetisch ongunstig verlopende reactie kan toch verlopen wanneer deze 
gekoppeld wordt aan een energetisch gunstig verlopende reactie, zodat de som van beide 
reacties resulteert in een negatieve AG In cellen worden reacties met een positieve AG vaak 
gekoppeld aan de hydrolyse van adenosine In fosfaat (ATP) De AG van deze laatste reactie is 
-7 3 kcal/mol ATP wordt daarom wel de brandstof van de humane cel genoemd De vnje 
energie in een ATP molecuul zit opgesloten in de fosfo-anhydnde binding Hydrolyse van 
deze binding resulteert in het vrijkomen van energie die ongebruikt vrijgegeven wordt in de 
vorm van warmte Veel enzymen kunnen deze energie echter gebruiken en aldus energetisch 
ongunstige reacties toch laten verlopen 
ATP kan uit veel voedingsbestanddelen worden gevormd, met als belangrijkste glucose en 
vetzuren Nadat glucose is opgenomen door de cel, wordt het in drie etappes afgebroken, 
waarbij het energierijke ATP wordt gevormd Deze drie etappes zijn de glycolyse, de 
citroenzuurcyclus en de oxidatieve fosforylenng Vetzuren worden na opname in de cel 
omgezet in acyl-CoA, dat al of niet in de vorm van een carnitine ester naar de mitochondnen 
wordt getransporteerd en aldaar verder wordt geoxideerd via een proces genaamd /3-oxidatie 
De /J-oxidatie levert uiteindelijk hetzelfde substraat op als glucose voor de citroenzuurcyclus, 
namelijk acetyl-CoA De glycolyse vindt plaats in het cytosol van de cel, de citroenzuurcyclus 
en oxidatieve fosforylcnng vinden plaats in de mitochondnen Tijdens de glycolyse, ß-
oxidatie en citroenzuurcyclus worden de substraten (NADH en FADH2) voor de laatste etappe 
van de energieproductie gevormd de oxidatieve fosforylenng 
Het oxidatieve (OXPHOS) lostorylenngssysteem bestaat uit vijf enzymcomplexen en is 
gesitueerd in de binnenmembraan van mitochondnen Complex I tot en met IV voorzien in het 
transport van elektronen van NADH en FADH2 naar zuurstof De energie die vrijkomt bij het 
transport van deze elektronen wordt geconserveerd door het gelijktijdige transport van 
protonen van de mitochondnele matrix naar de tussenmembraan ruimte Dit transport 
resulteert in een elektrochemische gradient, die gebruikt wordt door het vijfde complex, ATP 
synthase om ATP te vormen 
Sommige kinderen worden geboren met een stoornis in een of meerdere enzymcomplex(en) 
van de oxidatieve fosforylenng. Cellen van deze kinderen zijn dus met in staat om in de 
behoefte aan ATP te voorzien Dit uit zich onder meer in zeer ernstige multi-orgaan 
aandoeningen, waarbij organen die veel energie verbruiken als skeletspieren, hart en centraal 
zenuwstelsel het ernstigst zijn aangedaan Het onderzoek dat beschreven staat in dit 
proelschnft, ncht zich op kinderen met een stoornis in het eerste complex van de oxidatieve 
fosforylenng het NADH ubiqumon oxidoreductase (complex I) 
Complex I voorziet in het transport van elektronen van NADH naar ubiqumon en gekoppeld 
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hieraan het transport van protonen over de mitochondriële binnenmembraan naar de 
tussenmembraanruimte. Hierdoor levert complex I een bijdrage aan de elektrochemische 
prolongradiënt over de binnenmembraan van mitochondrien, welke gebruikt wordt door 
complex V om ATP te synthetiseren. Bij de mens bestaat complex I uit tenminste 42 
verschillende eiwitten, waarvan er 7even door het mitochondriële DNA (mtDNA) gecodeerd 
worden, de rest door het kern DNA (nDNA). 
Patiëntengroep. 
Het is mogelijk om in diverse weefsels van patiënten verdacht van een stoornis in de 
energiestofwisseling (b.v. in gekweekte huidfibroblasten, skeletspier-, hartspier-, lever- en 
hersenweefsel), de overall capaciteit van het oxidatieve fosforyleringssysteem m.b.t. de 
productie van ATP uit diverse substraten, alsmede de oxidatiesnelheden van diverse 
substraten te melen. Daarnaast is het mogelijk om de enzymactiviteit van de individuele 
complexen van dit systeem te meten. 
Voor onze studies selecteerden we 27 patiënten met een geïsoleerde complex I deficiëntie (in 
alle gevallen gemeten in gekweekte huidfibroblasten en in het merendeel van de patiënten ook 
in skeletspierwecfscl). De sekse verdeling liet een mannelijke meerderheid zien: 3,3 : 1. 
Klinische karakterisering van deze patiënten leverde een subclassificatie op in zes groepen. 
Een groot deel van de patiënten (26%) leed aan het syndroom van Leigh. Een ongeveer even 
groot deel leed aan een syndroom dat sterke gelijkenis vertoont met het syndroom van Leigh 
(22%; Leigh-likc), maar bij deze patiënten zijn postmortaal geen neuropathologische studies 
uitgevoerd die de diagnose Leigh syndroom hadden kunnen bevestigen. Verder vertoonde een 
deel van de patiënten bij de geboorte een neonatale cardiomyopathie en lactaat acidose (11%; 
NCLA) of fatale neonatale lactaat acidose (11%; FILA). Tenslotte vertoonde een klein deel 
van de patiënten macrocefalie en progressieve leukodystrofie (7%; MLD) en was hel in een 
substantieel deel van de patiënten niet mogelijk een encefalomyopathie verder te specifcrcn 
(22%). Veel voorkomende symptomen in onze patiënten groep zijn: hypotonie; psychomotore 
retardatie; respiratoire stoornissen; epilepsie; voedingsproblemen; lekenen van ziekte aan de 
piramidebanen; nystagmus en cardiomyopalhie. De gemiddelde leeftijd waarop symptomen 
zich manifesteerden was 4,6 maanden. De gemiddelde overlevingsduur na openbaring van de 
ziekte was 8,6 maanden. Op vijf kinderen na, zijn alle kinderen in de eerste vijf levensjaren 
overleden, 67% zelfs binnen de eerste twee levensjaren. De klinische kenmerken van de 
patiëntengroep staan beschreven in hoofdstuk 2 van dit proefschrift. 
Aangezien er nauwelijks succesvolle therapeutische mogelijkheden voor deze kinderen 
beschikbaar zijn, is het van het grootste belang om de genetische oorzaken op te sporen, zodat 
adequate en betrouwbare genetische counseling en prenatale diagnostiek kan worden 
aangeboden. Het overervingpatroon lijkt op grond van het hoge percentage consanguiniteit 
(26%) en de verdeling van aangedane en niet aangedane kinderen binnen de families in deze 
patiëntengroep autosomaal-recessief te zijn. Verder blijkt uit de literatuur dat veel 
voorkomende mutaties in het mitochondriële DNA die aanleiding kunnen geven tol OXPHOS 
stoornissen, slechts in een klein percentage van kinderen met een dergelijke ziekte voorkomen 
(-5%). In onze patiëntengroep zijn grote mutaties in hel mlDNA uitgesloten door middel van 
de "long template PCR" techniek. Verder zijn elf veel voorkomende pathogène puntmutalies 
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in het mtDNA eveneens uitgesloten door middel van polymerase kettingreactie (PCR) 
gecombineerd met restrictie enzym analyse Door dit alles lijken de genetische oorzaken van 
de complex I deficiëntie in deze patiëntengroep zich grotendeels te bevinden in het kern DNA 
en met in het mitochondnele DNA Een belangrijke groep kandidaat genen is dan natuurlijk 
de kemgecodeerde subeenheden die daadwerkelijk onderdeel uitmaken van complex I 
Voordat mutatie analyse studies in deze patiëntengroep uitgevoerd konden worden, moesten 
eerst de kemgecodeerde subeenheden gekarakteriseerd worden 
Karakterisatie van humane complex I subeenheden. 
Het complex 1 van prokaryoten wordt gezien als de minimale functionele variant van dit 
enzym complex Het bestaat uit 14 subeenheden, welke tezamen zowel het elektronen als het 
protonentransport verzorgen Eukaryotcn als bv Neurospora crassa. Bos taurus en Homo 
sapiens hebben een gecompliceerder complex I bestaande uit respectievelijk >35, >42 en 
nogmaals >42 subeenheden Op dit moment zijn alle 42 subeenheden van Bos taurus 
gekarakteriseerd op cDNA- en aminozuurniveau De sterke homologie tussen complex I 
eiwitten van de koe en de mens is gebruikt om de equivalenten van deze eiwitten bij de mens 
te karakteriseren Momenteel zijn alle 42 humane subeenheden gekaraktenseerd, waarvan 18 
door onze onderzoeksgroep Van deze 18 subeenheden, staan er 14 in dit proelschnll 
beschreven (hoofdstuk 4, 5, 6, 7 en 8) 
Nadat de cDNA structuur van deze kemgecodeerde complex I subeenheden opgehelderd was, 
werd een start gemaakt met mutatie analyse studies in onze patiëntengroep De biochemische 
enzym assay welke gebruikt werd om de complex I activiteit in fibroblasten te bepalen, is 
gebaseerd op meting van de omzetting van NADH naar NAD+ in een geïsoleerde 
mitochondnele eiwitfractie, m aanwezigheid van een ubiquinon-analoog in aan- en 
afwezigheid van de specifieke complex I remmer rotenon Dit impliceert dat een verlaagde 
activiteit van complex I vastgesteld met behulp van deze assay in wezen een stoornis in het 
transport van elektronen van NADH naar ubiquinon weerspiegelt Het flavoproteine (FP) deel 
en het ijzerzwavel proteïne (IP) deel welke op een na alle bekende katalytische centra van 
complex I bevatten, werden geselecteerd voor mutatie analyse studies In dit proefschrift staan 
de resultaten van de op cDNA niveau uitgevoerde mutatie detectie studies, van subeenheden 
aanwezig in de IP fractie, beschreven 
Mutatie analyse studies van subeenheden van de IP fractie van complex I. 
Indien men complex I fragmenteert met chaotrope agentia, kan men dne subfracties 
onderscheiden de genoemde flavoproteine fractie en de ijzerzwavel proteïne fractie, welke 
tezamen het deel van complex I vormen dat uitsteekt in de mitochondnele matrix, en de 
hydrofobe proteïne fractie die het membraan deel van complex I vormt 
De ijzerzwavel proteïne fractie bestaat uit de volgende zeven of acht eiwitten de NDUFS1-6, 
de NDUFS8 en de NDUFA5 (de aanwezigheid van het NDUFS8 eiwit in deze fractie is 
onderwerp van discussie) Bekend is dat hel NDUFS1 eiwit ten minste twee ijzerzwavel 
cluster bindingsplaatsen bevat, de NDUFS8 mogelijk ook twee, en de NDUFS2 zou belrokken 
zijn bij het binden van ubiquinon en rotenon Bij het rund is onlangs bewezen dat het 
NDUFS4 eiwit via een cAMP gereguleerde proteïne kinase gefosforyleerd wordt Dit eiwit 
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bevat in het C-terminale deel een consensus fosforyleringsplaats die geconserveerd is in /V 
crassa en de mens Deze fosforylermgsplaatsen hebben vaak een regulerende tunctie Van de 
overige eiwitten is in functioneel opzicht nog niets bekend Mutatie analyse studies dmv 
RT PCR gecombineerd met DNA sequentie-analyse van alle acht bovengenoemde 
subeenheden in onze patiëntengroep leverden de volgende resultaten op 
Als eerste werd een homozygote duplicatie van vijf baseparen gevonden in het NDUFS4 gen 
van een mannelijke patient die presenteerde met ernstig braken, groeiachterstand en spier 
hypotonie op een leeftijd van 8 maanden Dit beeld verslechterde progressief tol de dood 
volgde op een leettijd van 16 maanden De NDUFS4 subeenheid is een eiwit bestaande uit 
175 aminozuren waarvan studies gedaan met rund complex I hebben aangetoond dat deze een 
tAMP gereguleerde fosforyleringsplaats bevat De duplicatie bevindt zich direct na base 470 
van het cDNA Het gevolg van deze duplicatie is dat door de ontstane "frameshilt", de 18 C 
terminale aminozuren van het eiwit veranderen (met verlies van de consensus 
fosforyleringsplaats) Bovendien verdwijnt door de "frameshift" het reguliere stopcodon, 
zodat translatie verder gaat lot een volgend stopcodon, hetgeen resulteert in een eiwit dat 14 
aminozuren langer is Met behulp van Polyacrylamide gel electroforese werd de homozygote 
aanwezigheid van de duplicatie in het nDNA van de index patient bevestigd Beide ouders 
bleken heterozygoot te zijn voor de duplicatie en het niet aangedane broertje bleek de mutatie 
niet te hebben Dit is de eerste mutatie ooit gevonden in een kerngecodeerde subeenheid van 
complex I Details van deze studie slaan beschreven in hoofdstuk 8 van dit proefschrift 
De tweede mutatie in een kerngecodeerde subeenheid van complex I werd gevonden in het 
NDUFS8 gen Het open reading frame van de NDUFS8 bestaat uit 633 baseparen coderend 
voor 210 aminozuren Het betrof een patient lijdend aan het syndroom van Leigh, die 
presenteerde op een leeftijd van 5 weken met voedingsproblemen en perioden van apnoe en 
cyanose Ook deze patient vertoonde een progressief ziektebeloop en overleed op een leeftijd 
van 11 weken als gevolg van cardiorespiratoir falen Bij het syndroom van Leigh was eerder 
reeds vastgesteld dal een geïsoleerde complex I deficiëntie een van de belangrijkste oorzaken 
is, echler genetische oorzaken waren nooit aangetoond In de bovengenoemde patient werden 
twee puntmutaties in het NDUFS8 cDN A aangetroffen Het betrof een C236T mutatie leidend 
tot aminozuursubstitutie van proline naar leucine op positie 79 en een G305A mutatie leidend 
tot substitutie van arginine naar histidine op positie 102 Restnctie-enzym analyse bevestigde 
dat beide mutaties bij deze patient in verschillende allelen voorkwamen De vader van dit kind 
bleek drager van de C236T mutatie evenals het oudste broertje, de moeder was draagster van 
de G305A mutatie evenals het jongere zusje Het jongste broertje bleek geen van beide 
mutaties te bezitten Deze mutaties zijn de eerste ooit gevonden in een kerngecodeerde 
subeenheid van complex I in een patient met het syndroom van Leigh De resultaten van deze 
studie staan beschreven in hoofdstuk 9 van dit proefschrift 
Sequentie-analyse van hel NDUFS2 cDNA (open reading frame van 1392 baseparen coderend 
voor 463 aminozuren) in onze patiëntengroep leverde opnieuw mutaties op Het betrof hier 
drie families waarvan de ouders in twee families verwant waren De eerste familie bestond uit 
drie kinderen waarvan de laatste twee (een jongen en een meisje) leden aan een geïsoleerde 
complex I deficiëntie Het oudste kind is tot heden gezond In beide aangedane kinderen 
vonden we een homozygote G683A mutatie die leidt tot substitutie van arginine naar 
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glutamine op positie 228 Beide kinderen leden aan een progressieve encefalomyopathie met 
hypertrofische cardiomyopathie en opticus atrofie en overleden op een leeftijd van 
respectievelijk 24 en 18 maanden De mutatie werd bevestigd op nDNA niveau met behulp 
van restrictie-enzym analyse en was homozygoot aanwezig in beide index patiënten, 
heterozygoot in beide ouders en afwezig in het gezonde oudste kind 
In een tweede familie werd eveneens een mutatie gevonden in het NDUFS2 gen Het betrof 
hier een patientje dat leed aan een neonatale hypertrofische cardiomyopathie en lactaal 
acidose Hel kind overleed vier dagen na de geboorte als gevolg van cardiorespiratoir falen In 
hel NDUFS2 cDNA van deze patient werd een homozygote C686A mutatie gevonden leidend 
tot substitutie van proline in glutamine op positie 229 Restrictie-enzym analyse op nDNA 
niveau bevestigde dat de patient homozygoot is voor de mutatie en dat beide ouders 
heterozygoot zijn In het gezin zijn verder geen kinderen 
De derde familie bestaat uit vier kinderen waarvan de eerste drie (allen jongens) leden aan een 
complex I deficiëntie Het vierde kind werd gezond geboren na eiceldonatie Alle dne de 
aangedane kinderen leden aan een beeld van progressieve encefalomyopathie en overleden 
twee tot drie jaar na de geboorte In het tweede kind werd bij sequentie-analyse van het 
NDUFS2 cDNA een homozygote T1237C mutatie gevonden (leidend tot substitutie van senne 
in proline ter hoogte van aminozuurpositie 413) Beide ouders bleken heterozygoot te zijn 
voor de mutatie Helaas was van de andere kinderen geen DNA ol RNA beschikbaar 
Alle drie de mutaties resulteren in de substitutie van aminozuren die door de evolutie heen in 
vele soorten geconserveerd zijn, wat een indicatie is voor het functionele belang van deze 
aminozuren De resultaten van deze mutatie analyse studie slaan beschreven in hoofdstuk 10 
van du proefschrift Alle gevonden mutaties (hoofdstuk 8, 9 en 10) zijn uitgesloten in een 
grote controle populatie 
cDNA amplificatie gevolgd door sequentie-analyse van de overige subeenheden van de IP 
fractie, NDUFS1, NDUFS3, NDUFS5, NDUFS6 en NDUFA5, leverde geen ziekte 
veroorzakende mutaties op De resultaten van deze studies staan beschreven in hoofdstuk 5 en 
11 van dit proefschrift 
Mutatie analyse studies met NDUFAI en NDUFB6 cDNA en chromosomale lokalisatie 
van het NDUFS2, NDUFS3, NDUFS4 en NDUFS5 gen. 
Tenslotte hebben we nog het cDNA bestudeerd van twee subeenheden aanwezig in de 
hydrofobe fractie, namelijk NDUFAI en NDUFB6 De NDUFAI subeenheid is momenteel 
hel enige complex I eiwit waarvan het bekend is dat het gen gelegen is op het X-chromosoom 
Het feit dat het merendeel van onze complex I patiënten uit mannen bestaat, wijst op 
mogelijke betrokkenheid van een X-gekoppelde factor We hebben om die reden de 
chromosomale lokalisatie bepaald van 4 genen coderend voor complex I subeenheden 
beschreven in dit proefschrift, namelijk de NDUFS2, NDUFSJ, NDUFS4 en NDUFS5 Op dit 
moment is de chromosomale lokalisatie van 30 van de 35 kemgecodeerde subeenheden van 
complex I bekend, wat een random verdeling over de chromosomen laat zien Mutatie analyse 
van het NDUFAI en NDUFB6 cDNA leverde geen mutaties op in onze patiënten De 
resultaten van deze studies staan beschreven in hoofdstuk 3 en 4 van dit proefschrift 
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Conclusies en toekomst. 
Als eerste stap in de opheldering van de veronderstelde nucleair-genetische oorzaken bij 
kinderen met een geïsoleerde complex I deficiëntie hebben we alle onbekende nucleair 
gecodeerde eiwitten van complex I gekarakteriseerd Mutatie analyse studies van het cDNA 
van de complex I subeenheden aanwezig in de ijzerzwavel proteïne fractie, leverde mutaties 
op in vijf families Alle mutaties zijn gelegen in genen coderend voor subeenheden die sterk 
geconserveerd zijn gedurende de evolutie wat hel belang van deze subeenheden illustreert 
Verder cosegregeerden alle mutaties in de families en werden ze uitgesloten in een grote 
controlepopulatie, hetgeen populatiepolymorfismen onwaarschijnlijk maakt Toekomstige 
expressiestudies moeten de pathogeniciteil van de gevonden mutaties definitief bewijzen 
Eveneens moeten de frequentie van deze mutaties, alsmede de betrokkenheid van mogelijke 
andere mutaties binnen deze gemuteerde subeenheden in een grote groep complex I deficiente 
patiënten bepaald worden Het vinden van genetische oorzaken leidt tot een meer betrouwbare 
genetische counseling in het algemeen en prenatale diagnostiek in het bijzonder 
Op dit moment zijn alle 15 bekende kemgecodeerde subeenheden van complex I onderzocht 
op de aanwezigheid van mutaties in onze patiëntengroep Dit bracht in ±40% de genetische 
oorzaak aan het licht Hoe nu verder om in de overige patiënten het genetische defect op te 
helderen9 Een van de mogelijkheden is hel creëren van complementdtiegrocpen waarbij 
patiënten die tot een bepaalde complementatiegroep behoren het defect in hetzelfde gen 
hebben liggen De techniek van "microcell-mediated chromosome transfer" stelt ons in staat 
om in zo'η complementatiegroep "gezonde" chromosomen eén voor éen in te brengen tot 
herstel van de complex I activiteit optreedt, waardoor vastgesteld wordt op welk chromosoom 
het gemuteerde gen ligt Een aantal technieken als "deletion mapping" en 
positioneel/functioneel doneren stellen ons dan in staat om het gemuteerde gen op te sporen 
Naast het ophelderen van het genetische defect in complex I deficiente patiënten, zijn studies 
naar de pathofysiologische consequenties van deze mutaties van uitermate groot belang 
Factoren die een rol spelen bij de pathofysiologie van complex I deficiëntie zijn onder andere 
een verminderde ATP productie, een verlaging van de mitochondnele membraanpotentiaal, 
radikaalvorming en een gestoorde cellulaire calciumhuishouding Hopelijk leidt meer inzicht 
in deze processen uiteindelijk tot een rationele therapie waar patiënten profijt van hebben 
Genezing van deze patientjes is immers het uiteindelijke doel 
De conclusies en toekomstperspectieven staan beschreven in hoofdstuk 12 van dit 
proefschrift 
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Summary. 
Introduction. 
Many biochemical reactions take place within human cells Some of these reactions run 
spontaneously, because conditions after the reaction are energetically favourable with respect 
to conditions betöre In this case, the reaction's free energy (AG) is negative Other 
biochemical reactions do not run spontaneously because they are energetically unfavourable 
(AG is positive) A biochemical energetically unfavourable reaction can run when it is linked 
to a biochemical favourable reaction The sum of these reactions then results in a negative AG 
Within cells, reactions with a positive AG are often linked to the hydrolysis of adenosine 
triphosphate (ATP) The AG ol this latter reaction is -7 3 kcal/mol Thcrelore ATP is often 
called the energy source ot human cells The free energy of an ATP molecule is situated in its 
phosphoanhydnde bond Hydrolysis of this bond results in the release of free energy, which 
(when unused) is released as heat However, many enzymes can use this energy to make 
energetically unfavourable reactions possible 
ATP can be synthesised from many food components, with as main contributors glucose and 
fatly acids After glucose is taken up by the cell, it is degraded in three stages glycolysis, 
citric acid cycle and oxidative phosphorylation After entering the cell, fatty acids are 
converted into acyl-CoA and can be transported in the form of a carnitine ester into 
mitochondria, where they are further oxidised by a process which is called ß-oxidation This 
ß-oxidalion eventually results in the same substrate as degradation of glucose does, namely 
acetyl CoA, which can enter the cilnc acid cycle Glycolysis takes place in the cytosol of the 
cell, the citric acid cycle and oxidative phosphorylation take place in mitochondria During 
glycolysis, ß-oxidation and citric acid cycle, the substrates (NADH and FADH->) are formed 
for the last stage of energy production oxidative phosphorylation 
The oxidative phosphorylation (OXPHOS) system, which is localised in the inner 
mitochondrial membrane, is composed of five enzyme complexes Complex I to IV transport 
electrons Irom NADH and FADH2 to oxygen The energy that is released by the transport ol 
these electrons is conserved by the simultaneous transport of protons from the mitochondrial 
matrix into the intermembrane space This transport results in an electrochemical gradient, 
which is used by the hfth complex (ATP synthase) to generate ATP 
Some children are born with a disturbance of one or more enzyme complex(es) of the 
OXPHOS system Cells of these children are therefore incapable to meet their need for ATP 
This expresses (amongst others) as serious multiple-organ disease, with most prominent 
involvement of organs with high-energy demands like heart, central nervous system and 
skeletal muscle The research described in this thesis, focuses on children with a disturbance 
in the first complex ol the OXPHOS system NADH ubiquinone oxidoreductase (complex I) 
Complex I transports electrons from NADH to ubiquinone and simultaneously to this electron 
transport, protons are translocated across the inner mitochondrial membrane to the 
intermembrane space Because of this, complex I contributes to the electrochemical 
protongradienl across the inner membrane of mitochondria, which is used by complex V to 
synlhesise ATP In humans, complex I exists ol at least 42 different proteins, of which seven 
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are encoded by the mitochondrial DNA (mtDNA). The remainder are encoded by nuclear 
DNA (nDNA). 
Patientgroup. 
The overall capacity of the oxidative phosphorylation system with regard to the production of 
ATP from several substrates, as well as the oxidation rates of substrates can be measured in 
several tissues (like cultured skin fibroblasts, skeletal muscle, brain, heart and liver tissue) of 
patients suspected to suffer from a disturbance in the cellular energy production. Furthermore, 
it is possible to measure the enzyme activity of the individual complexes of this system. 
We selected 27 patients suffering from an isolated complex I deficiency (measured in all cases 
in cultured skin fibroblasts and in the majority of these patients also in skeletal muscle tissue). 
The sex distribution showed a strong male preponderance: 3.3 : I. Clinical characterisation of 
these patients resulted in a classification into six subgroups. A large part of the patients 
suffered from Leigh syndrome (26%). A similar percentage suffered from a syndrome, which 
has strong resemblance to Leigh syndrome (22%; Leigh-like syndrome), however autopsy has 
not been performed in these patients, which could have confirmed the diagnosis Leigh 
syndrome. Furthermore, a part of our isolated complex 1 deficient patients suffered at birth 
from a hypertrophic cardiomyopathy and lactic acidosis (11%; NCLA) or fatal infantile lactic 
acidosis (11%; FILA). Finally, a small part of our patients suffers from macrocephaly and 
progressive leukodystrophy (7%; MLD). In a substantial part of our patients it was not 
possible to specify an encephalomyopathy (unspecified encephalomyopathy (UE); 22%). 
Frequent symptoms observed in our patient group are: hypotonia; psychomotor retardation; 
respiratory disturbances; epilepsy; feeding problems; pyramidal signs; nystagmus and 
cardiomyopathy. Mean age of disease presentation within our patientgroup was 4.6 months. 
The mean survival interval after disease presentation was 8.6 months. All but five children 
died within the first five years of life, 67% died within the first two years. The clinical 
characteristics of our patient group are described in chapter 2 of this thesis. 
Since there are no successful therapeutic possibilities for these children available, it is of 
utmost importance to find the genetic causes, which will give us the opportunity to offer 
adequate genetic counselling and prenatal diagnostics. On the basis of the high percentage of 
consanguinity (26%) and the distribution of affected and non-affected children within families 
with isolated complex I deficient patients, the inheritance pattern seems to be autosomal-
recessive. Furthermore, recent literature revealed that common mtDNA mutations, which can 
result in OXPHOS disturbances, are usually not present in children with such a disease. In our 
patientgroup, major rearrangements of mtDNA are excluded with the long mtDNA template 
polymerase chain reaction (PCR) technique. Furthermore, eleven common pathogenic mtDNA 
mutations have been excluded by means of PCR combined with restriction enzyme analysis. 
The factors mentioned in this paragraph concerning the possible genetic origin of isolated 
complex I deficiency in our patient group, make mutations in the nuclear DNA compared to 
mutations in the mtDNA, more likely. An important group candidate genes are therefore the 
nuclear genes, which encode subunits which are part of complex I. Before mutational analysis 
studies could be performed in our patientgroup, we had to elucidate the cDNA and amino acid 
sequence of these nuclear encoded subunits. 
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Characterisation of human complex I subunits. 
Prokaryotic complex I is generally considered to be the minimal functional version of this 
enzyme complex It consists of fourteen subunits, which together take care of the electron-
and protontransport Eukaryotes like Neurospora crassa, Bos taurus and Homo sapiens have a 
more complicated complex I, consisting of >35, >42 and again >42 subunits, respectively At 
this moment, all 42 subunits of Bos taurus have been charactensed at cDNA and amino acid 
level The strong resemblance between subunits of cow and humans has been used to 
characterise the human equivalents of these bovine subunits Currently, all 42 human subunits 
have been characterised, of which 18 by our researchgroup Of these latter subunits, 14 are 
described in this thesis (chapter 4, 5, 6, 7 and 8) 
When the cDNA structure of all nuclear encoded complex I subunits was elucidated, we 
started with mutational analysis studies within our patient group The biochemical enzyme 
assay we used to measure the complex I activity in fibroblasts, is based on the conversion of 
NADH to NAD+ in an isolated mitochondrial protein fraction in the presence ol a ubiquinone 
analogue and in presence or absence of the specific complex I inhibitor rotenone This 
implicates that a reduced complex 1 activity according to this assay actually reflects a 
disturbance in the transport of electrons trom NADH to ubiquinone The flavoproteine (FP) 
fraction and the iron-sulphur protein (IP) fraction, which contain all but one known catalytic 
centres of complex I, were selected for mutational analysis studies In this thesis the results of 
these studies (at cDNA level) are described 
Mutational analysis studies of subunits present in the IP fraction of complex I. 
It is possible to fragment complex I with chaotropic agents, which results in three 
subtractions the previously mentioned flavoprotein (FP) and iron-sulphur protein traction, 
which together constitute the part of complex I which protrudes into the mitochondrial matrix, 
and a hydrophobic protein fraction (HP), which largely forms the membranous part of 
complex I 
The iron-sulphur protein fraction consists of seven or eight proteins NDUFS1-6, NDUFS8 
and NDUFA5 (the presence of the NDUFS8 subumt in this fraction is subject of debate) It is 
known that the NDUFS1 subumt contains at least two iron-sulphur cluster bindings sites, the 
NDUFS8 possibly also two and the NDUFS2 is hypothesised to participate in ubiquinone and 
rotenone binding Recently, it was found that the NDUFS4 subumt of Bos taurus is 
phosphorylated by a cAMP dependent protein kinase The NDUFS4 contains a consensus 
phosphorylation site in the C-terminal part ot the protein, which is conserved in iV crassa and 
humans These phosphorylation sites often have a regulating function Currently, nothing is 
known of the function of the other proteins present in the iron-sulphur protein fraction 
Mutational analysis studies by means of RT-PCR and DNA sequence analysis of these eight 
subunits revealed the following results 
The first mutation we found was a homozygous 5 bp duplication in the NDUFS4 gene of a 
male patient who presented at the age of eight months with serious vomiting, failure to thrive 
and muscle hypotonia The clinical course was rapidly progressive, until the child's death at 
the age of 16 months The NDUFS4 protein consists of 175 amino acids As mentioned 
previously, the bovine equivalent of the NDUFS4 subumt contains a cAMP regulated 
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phosphorylationsite. The duplication is present directly after cDNA base 470. The results of 
this duplication (due to the frameshift) for the translation product are change of the 18 
C-terminal amino acids (with destruction of the cAMP consensus phosphorylationsite) and 
destruction of the stopcodon, which theoretically results in elongation of the translation 
product until the next inframe stopcodon, which elongates the NDUFS4 in this patient with 14 
amino acids. We confirmed the homozygous presence of the duplication in the nuclear DNA 
(nDNA) of the index patient with Polyacrylamide gel electrophoresis. Both parents were 
heterozygous for the duplication while nDNA of the healthy sibling only contained wildtype 
alleles. This duplication was the first mutation found in a nuclear gene encoding a subunit of 
complex I. Details of this study are described in chapter 8 of this thesis. 
The second mutation we found in a nuclear encoded subunit of complex I was located in the 
NDUFS8 subunit. The open reading frame (ORF) of the NDUFS8 cDNA contains 633 base 
pairs, encoding 210 amino acids. It concerned a patient who suffered from Leigh syndrome, 
who presented at the age of 5 weeks with feeding difficulties and periods of apnoea and 
cyanosis. This patient expressed a progressive clinical course and died at the age of eleven 
weeks as a consequence of cardiorespiratory failure. Isolated complex I deficiency was 
previously recognised as a frequent cause of Leigh syndrome, however genetic links had never 
been found. We found two compound heterozygous mutations in the NDUFS8 cDNA of the 
patient described in this paragraph. It concerned a C236T mutation leading to the substitution 
of proline into leucine at position 79 and a G305A mutation leading to the substitution of 
arginine to histidine at position 102. Restriction enzyme analysis performed with amplified 
NDUFS8 cDNA of this patient confirmed that both mutations were located on different 
alleles. The father of this child is carrier of the C236T mutation just as the younger brother, 
while the mother is carrier of the G305A mutation just as the younger sister. The youngest 
brother does not contain either of the two mutations. These mutations were the first to be 
found in a nuclear encoded subunit of complex I in a patient with Leigh syndrome. The results 
of this study are described in chapter 9 of this thesis. 
Sequence analysis ol the NDUFS2 cDNA (ORF of 1392 base pairs encoding 463 amino acids) 
in our patientgroup again revealed mutations. These mutations were encountered in three 
families, of which two were known with consanguinity. The first family consisted of three 
children, of whom the latter two suffered from isolated complex I deficiency. The oldest child 
is currently alive and healthy. Both complex I deficient children contained a homozygous base 
substitution in their NDUFS2 cDNA (G683A) leading to the substitution of arginine into 
glutamine at position 228. Both children suffered from a progressive encephalomyopathy, 
hypertrophic cardiomyopathy and optic atrophy and died at the age of 24 and 18 months, 
respectively. The mutation was confirmed to be homozygously present in the nuclear DNA of 
both patients by means of restriction enzyme analysis, while both parents turned out to be 
heterozygous for the mutation, and the healthy child contained only wildtype alleles. 
We found a homozygous C686A mutation leading to the substitution of proline into glutamine 
at position 229 in a complex I deficient child of a second family. The child suffered from a 
neonatal cardiomyopathy and lactic acidosis and died 4 days after birth of cardiorespiratory 
failure. Restriction enzyme analysis with amplified nDNA fragments confirmed the presence 
of the homozygous mutation in the patient, while both parents turned out to be heterozygous 
190 
English summary 
carriers. There were no other siblings in this family. 
The third family consisted of four children, of whom the oldest three (all boys) suffered from 
isolated complex I deficiency. The fourth child was born healthy after egg cell donation. All 
three affected children suffered from a clinical phenotype of progressive encephalomyopathy 
and died two to three years after birth. We found in the second affected child by means of 
sequence analysis with amplified NDUFS2 cDNA a homozygous T1237C mutation leading to 
the substitution of serine into proline at amino acid position 413. This mutation was also 
homozygously present in the nDNA of this patient, while both parents are heterozygous 
carriers. Unfortunately, DNA and RNA of the other three children were unavailable. 
All three mutations result in the substitution of amino acids, which are highly conserved in 
many species during evolution, which is indicative for the functional importance of these 
amino acids. The results of these mutational analysis studies are described in chapter 10 of 
this thesis. All found mutations (chapter 8, 9 and 10) have been excluded in a large control 
population. 
cDNA amplification followed by sequence analysis of the other subunits of the IP fraction 
(NDUFS1, NDUFS3, NDUFS5, NDUFS6 and NDUFA5) did not reveal any disease causing 
mutations. The results of these studies are described in chapter 5 and 11 of this thesis. 
Mutational analysis studies of NDUFA1 and NDUFB6 cDNA and chromosomal 
localisation of the NDUFS2, NDUFS3, NDUFS4 and NDVFSS gene. 
Finally we checked the cDNA for mutations of two subunits present in the hydrophobic 
subfraction, namely the NDUFA1 and NDUFB6 subunit. The NDUFA1 subunit is presently 
the only complex I protein, whose gene is located on the X-chromosome. The fact that the 
majority of our complex I deficient patients is male, points to the possible involvement of an 
X-linked factor. For this reason we performed the chromosomal localisation of four genes 
encoding complex I subunits, namely the NDUFS2, NDUFS3, NDUFS4 and NDUFS5. At this 
moment the chromosomal localisation of 30 of the 35 nuclear encoded subunits of complex I 
is known, which shows a random distribution across the chromosomes. Mutational analysis 
studies of the NDUFA1 and NDUFB6 cDNA revealed no mutations within our patients. The 
results of these studies are described in chapter 3 and 4 of this thesis. 
Conclusions and future perspectives. 
As a first step in the elucidation of the hypothesised nuclear-genetic causes in children with an 
isolated complex I deficiency we characterised all unknown nuclear encoded subunits of 
complex I. Mutational analysis studies on cDNA level of the subunits present in the iron-
sulphur protein fraction revealed mutations in five pedigrees. All mutations are present in 
subunits that are highly conserved during evolution. All mutations cosegregated within the 
families and were excluded in a large control population, which makes the mutations being 
rare population polymorphisms unlikely. Future expression studies should prove the 
pathogenicity of the found mutations. Likewise the frequency of these mutations in a large 
group of complex I deficient patients as well as the presence of new mutations in these 
mutated subunits has to be investigated. The elucidation of genetic causes of complex I 
deficiency leads to a more accurate genetic counselling and prenatal diagnostics. 
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At this moment, all 35 known nuclear encoded subunits of complex I have been checked for 
mutations in our initial group of 20 isolated complex I deficient patients This revealed the 
genetic cause in -40% Which path should we follow next in order to elucidate the genetic 
cause in our remaining patients9 One of the possibilities is the generation of complementation 
groups (patients belonging to the same complementation group carry the genetic defect in the 
same gene) The technique of microcell-mediated chromosome transfer will give us the 
opportunity to introduce "healthy" chromosomes one by one in cells of patients belonging to 
the same complementation group When the introduction of a specific chromosome results in 
recovery of the complex I activity, the mutated gene is located on that specific chromosome 
Techniques like deletion mapping and positional/functional cloning give us the opportunity to 
locate the mutated gene 
Besides the elucidation of the genetic causes of complex I deficiency, studies of the 
pathophysiological consequences of this disease are very important Factors which play a role 
in the pathophysiology of complex I deficiency are amongst others diminished ATP 
production, reduction of the mitochondrial membrane potential, reactive oxygen species 
(ROS) formation and a disturbed cellular calcium maintenance Hopefully these studies lead 
to increased understanding of these processes, which may result in a rational therapy Cure of 
our patients is after all our final goal 
The conclusions and future perspectives are described in chapter 12 of this thesis 
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Dankwoord. 
Eindelijk ben ik bij het laatste en leukste deel van dit proefschrift aangekomen. Niet alleen 
leuk omdat nu eindelijk een eind komt aan dat eindeloze geram op mijn toetsenbord, maar 
ook omdat ik het leuk vind om mensen die (al dan niet bewust) een steentje hebben 
bijgedragen aan de totstandkoming van dit proefschrift persoonlijk te bedanken. Allereerst 
wil ik mijn geweten zuiveren door mijn excuses aan te bieden aan eenieder die hier niet 
genoemd wordt en wel genoemd had moeten worden. 
Ouders en patientjes. Allereerst wil ik alle ouders en patientjes bedanken voor hun 
medewerking. Zonder hun welwillende hulp zal het onderzoek op welk vakgebied dan ook 
altijd in de kinderschoenen blijven staan. 
Promotor Prof. dr. ir. JMF Trijbels. Geachte prof. Trijbels, ik wil u graag bedanken voor het 
feit dat u me drie jaar geleden de gelegenheid bood om mijn "onderzoekskunsten" te mogen 
komen vertonen op uw laboratorium. Uw grote kennis met betrekking tot de mitochondriële 
myopathieën hebben mijn onderzoek enorm vooruit geholpen. Dankzij uw grote kennis van 
de Engelse en Nederlandse taal heeft u menig spel- en grammaticafout in mijn artikelen en 
andere schrijfsels getraceerd en geëlimineerd. Verder hebt u zonder al te veel succes drie jaar 
tegen mij gezegd dat u getutoyeerd wil worden en aangesproken wil worden met Frans in 
plaats van professor Trijbels. Daar wil ik op dit moment dan toch verandering in brengen. 
Dus: Frans bedankt! 
Prof. dr. RCA Sengers. Geachte prof. Sengers, zonder uw steun had dit proefschrift nooit het 
levenslicht gezien. U hebt samen met prof. Trijbels het huidige centrum voor mitochondriële 
ziekten in Nijmegen opgericht en zo de basis gelegd voor het in dit proefschrift beschreven 
onderzoek. Uw grote kennis met betrekking tot dit vakgebied alsmede uw nimmer aflatend 
enthousiasme en steun voor wetenschappelijk onderzoek in het algemeen en mitochondriële 
encefalomyopathieën in het bijzonder hebben mijn onderzoek een grote sprong voorwaarts 
doen maken. Ook wil ik u bedanken voor de steun die ik van u ontvangen heb bij mijn 
overstap van het laboratorium werk naar de klinische Kindergeneeskunde. 
Copromotor dr. JAM Smeitink. Beste Jan, een jaar of vijf geleden klopte ik voor het eerst op 
jouw deur (destijds stond die deur nog in Utrecht). We werkten samen aan een project 
betreffende de toepasbaarheid van de orale glucose tolerantie test bij kinderen verdacht van 
een ademhalingsketendefect. We hebben daar destijds zelfs een artikel uit gedestilleerd 
(moeten we toch eens opsturen). Daarna vertrok jij naar Nijmegen. Ook daar bleef ik je lastig 
vallen met verzoeken om gezamenlijke projecten uit te voeren. Uiteindelijk gaf je gehoor aan 
deze verzoeken en bood je mij de kans om binnen de subafdeling Metabole ziekten 
promotieonderzoek te komen verrichten. Daar ben ik je uiteraard nog steeds enorm 
dankbaar voor. Ik heb je leren kennen als iemand die met buitenaardse gedrevenheid zijn 
vak uitoefent, nooit nee zegt wanneer men met een zinnig verzoek komt en wat ik het 
allerbelangrijkste vind, je bent een man van je woord. Verder heb je grote diplomatieke en 
organisatorische kwaliteiten die eenieder van ons grote voordelen opgeleverd hebben 
(buitenlandse congressen, stageplaatsen etc.) en in de toekomst op zullen leveren. 
Jan, bedankt voor alles. Ik hoop dat we nog vele jaren zaken kunnen doen. 
Copromotor dr. LP van den Heuvel. Beste Bert, drie jaar geleden kwam Jan aanzetten met 
een student die hij nog kende vanuit Utrecht en die op jouw deel van het laboratorium LKN 
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geplaatst moest worden Geneeskunde student nog wel, lab ervaring nul Ik wil je bedanken 
voor het feit dat je je gezonde scepsis opzij hebt gezet en mij de gelegenheid hebt gegeven 
om onderzoek te komen doen Ik heb veel respect voor de manier waarop jij vele AIO's en 
promovendi begeleidt op verschillende vakgebieden Ondanks de vele commissies waar je 
zitting in hebt konden wij altijd bij je terecht voor vragen, verzoeken of gewoon een potje 
klagen Je grote kennis van DNA- en eiwitonderzoek vormt het fundament waarop ons 
onderzoek is gebouwd Bert, bedankt voor alle hulp 
Roel "de Loer" Smeets. Beste Roel, drie jaar geleden kreeg JIJ mij in de maag gesplitst Jij 
moest mij binnen drie weken inwijden in de DNA geheimen Dit heeft uiteindelijk drie jaar 
geduurd, en nog steeds kan ik niet zonder jou hulp Gezamenlijk zijn we gestart met ons 
onderzoek (zo zie ik het toch een beetje) en het eerste deel wordt met dit boekje afgerond Ik 
wil je bedanken voor alle hulp die je verleend hebt en het geduld waarmee je al mijn stomme 
vragen hebt beantwoord Het is vanzelfsprekend dat JIJ één van de twee paranimfen bent 
Het feit dat we over een soortgelijke humor beschikken (die overigens door veel mensen niet 
als humor bestempeld wordt, maar dat terzijde), leverde vele, door sommigen onbegrepen, 
lachsalvo's op Ik hoop dat we in de toekomst nog vele malen gezamenlijk gaan stappen, 
niet meer als collega's maar als vrienden 
Ralf "de Rug" Triepels. Beste Ralf, als medepromovendus op het gebied van complex I zaten 
we dicht bij elkaar m het onderzoeksvaarwater Dat leidde soms wel eens tot kleine 
meningsverschillen maar door de bank genomen hebben wij de zaken prima opgelost De 
vele therapeutische gesprekken die we voerden in de Radboudschool deden ons beider 
nachtrust goed Je "recht voor zijn raap" humor heeft vele malen geleid tot hilarische 
taferelen waardoor de stemming er op en buiten het werk altijd goed in zat Ik wens je alle 
succes met het verdere verloop van je onderzoek en wanneer je hulp nodig hebt weet je me 
te vinden 
Cariti Buskens. Beste Cann, ik wil jou speciaal bedanken voor alle keren dat je mij veilig en 
wel in Oss afzette na een avondje stappen met alle lab collega's ledere keer wanneer ik weer 
eens vroeg om mee te mogen rijden, zei je altijd direct ja Hartstikke bedankt daarvoor' 
De squash bende. Roel, Maarten "Koning P" Smit, Erik "de Knaning" Stevens, Erwin, en Ralf 
Twee jaar hebben we aan onze conditie gewerkt op de squashbaan Ik zal het hardwerkende 
XAT personeel en onze stimulerende gesprekken na het squashen missen 
DNA lab en AIO's. Ik wil graag alle mensen van het DNA lab waar ik mee heb 
samengewerkt bedanken voor alle hulp en gezellige uitstapjes die we samen gemaakt 
hebben Dit was zonder meer de gezelligste werkplek waar ik tot nu toe gepositioneerd ben 
geweest' Belinda, Cann B, Erik J, Enk S, Henk van D, Henny, Iwan, Jacqueline, Kann A, 
Karin L, Lambert, Leo, Lydia, Maarten, Manlio, Marieke, Markus, Marije, Marjan, 
Maroushka, Nathalie, Peter, Roel, Ralf, Raoul, Sandra, Sander, Sandy en de studenten 
Anouk H, Bianca, Cicilia, Gijs, Gracia, Joep, Liesbeth, Martine van Β, Nicole 
Anouk en Jorrit. Bedankt voor jullie inzet tijdens jullie onderzoeksstages op het gebied van 
complex I Anouk, dat je maar een goede kinderdokter mag worden' 
Spiergroep en Weefselkweek. Hoewel we zelf (deel van de DNA groep) ook tot de 
spiergroep behoren wordt nog steeds met deze naam de groep van de mitochondriele 
enzymdiagnostiek aangeduid Anneke, Antoon, Christine, Diana en Liesbeth, jullie werk 
vormt de basis van het mitochondriele onderzoek Bedankt voor alle hulp en voor het rustig 
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beantwoorden van al mijn vragen. Frans, Gera, Irma, Janette en Marianne, zonder jullie hulp 
wordt er geen cel gekweekt, geen streng DNA geïsoleerd, geen enzymbepaling gedaan. Het 
spreekt dus voor zich dat jullie werk van groot belang is geweest voor mijn onderzoek. 
Bedankt voor alle hulp bij het aanleren van de weefselkweek technieken. 
Lab K+N. Ik wil graag alle mensen van het laboratorium Kindergeneeskunde en Neurologie 
bedanken voor alle hulp. Dankzij de toegankelijkheid van alle deelgroepen zijn er grote 
mogelijkheden om binnen het lab nieuwe dimensies aan je onderzoek te geven. 
Mensen achter de schermen. Ik wil graag Anita Κ, Sandra E, Sandra S, Frans Ζ en Maja 
(prettig weekend!), bedanken voor al hun hulp. 
Vakgroep Biochemie Trigon. Janet, Peter en Werner enorm bedankt voor alle hulp die jullie 
gegeven hebben bij het calciumonderzoek. 
Sponsors. Ik wil graag alle sponsoren (Meubitrend BV te Oss, Sigma Tau Ethifarma B.V. te 
Assen, de stichting voor kinderen die wel willen maar niet kunnen en de FBW stichting van 
de afdeling Kindergeneeskunde van het Universitair Medisch Centrum St. Radboud, 
BIOzymTC BV te Landgraaf, Clean Air Techniek bv te Woerden, Genzyme BV te Naarden, 
Sigma-Aldrich te Zwijndrecht) bedanken voor hun genereuze bijdrage in de drukkosten van 
dit proefschrift. 
Familie en vrienden. Ik wil alle vrienden en familieleden bedanken die altijd belangstelling 
hebben getoond voor het wel en wee in onderzoeksland. Zonder jullie peptalks en gezellige 
avonden stappen was ik niet verder gekomen dan de introductie. Speciaal wil ik Sven 
bedanken waarmee ik 15 jaar lang door alle opleidingen heen trok. Het was voor mij 
duidelijk dat jij de tweede paranimf moest zijn. Roel en Sven, bedankt dat jullie ook op deze 
dag aan mijn zijde staan. 
Nu ik aan het eind van deze lange lijst ben aangekomen wil ik de aandacht vestigen op die 
mensen die het meest bijgedragen hebben aan de goede afloop van deze promotie: mijn 
zusjes Hélène en Riet en hun wederhelften Arien en Frank, voor hun grote belangstelling in 
de voortgang van het onderzoek en voor de nodige afleiding die zij mij gaven wanneer ik 
die het meest nodig had. Mijn vriendin Jany die altijd weer een luisterend oor had voor alle 
problemen binnen LKN. Tenslotte wil ik mijn ouders noemen die mij op alle fronten door 
dik en dun gesteund hebben. Jullie instelling van aanpakken in plaats van bij de pakken 
neer zitten heeft mij door vele moeilijke momenten heen geholpen. Het allerbelangrijkste is 
dat jullie deur op ieder tijdstip van de dag open staat voor goede raad of gewoon een beetje 
gezellig kletsen. Lieve ouders, bedankt voor alles! 
Jan. 
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Curriculum vitae. 
Johannes Lambertus Chnstianus Mana Loeffen werd geboren op 6 mei 1970 te Oss Na het 
voltooien van de opleiding VWO/J aan het Titus Brandsma Lyceum te Oss werd wegens 
uitloting voor de studie Geneeskunde aangevangen met de studie Gezondheidswetenschappen 
te Nijmegen In de loop van het studiejaar deed de gelegenheid zich voor over te stappen naar 
de studie Geneeskunde te Utrecht Hel doctoraal examen Geneeskunde werd in 1995 afgelegd 
wat gevolgd werd door het artsexamen in apnl 1997 Tijdens de opleiding tot arts 
participeerde hij in diverse wetenschappelijke projecten bij de afdeling Interne Geneeskunde 
(Diakonessenhuis te Utrecht), afdeling Kindergeneeskunde, subafdeling voedingsallergieen 
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Kindergeneeskunde en Neurologie (Universitair Medisch Centrum St Radboud) 
Van apnl 1997 tot en met december 1999 was hij als artsonderzoeker verbonden aan het 
Laboratorium voor Kindergeneeskunde en Neurologie (hoofd Prof dr ir JMF Tnjbels) en de 
subafdeling Metabole Ziekten (hoofd Dr JAM Smeitink) van de afdeling Kindergeneeskunde 
(hoold Prof dr RCA Sengers) van het Universitair Medisch Centrum St Radboud, alwaar 
het in dit proefschrift beschreven onderzoek is uitgevoerd Vanaf 1 apnl 2000 is hij 
teruggekeerd naar de klinische patiëntenzorg en werkt hij als arts bij de afdeling 
Kindergeneeskunde van het Universitair Medisch Centrum St Radboud te Nijmegen 
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